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I 
ABSTRACT 
SUMOylation is a posttranslational modification of proteins that is found in the 
eukaryotic kingdom, but not in bacteria or archeae. During this process, SUMO, 
the Small Ubiquitin related modifier protein, is covalently attached onto its targets 
via an enzymatic cascade. SUMOylation can prevent or induce other modifications 
of the substrate, can lead to conformational changes and generates or abolishes 
binding interfaces. SUMOylation can therefore change the localization, activity, 
interactions or life span of a protein. 
Although SUMOylation is vital in the model plant Arabidopsis thaliana (Saracco et 
al., 2007), only little is known about regulation and substrates of SUMO 
conjugation, as the temporary nature of this modification and the fact that only a 
small subset of substrate is modified at a given time, makes the study of 
SUMOylation in plants extremely difficult. 
In this work, several aspects of Arabidopsis SUMOylation are discussed: 
  
• An in vitro SUMOylation assay that utilizes plant recombinant proteins was 
developed. This system allows quick analysis of potential SUMOylation 
enzymes and substrates in vitro.  
 
• The features of a SUMO1 variant, SUMO1 Q90A, in which a conserved 
glutamine residue at position -4 from the carboxyl terminus is changed to 
alanine, were analyzed in vitro. It was shown that this mutant variant leads 
to increased conjugate stability towards Early in Short Days 4 (ESD4), a 
major SUMO protease of Arabidopsis. As SUMO1 Q90A did not differ 
during conjugation from the wild type SUMO1 in vitro, this variant might 
be a valuable tool for future experiments to generate SUMOylated proteins, 
which are easier to detect and to analyze due to increased stability. 
 
 
II Abstract 
• Analysis of the potential SUMO ligases PIAS-LIKE1 (PIL1) and PIAS-LIKE2 
(PIL2) indicated a slight contribution to bulk SUMO conjugation and only a 
minor role in flowering time regulation compared to the already well 
described SUMO ligase SIZ1, strengthening the importance of SIZ1 as 
major Arabidopsis SUMO ligase. 
 
• Plants with mutation in the SUMO protease ESD4 have growth defects with 
similarity to those of plants mutated in SIZ1. In contrast to siz1 mutants, 
however, the growth defect of esd4 mutants is not due to altered levels of 
the stress hormone salicylic acid. Furthermore, studies of the related SUMO 
protease Early in Short Days-Like1 (EL1) demonstrated that the latter 
enzyme does not localize to the nucleus if transiently expressed in Nicotiana 
benthamiana, and plays no obvious role in the regulation of flowering time, 
as el1 mutants flower at a time similar to wild type. However, an el1 
mutation in the background of ecotype Wassilwskija might cause an altered 
tissue composition in the shoot. 
 
• Analysis of the type III effector protein Factor X of the plant pathogen 
Xanthomonas campestris (in cooperation with Prof. Ulla Bonas and Robert 
Szczesny, University Halle) indicated no in vitro activity of this protein as 
SUMO, Rub1 or Ubiquitin protease. 
 
The broad variety of aspects discussed in this work emphasizes the importance 
and complexity of Arabidopsis SUMOylation and indicates that the understanding 
of this modification in plants can only be achieved by further studies and 
identification of in vivo SUMO substrates. In future the SUMOylation assay 
system, developed in this work, and the described SUMO1 Q90A variant might 
help to accomplish these tasks. 
 
 
III 
ZUSAMMENFASSUNG 
SUMOylierung ist eine post-translationale Proteinmodifikation, die bei 
eukaryotischen Organismen, nicht aber bei Bakterien oder Archeaen auftritt. 
Während dieses Prozesses wird SUMO, das Small Ubiquitin related modifier 
Protein, durch einen enzymatischen Zyklus kovalent an seine Zielproteine 
gebunden. SUMOylierung kann andere Modifikationen verhindern oder 
unterstützen, Konformationsänderungen hervorrufen oder Bindestellen für 
andere Interaktionspartner generieren oder zerstören. Folglich kann 
SUMOylierung die Lokalisation, Aktivität, Wechselwirkungen oder Lebenszeit 
des modifizierten Proteins verändern.  
Obwohl SUMOylierung für die Modellpflanze Arabidopsis thaliana 
überlebensnotwendig ist (Saracco et al., 2007), ist bisher nur wenig über ihre 
Regulation und die SUMO-Substrate bekannt. Die Erforschung der 
SUMOylierung in Pflanzen wird dadurch extrem erschwert, dass diese 
Modifikation nicht permanent ist und nur ein kleiner Teil des Substrates zu einem 
bestimmten Zeitpunkt modifiziert wird. 
In dieser Arbeit werden verschiedene Aspekte der SUMOylierung in Arabidopsis 
diskutiert: 
  
• Ein in vitro SUMOylierungsassay basierend auf pflanzlichen, 
rekombinanten Proteinen wurde entwickelt. Diese Methode erlaubt die 
schnelle Analyse potentieller SUMOylierungsenzyme und Substrate in 
vitro. 
 
• Die Eigenschaften eines mutierten SUMO1 mit Q90A Mutation, in dem ein 
konserviertes Glutamin an der Position -4 vom Carboxylterminus gegen 
Alanin ausgetauscht wurde, wurden ebenfalls in vitro analysiert. Es konnte 
gezeigt werden, dass diese mutierte Version von SUMO1 zu einer 
 
IV Zusammenfassung 
gesteigerten Stabilität der Konjugate gegen Early in Short Days 4 (ESD4), 
der wichtigsten SUMO-Protease in Arabidopsis, führt. Da sich SUMO1 Q90A 
in vitro während der Konjugation nicht vom ursprünglichen SUMO1 
unterscheidet, könnte diese Variante in zukünftigen Experimenten ein 
Werkzeug darstellen, um SUMOylierte Proteine zu erzeugen, die aufgrund 
ihrer erhöhten Stabilität leichter zu untersuchen sind. 
  
• Die Analyse der potentiellen SUMO-Ligasen PIAS-LIKE1 (PIL1) und PIAS-
LIKE2 (PIL2) impliziert sowohl einen geringen Effekt dieser Proteine auf 
die Häufigkeit an SUMO-Konjugaten in der Pflanze, als auch eine 
untergeordnete Rolle bei der Blühzeitpunktkontrolle im Vergleich zu der 
bereits gut beschriebenen SUMO-Ligase SIZ1, wodurch die Rolle von SIZ1 
als wichtigste SUMO-Ligase in Arabidopsis bestätigt wird. 
 
• Pflanzen mit einer Mutation der SUMO-Protease ESD4 haben einen 
ähnlichen Wachstumsdefekt wie Pflanzen mit einer Mutation von SIZ1. Im 
Gegensatz zu siz1 ist dieser Wachstumsdefekt jedoch nicht auf veränderte 
Level des Stresshormones Salicylsäure zurückzuführen. Darüber hinaus 
haben Untersuchungen der ähnlichen SUMO-Protease Early in Short Days-
Like1 (EL1) gezeigt, dass dieses Enzym bei transienter Expression in 
Nicotiana benthamiana nicht im Nukleus lokalisiert ist und dass es keine 
offensichtliche Rolle in der Regulation des Blühzeitpunktes spielt, da el1 
Mutanten zu einem ähnlichen Zeitpunkt wie der Wildtyp blühen. 
Allerdings scheint eine el1 Mutation im Ökotypen-Hintergrund 
Wassilewskija eine veränderte Gewebezusammensetzung im Spross 
hervorzurufen.  
  
 
V Zusammenfassung 
• Die Analyse des Typ III-Effektors Faktor X des Pflanzenpathogens 
Xanthomonas campestris impliziert, dass dieses Protein in vitro weder als 
SUMO-, noch als Rub1- oder als Ubiquitin-Ligase aktiv ist (in Kooperation 
mit Prof. Ulla Bonas und Robert Szczesny, University Halle). 
 
Die Bandbreite an Aspekten, die in dieser Arbeit besprochen wird, zeigt die 
Wichtigkeit und Komplexität der SUMOylierung in Arabidopsis auf. So wird 
deutlich, dass ein besseres Verständnis dieser Modifikation in Pflanzen nur durch 
weitere Untersuchungen und durch die Identifikation von SUMO-Substraten in 
vivo erreicht werden kann. In Zukunft könnten der in vitro SUMOylierungsassay, 
welcher in dieser Arbeit entwickelt wurde, und die beschriebene SUMO-Variante 
SUMO1 Q90A dabei helfen, dieses Ziel zu erreichen.  
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1 
1 INTRODUCTION 
During their development or as a response to biotic or abiotic influences from the 
environment, organisms have to control the activity of proteins. One way to adjust 
the abundance of proteins indirectly is the regulation of transcription, RNA 
processing and translation, to modify the synthesis of proteins. Another concept 
are post-translational modifications that alter the characteristics of already existing 
proteins. 
Often proteins are modified via the attachment of small groups to certain residues, 
for example phosphate or acetyl groups. Another way to alter proteins in 
eukaryotic organisms, which gets more and more into focus, is the covalent 
attachment of small proteins.  
A well-studied example for these regulatory proteins is Ubiquitin, but several 
protein modifiers have been found so far (Dohmen, 2004). As they usually share 
the typical Ubiquitin fold and are similarly attached to their substrates via an 
enzymatic cascade, they are named Ubiquitin-like proteins (Ubls). Different Ubls 
are believed to have distinct and diverse effects on their substrates.  
SUMO, the Small Ubiquitin-related Modifier protein, is one of these proteins. It 
plays an important role during development and response to environmental 
factors and modifies a vast abundance of substrates. Although SUMOylation is 
vital for most eukaryotic organisms, only little is known about this process in the 
model plant Arabidopsis thaliana. This work focuses on the enzymes involved in 
Arabidopsis SUMOylation, potential substrates and the development of an 
in vitro SUMOylation assay, which allows the analysis of plant recombinant 
proteins for their modification by SUMO and the detailed study of components of 
the enzymatic cycle of SUMOylation. 
 
  
2 Introduction 
1.1 SUMOylation 
1.1.1 SUMO 
SUMO was discovered independently in different studies in 1996. This explains, 
why it is found under many different names like “SMT3”, “Sentrin”, “Ubl1”, 
“PIC1” or “GMP-1”. As the most common term and the name that is used for the 
Arabidopsis proteins is “SUMO”, this notation is used in this work. 
SUMO, the Small Ubiquitin-related Modifier protein, belongs to the group of the 
Ubls, Ubiquitin-like proteins that share the typical beta grasp (ββαββαβ) fold of 
Ubiquitin (Dohmen, 2004). Like all known Ubls so far it is exclusively found in 
eukaryotic organisms, but absent in bacteria and archeae (Meulmeester & 
Melchior, 2008), although there seems to be an evolutionary link to proteins 
involved in bacterial Molybdenum metabolism (Dohmen, 2004). 
Unlike some other Ubls, SUMO has only a low sequence similarity of about 18% to 
Ubiquitin. It is also distinguished by a flexible N-terminal extension and differs in 
its surface charge. It was shown that human SUMO2 has a strongly negative 
region, while the corresponding area in Ubiquitin is neutral (Huang et al., 2004). 
Both protein modifiers have a di-glycine (Gly-Gly) motif at the carboxyl terminus 
and are attached to their substrate via a similar enzymatic cycle. 
 
 
1.1.2 The SUMOylation process 
Like Ubiquitin, SUMO is transferred onto its substrated via an enzymatic cascade 
that is similar to the different steps of Ubiquitylation.  
In Figure 1.1 a scheme of the SUMOylation cycle (in Arabidopsis thaliana) is shown. 
 
 
  
Figure 1.1: SUMOylation Cycle
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4 Introduction 
After thioester formation with the E2, two different possibilities exist: 
On the one hand, SUMO can be directly transferred onto its target proteins by the 
E2. This is the case, if the substrate has a so-called SUMOylation consensus 
sequence, a tetrapeptide consisting of the amino acids ΨKxE/D. In this motif a 
bulky hydrophobic amino acid, Ψ, is followed by the lysine to which the SUMO is 
attached, and after the spacer residue x the consensus motif ends with an acidic 
residue. It was shown that the E2 can bind at least a subset of substrates via this 
motif (Sampson et al., 2001). This recognition motif can be extended to the PDSM, 
the phosphorylation-dependent SUMOylation motif (ΨKxE/DxxSP), which 
contains an additional phosphorylation site in a defined distance or to the NDSM, 
the negatively charged amino acid-dependent SUMOylation motif that has 
negatively charged residues at position +3 to +6 from the consensus motif (Anckar 
et al., 2006; Hietakangas et al., 2006; Yang et al., 2006). 
On the other hand, motifs with no resemblance to the consensus sequence can be 
SUMOylated nevertheless. In this case, an additional SUMO ligase is needed, to 
promote SUMOylation by bringing the SUMO-E2 conjugate and the substrate in a 
favorable spatial relation.  
 
 
1.1.3 Mechanisms and interactions with other signaling pathways 
SUMOylation can alter the fate of its target proteins by different mechanisms. 
On the one hand, the SUMO moiety can block the lysine residue to which it is 
attached. So it can prevent other post-translational modifications like 
Ubiquitylation, acetylation or methylation (Meulmeester & Melchior, 2008). The 
SUMO protein can also block a potential binding side for another interacting 
protein, or on the other hand it can generate a binary binding site, which allows 
high-affinity interactions with another binding partner. The latter is often the case, 
if the interactor contains a so called SUMO Interacting Motif (SIM). This motif 
compromises the sequence V/I/L V/I/L x V/I/L or V/I/L x V/I/L V/I/L and is often 
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accompanied by a stretch of acidic amino acids. It can form a beta sheet with the 
second beta strand of the SUMO moiety either in parallel or anti-parallel (Hecker 
et al., 2006; Knipscheer et al., 2008; Meulmeester & Melchior, 2008; Perry et al., 
2008). 
These types of motifs were found in Ubiquitin ligases of different organisms, 
leading to their classification as SUMO targeted Ubiquitin ligases (StUbls). It was 
demonstrated that this group of enzymes preferably ubiquitylates substrates that 
were SUMOylated before, undermining the traditional idea that SUMO generally 
stabilizes substrates by preventing their Ubiquitiylation (Lallemand-Breitenbach et 
al., 2008; Mullen & Brill, 2008; Prudden et al., 2007; Tatham et al., 2008). 
Hietakangas and others could identify the phosphorylation-dependent 
SUMOylation motif (PDSM), ΨKxE/DxxSP, and demonstrated that 
phosphorylation of a serine residue at a conserved distance can directly trigger 
SUMOylation of mammalian proteins, for example heat shock factors 
(Hietakangas et al., 2006). This result suggests a direct link between SUMOylation 
and the diverse signaling pathways via MAP kinases. 
It is also possible that SUMOylation leads to an intramolecular conformational 
change if the target protein contains not only a SUMOylation site but also a SUMO 
interaction motif (Meulmeester & Melchior, 2008). Figure 1.2 shows an overview 
of the working mechanisms underlying SUMOylation. 
 
  
Figure 1.2: Mechanisms of SUMOylation
 The attachment of a SUMO moiety to a target protein can have several effects. On 
the one hand, it can block a binding site of other proteins (depicted in green) or 
prevent other modifications of the lysine residue to which it is attached. On the 
other hand, SUMOylation can create new binding interfaces or leads to 
intermolecular changes, if the interactor or the substrate itself con
interaction motif symbo
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7 Introduction 
is cytoplasmic in its non-SUMOylated state, but if SUMOylated, it interacts with 
RanBP2, a SUMO ligase, which is part of the Nuclear Pore Complex (NPC). It was 
also reported that for some proteins like NEMO, which is involved in signal 
transduction after genotoxic stress, SUMOylation is sufficient to facilitate nuclear 
localization (Huang et al., 2003). Not only import into the nucleus can be 
dependent on SUMOylation, but also subnuclear localization is regulated by 
SUMO. In case of so-called PML nuclear bodies, which are characterized by the 
tumor suppressor promyelocytic leukemia protein (PML), SUMOylation of PML is 
vital for formation of these compartments (Duprez et al., 1999; Shen et al., 2006). 
Many other proteins are found in PML bodies only in their SUMOylated state 
(Gill, 2004; Janssen et al., 2007). 
 
As SUMOylated proteins are often found in the nucleus, it is not surprising that 
many processes in this organelle are regulated by SUMOylation. A major effect of 
SUMOylation is transcriptional repression. Many transcription factors can be 
inhibited by SUMO modification, because SUMOylation can trigger interaction 
with co-repressors (Gill, 2005). It was also proposed that SUMO regulates 
chromatin structures by targeting several histone deacetylases such as HDAC1 or 
HDAC4, resulting in increased transcriptional repression by these proteins (David 
et al., 2002). SUMOylation of histone H4 also mediates silencing by attracting 
histone deacetylases (Shiio & Eisenman, 2003). 
Another process regulated by SUMO is cell division. Studies in yeast and 
mammalian systems revealed that SUMOylation functions in cell cycle control by 
modifying distinct proteins only at certain phases of the cell cycle. Therefore, a 
disturbance of the SUMO cycle can cause problems in progression of the cell cycle 
and chromosome segregation (Dieckhoff et al., 2004; Hayashi et al., 2002; 
Makhnevych et al., 2007; Nacerddine et al., 2005). 
SUMO influences also DNA damage repair. In budding yeast, the Proliferating 
Cell Nuclear Antigen (PCNA) is SUMOylated at its lysine residue K164, and by 
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this modification Ubiquitin-dependent DNA damage tolerance is inhibited, as 
both Ubiquitin and SUMO compete for attachment to this residue (Ulrich, 2004; 
Ulrich, 2007).  
SUMO is also involved in the signaling response to different environmental 
factors. In different organisms an increase of SUMO conjugates was observed after 
stress treatment such as heat shock (Anckar et al., 2006; Hietakangas et al., 2006; 
Kurepa et al., 2003; Saitoh & Hinchey, 2000) and many proteins involved in signal 
transduction are SUMOylated in mammalian cells (Dohmen, 2004; Gao & Karin, 
2005; Gill, 2004; Huang et al., 2003). 
 
Even mitochondrial fission (in mammals) seems to be regulated via SUMOylation 
of the Dynamin Related Protein 1 (DRP1), although these organelles are of 
bacterial origin (Harder et al., 2004; Zunino et al., 2007). 
 
Links to different diseases are also found for SUMOylation. On the one hand, 
SUMOylation plays an important role in diseases such as cancer that are caused by 
an aberrant cell cycle, and in (often neuro-degenerative) diseases such as 
Alzheimer´s disease or Huntington, which are caused by increased stability and 
accumulation of certain proteins (Dorval & Fraser, 2007; Kim & Baek, 2006; 
Lallemand-Breitenbach et al., 2008; Mo & Moschos, 2005; Steffan et al., 2004; Zhang 
& Sarge, 2008).  
Some pathogens, for example herpes virus, also inject proteins into host cells, 
which can either be SUMOylated by the host SUMO system or that manipulate 
SUMOylation of the host cell to promote the infection (Adamson & Kenney, 2001; 
Bailey & O'Hare, 2002; Boggio & Chiocca, 2006; Kang et al., 2006; Lee et al., 2004; 
Muller & Dejean, 1999; Orth et al., 2000). 
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1.3 The Arabidopsis thaliana SUMO conjugating system 
The Arabidopsis SUMO conjugating system is distinct from those of other 
organisms by its broad abundance of different SUMO isoforms. Baker´s yeast has 
only a single SUMO gene, smt3, and four SUMO isoforms were found in humans 
so far. The Arabidopsis genome codes for eight different SUMO isoforms, of which 
at least four are expressed to a significant extent (Novatchkova et al., 2004). Below 
an alignment of the SUMO variants is shown. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3: Different SUMO isoforms of Arabidopsis thaliana 
 The shown alignment of the different SUMO isoforms in Arabidopsis was modified 
after Novatchkova et al., 2004.  
Amino acids, which are generally conserved in the SUMO core, are highlighted in 
yellow. Additional residues that are absent in other SUMO variants are shown in 
grey. Differences from the conserved glutamine residue at position -4 from the 
carboxyl terminus are depicted in red and aberrations from the conserved di-glycine 
motif in blue. The SUMOylation consensus site within SUMO2 is highlighted in 
green (Colby et al., 2006). A cDNA splicing variant of SUMO7 is listed as SUMO7v. 
The cleavage side for SUMO proteases, which reveals the di-glycine motif during 
maturation, is indicated by a slash. 
 
 
 
SUMO1    .............MSANQEEDKKPGDGGAHINLKVKGQDGNEV.FFRIKRSTQLKKLM 
SUMO2    .............MSATPEEDKKP.DQGAHINLKVKGQDGNEV.FFRIKRSTQLKKLM 
SUMO3    .............MSNPQDDKPIDQEQEAHVILKVKSQDGDEV.LFKNKKSAPLKKLM 
SUMO5    ...MVSSTDTISASFVSKKSRSPETSPHMKVTLKVKNQQGAED.LYKIGTHAHLKKLM 
SUMO4    MST..TSRVGSNEVKMEGQKRKVV.SDPTHVTLKVKGQDEEDFRVFWVRRNAKLLKMM 
SUMO6    MSTKSSSIHGRNEVKMEGEKRKDVESESTHVTLNVKGQDEEGVKVFRVRRKARLLKLM 
SUMO7    ................MSAADKKPLIPPSHITIKIKSQDDICV.YFRIKRDVELRTMM 
SUMO7v   ................MSAADKKPLIPPSHITIKIKSQDDICV.YFRIKRDVELRTMM 
SUMO8    ................MSSSDKKPLIPSSHITVKVKNQDDICV.YFRIKRDVELRKMM 
 
 
SUMO1   NAYCDRQSVDMNSIAFLF.DGRRLRAEQTPDE...LDMEDGDEIDAMLHQTGG/SGGGATA 
SUMO2   NAYCDRQSVDFNSIAFLF.DGRRLRAEQTPDE...LEMEDGDEIDAMLHQTGG/GAKNGLKLFCF 
SUMO3   YVYCDRRGLKLDAFAFIF.NGARIGGLETPDE...LDMEDGDVIDACRAMSGG/LRANQRQWSYMLFDHNGL 
SUMO5   SAYCTKRNLDYSSVRFVY.NGREIKARQTPAQ...LHMEEEDEICMVMELGGG/GPYTP 
SUMO4   ELYTKMRGIEWNTFRFLF.DGSRIREYHTPDE...LERKDGDEIDAMLCQQSG/FGPSSIKFRV 
SUMO6   EYYAKMRGIEWNTFRFLSDDGSRIREYHTADD...MELKDGDQIDALLPQESG/FGPSTVFRV 
SUMO7   QAYSDKVGQQMSAFRFHC.DGIRIKPNQTPNE...LDLEDGDEIDAFVDQIAG/FSHRH 
SUMO7v  QAYSDKVGQQMSAFRFHC.DGIRIKPNQTPNEELQLDLEDGDEIDAFVDQIAG/FSHRH 
SUMO8   HAYSDKVGVEMSTLRFLF.DGNRIKLNQTPNE...LGLEDEDEIEAFGEQLGG/FSFFHRH 
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As depicted above in Figure 1.3, the Arabidopsis genome encodes eight potential 
SUMO isoforms and a ninth pseudo gene that encodes no complete protein and is 
therefore not shown. The isoforms SUMO1 (At4g26840) and SUMO2 (At5g55160), 
SUMO4 (At5g48710) and SUMO6 (At5g48700), SUMO7 (At5g55855) and SUMO8 
(At5g5585x) are closely related and are probably derived from genome duplication 
and rearrangement events (Novatchkova et al., 2004). SUMO8 lies between 
At5g55855 and Atg55860 and overlaps with SUMO7 (Novatchkova et al., 2005). 
It seems that only the isoforms SUMO1, 2, 3 and 5 are expressed to a significant 
extent and therefore this work is restricted to those variants (Kurepa et al., 2003; 
Saracco et al., 2007). 
The isoforms SUMO1 and SUMO2 show the highest resemblance to human 
SUMO2 and SUMO3. Like the mammalian isoforms, they form conjugates in vivo 
and after stress treatment the level of those conjugates increases drastically 
(Kurepa et al., 2003). Thomas Colby and co-worker demonstrated chain formation 
of SUMO2, during which a lysine residue close to the carboxyl terminus that is 
part of a consensus motif is modified (Colby et al., 2006). 
Only little is known about SUMO3 and SUMO5. Both variants seem to form 
conjugates in vivo, but the conjugate level is not influenced by stress treatment 
such as heat shock (Budhiraja, 2005; Kurepa et al., 2003). Due to the lack of a 
conserved glutamine residue at position -4 of the amino terminus, the conjugate 
stability of SUMO3 and SUMO5 might be increased, because this amino acid is 
part of a recognition site for SUMO proteases (Mossessova & Lima, 2000; Reverter 
& Lima, 2004; this work). 
Novatchkova and co-workers identified not only the different SUMO isoforms but 
also a broad variety of potential SUMOylation enzymes in Arabidopsis with 
homology to the respective yeast orthologs as shown in Table 1.1. 
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Table 1.1: Components of the Arabidopsis SUMO conjugating system 
 
 
This figure was taken from Novatchkova et al., 2004. Potential orthologs of Saccharomyces cerevisae 
and Arabidopsis thaliana were identified. SUMO is abbreviated as SUM. 
 
As depicted above in Table 1.1, Arabidopsis encodes two different isoforms of the 
subunit 1 of the SUMO activating enzyme. Either SAE1a (At4g24940) or SAE1b 
(At5g50680) can form a heterodimer with SAE2 (At2g21470) to generate the 
functional enzyme. Only a single gene coding for the SUMO conjugating enzyme 
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is found in Arabidopsis. In this, SUMOylation differs clearly from Ubiquitylation as 
many different conjugating enzymes for Ubiquitin are known (Bachmair et al., 
2001; Dohmen, 2004). Three potential SUMO ligases exist in Arabidopsis, but only 
one of them, the SIZ1 (At5g60410) has already been described and its biological 
relevance was demonstrated. The other two members of the SIZ/PIAS protease 
family in Arabidopsis, PIAS-Like1 (At1g08190) and PIAS-Like2 (At5g41580) will be 
discussed in this work. 
The Arabidopsis genome codes for several potential SUMO proteases, but Colby 
and others demonstrated that SENPLike1 (At5g60190) is more likely processing 
Rub1, another member of the Ubl family (Colby et al., 2006). In vitro SUMO 
protease activity for Ulp1d (At1g60220), Ulp1c (At1g10570), ESD4 (At4g15880) and 
Ulp1a, also named Early in short days 4-Like 1 (EL1, At3g06910) was 
demonstrated (Colby et al., 2006; Murtas et al., 2003), but only the influence of 
Early in short days 4 (ESD4) has been analyzed in planta as described in the next 
chapter. EL1, the closest homolog of ESD4 in Arabidopsis, will be further 
investigated in this work. 
 
 
 
1.4 The role of SUMO in Arabidopsis thaliana 
Richard Vierstra and his co-workers demonstrated the vital role of SUMOylation 
in Arabidopsis. They showed that disruption of the SUMO cycle caused either by 
the double knockout of the nearly identical isoforms SUMO1 and SUMO2 or by 
loss of function mutations in SCE or SAE2, which are both encoded by single 
genes, are lethal during early plant embryogenesis (Saracco et al., 2007).  
SUMOylation is involved in many different developmental processes and 
responses to biotic and abiotic factors in plants. Most of these insights were 
obtained by studying mutants in different SUMOylation enzymes. 
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It was shown that the amount of SUMO1 and SUMO2 conjugates increases in 
Arabidopsis after stress treatments, for example heat shock (Kurepa et al., 2003). 
This result parallels the increased occurrence of SUMO conjugates in other 
organisms after stress and is strengthened by the result that plants, lacking SIZ1, a 
SUMO protease of the PIAS family, show reduced tolerance to drought, cold stress 
and phosphate starvation (Catala et al., 2007; Miura et al., 2007; Miura et al., 2005; 
Yoo et al., 2006). 
 SUMOylation plays also a role in plant hormone signaling. It was demonstrated 
that siz1 mutant plants have elevated levels of salicylic acid (Jin et al., 2008b; Lee et 
al., 2007). Recent findings suggest that the reduced growth of siz1 plants is partly 
due to decreased expression of genes involved in brassinosteroid synthesis in 
signaling (Catala et al., 2007). SIZ1 does not seem to be involved in jasmonic acid 
signaling (Lee et al., 2007). However, SUMOylation seems to modify absicisic acid 
(ABA) signaling in plants. It was shown that overexpression of SUMO1 and 
SUMO2 in Arabidopsis attenuates ABA-induced growth arrest and leads to a 
stronger induction of ABA- and stress-responsive genes, while reduction of the 
SCE expression has an opposite effect (Lois et al., 2003). Paul Hasegawa and his co-
workers recently suggested a role for SIZ1-mediated SUMOylation in the 
regulation of auxin signaling and transport during phosphate starvation, but up to 
now this theory is lacking full experimental proof (Miura et al., 2007; Miura et al., 
2005). The SUMOylation system is also involved in plant-pathogen interactions. 
Siz1 mutant plants show constitutive systemic acquired resistance due to their 
elevated salicylic acid levels and constitutive expression of genes involved in 
pathogenesis with the effect of increased resistance to Pseudomonas syringae (Lee et 
al., 2007). The pathogenic bacterium Xanthomonas campestris, for example, secretes 
the virulence factors AvrXv4 and XopD into host cells, which show SUMO 
protease activity (Chosed et al., 2007; Colby et al., 2006; Gurlebeck et al., 2006; 
Hotson et al., 2003; Roden et al., 2004). The bacterial protein XopD seems to be 
highly specialized in the cleavage of plant proteins, because it was demonstrated 
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that this enzyme can process efficiently tomato and Arabidopsis SUMO precursors 
and conjugates but not mammalian and yeast SUMO isoforms (Chosed et al., 2007; 
Colby et al., 2006; Hotson et al., 2003). These results lead to the idea that plant 
pathogens use proteins with SUMO protease activity to perturb the host´s 
SUMOylation system. 
SUMOylation has also a function in the control of flowering time. Mutants of the 
SUMO ligase SIZ1 or of the SUMO protease ESD4 both flower early under short 
day conditions (Jin et al., 2008; Murtas et al., 2003). SUMO protease activity for 
ESD4 was demonstrated in vitro and this protein seems to regulate the abundance 
of Flowering Locus C (FLC), a floral repressor (Colby et al., 2006; Murtas et al., 
2003; Reeves et al., 2002). The early flowering of siz1 mutant plants might be 
caused by their altered levels of salicylic acid, or by a lower level of FLC, which is 
repressed by the floral promoter Flowering Locus D (FLD) (Jin et al., 2008; Lee et 
al., 2007). SIZ1 seems to negatively control flowering time by inactivating FLD 
through SUMOylation (Jin et al., 2008). 
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2 RESULTS 
In this work, several aspects of Arabidopsis SUMOylation are discussed. Therefore, 
this chapter addresses the following subjects: the development of an in vitro 
SUMOylation assay system, the mutant variety SUMO1 Q90A, different SUMO 
ligase and protease mutants and a potential bacterial SUMO protease. Nonetheless 
all projects aim hand in hand to achieve a better understanding of the plant SUMO 
system and benefit from each other.  
 
 
 
2.1 In vitro SUMOylation  
Due to the transient nature of modification by SUMO and to the small subset of 
proteins modified at a given time, SUMOylation is extremely hard to detect 
in vivo. Therefore we developed a SUMOylation assay system that allows the 
quick analysis of a broad variety of proteins for their SUMOylation by different 
SUMO isoforms in vitro. The assay is based on a system described by Prof. Frauke 
Melchior but the novelty is that it is entirely based on and adapted to plant 
recombinant proteins (Bossis & Melchior, 2006; Pichler et al., 2005). 
 
 
2.1.1 In vitro SUMOylation assays – a handy technique 
For in vitro SUMOylation assays, the necessary enzymes, SUMO moieties and 
potential target proteins were produced as plant recombinant proteins in E. coli. 
The SUMO activating enzyme (SAE) consists of two subunits, SAE1, for which 
two isoforms (SAE1a and SAE1b) exist in Arabidopsis, and SAE2 that is encoded by 
only a single gene and contains the catalytically active cysteine. Previous results 
indicated that the SAE2 subunit is not very active if singly expressed in E. coli. This 
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heterodimeric enzyme was therefore expressed in E. coli using a dicistronic 
construct in which the SAE2 subunit is expressed as first reading frame, followed 
by either the SAE1a or the SAE1b subunit with an amino terminal hexa-histidine 
tag. This construct resembles poly-cistronic mRNAs of E. coli that encode 
ribosomal proteins (Yates & Nomura, 1980). It was assumed that this avoids 
ribosome disassembly after translation of the first protein, allowing nearly 
equimolar production of the two SAE subunits. To strengthen their interaction, 
ATP was added to a final concentration of 1 mM during protein purification. 
The SUMO conjugating enzyme (SCE) was also purified as an untagged protein, 
because it was not possible to maintain this protein in a stably active form with 
either carboxyl or amino terminal His tag (data not shown).  
In contrast to SCE, the other proteins were produced as His tag fusions to allow 
cheap and easy purification. The potential substrates and the SUMO moieties 
carried additional tags to allow their detection and distinction by Western blot. 
For a typical in vitro SUMOylation assay 100 µg SUMO, 4 µg SAE, 0.6 µg SCE and 
0.15 µg SIZ1 fragment were incubated with usually 10 µg substrate in an ATP and 
MgCl2 containing buffer at 30°C for four hours or overnight. Afterwards 10 µl of 
the reaction were separated via SDS-PAGE and analyzed by Western blot. 
It might be difficult to purify active recombinant plant SCE, but as shown in 
Figure 2.1, SUMOylation with SUMO3 can be more efficient with Arabidopsis 
enzymes than with commercially available human enzymes.  
  
  
 
Figure 2.1: Higher efficiency of 
 Recombinant model substrate NAF, 
tag, was incubated with recombinant SAE, and SUMO1 in ATP 
the positive samples (+) active SCE was added, in the negative controls (
mutant SCE (C94S) was used
human recombinant 
molecular weight bands, indicating SUMOylation, are highlighted by 
while unmodified substrate is marked with a black dot
 
Above, the in vitro SUMOylation of the model substrate NAF, a 
Assembly Factor, with SUMO3 was monitored.
Therefore recombinant enzymes, SUMO moieties and the Flag
were incubated in an ATP containing buffer, separated by SDS
analyzed by Western blot with anti
active SCE was compared to a negative 
used. A higher molecular weight band, marked by an asterisk, indicates mono
SUMOylation of NAF, because the mobility on the gel corresponds to the 
combined mass of the NAF protein and a recombinant SUMO moiety. In t
experiment, SUMOylation of NAF with SUMO3 is far stronger, if plant 
recombinant SCE is used in comparison to 
For the SUMO isoform SUMO1 such a difference was not detected. In some cases 
later on human recombinant E2 and E1 (BostonBiochem) were 
proved to be difficult to get the SAE and SCE as recombinant plant proteins 
reliably active. 
Results
Arabidopsis recombinant SCE  
Nucleosome Assembly Factor, carrying a Flag 
containing buffer. In 
 that is no longer catalytically active. The results for 
HsSCE were obtained by Dr. Ruchika Budhiraja. Higher 
. 
 
-NAF construct 
-Flag antibody. Always a positive sample with 
control, in which inactive SCE(C94S) was 
HsSCE.  
used, because it 
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To monitor the differences between the two isoforms of SAE1, SAE1a and SAE1b, 
and to access the influence of a functional fragment of the SUMO lig
effect on chain formation of different SUMO isoforms was investigated (
2.2). 
Figure 2.2: Effects of different SAE isoforms and a SIZ1 fragment on SUMO 
chain formation 
 SUMO1 moieties carrying an HA
SAE1b, SCE and a functional fragment of SIZ1 as indicated. An aliquot was 
separated by SDS PAGE and
 
As shown in Figure 2.2, the ability of different SUMO isoforms for chain formation 
was tested. Therefore recombinant SUMO moieties carrying an HA tag were 
incubated with the necessary enzymes in an ATP containing buffer. An aliquot 
was separated by SDS-PAGE and the SUMO moieties were detected by Western 
blot with antibodies targeting the HA epitope.
SUMO1 and the nearly identical SUMO1 Q90A, in which a glutamine residue 
close to the C-terminus is exchanged, form 
identical pattern. The efficiency of chain formation by the two SUMO variants 
Results
ase SIZ1, their 
 tag were incubated with recombinant
 SUMO moieties were detected by anti-HA antibody.
 
in vitro poly-SUMO chains with an 
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differs. However, in the shown experiment, more SUMO1 Q90A was used, so that 
the bands cannot be compared quantitavely.  
In case of the isoforms SUMO3 and SUMO5, the formation of slower migrating 
bands is far weaker and only one higher molecular weight band, presumably di-
SUMO is prominently detected. Chain formation was increased, if the SAE1b 
isoform of the SUMO activating enzyme instead of SAE1a was used. The reaction 
could also be increased by addition of a functional fragment of the SUMO ligase 
SIZ1. SAE1b and the SIZ1 fragment were therefore used in subsequent 
experiments. 
 
To use tagged fusion proteins in subsequent in vitro SUMOylation experiments, it 
was necessary to determine which tags cannot be SUMOylated themselves to 
avoid false positive results later on. Figure 2.3 shows the assessment of different 
tag constructs.  
 
 
Figure 2.3: SUMOylation of different tag constructs  
 Different recombinant tag constructs were incubated with recombinant SAE and 
SUMO1 in ATP containing buffer. As the Flag peptide is too small to be expressed 
and purified from E. coli, this tag was generated as a fusion to the protein UBC27. In 
the positive samples (+) active SCE was added, in the negative controls the mutant 
SCE(C94S) was used that is no longer catalytically active. An aliquot was separated 
by SDS-PAGE and the constructs were detected by Western blot with either anti-
Flag or anti-GST antibodies. Higher molecular weight bands, indicating 
SUMOylation, are highlighted by asterisks. 
 
As shown in Figure 2.3, commonly used tags were analyzed for their in vitro 
modification by SUMO1 to establish which types of fusion proteins can be used in 
subsequent experiments. Only the modification by SUMO1 was tested, because 
this isoform was far better transferred onto target proteins during in vitro 
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experiments and to a larger extend than SUMO3 and SUMO5. As the Flag peptide 
is too small to be purified from E. coli cells, it was produced as a fusion protein 
with UBC27, a protein that was not modified by any tested SUMO isoform.  
To test the different tags for their potential in vitro SUMOylation, they were 
incubated with the necessary enzymes and recombinant SUMO moieties and 
afterwards analyzed by Western blot with antibodies against the tested tag. As 
shown above, neither the UBC27-Flag construct, nor the combination of GST 
moiety and S peptide (GST-S) are SUMOylated. Still, if all three tags are combined 
in the protein GST-S-Flag, a higher molecular weight band occurs in the positive 
sample, indicating mono-SUMOylation of this construct. To determine the residue 
within this construct to which SUMO is attached, a lysine residue at the carboxyl 
terminus of the GST moiety that is in a context with similarity to a SUMOylation 
consensus motif, was exchanged to arginine to generate the GST(K217R)-S-Flag 
protein. Still, this protein did not differ in its SUMOylation from the unaltered 
GST-S-Flag. Therefore it was assumed that a lysine residue within the S peptide 
that is part of a high probability SUMOylation site might be modified and the 
protein GST-Flag was created. GST-Flag was no longer a substrate for SUMO1 and 
therefore the GST moiety and the Flag peptide have been used to create fusion 
proteins for subsequent experiments. 
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2.1.2 In vitro SUMOylation of different substrates 
We tried to demonstrate the SUMOylation of various substrates by different 
SUMO isoforms. Here, we focused on SUMO1, SUMO3 and SUMO5, because 
these variants are expressed to a significant extent. The role of SUMO2 was not 
further investigated, although it is expressed to a similar extent as SUMO1, 
because the two isoforms are highly similar and their functional redundancy was 
recently demonstrated (Saracco et al., 2007).  
A former member of our group, Dr. Ruchika Budhiraja, identified potential in vivo 
substrates of SUMO3 and 5 and a mutant version of SUMO1, the SUMO1 Q90A, 
from Arabidopsis. SUMO1 Q90A is identical to SUMO1 except for a one amino acid 
exchange at position -4 from the C-terminus, where the conserved Glutamine 
residue is changed to alanine. 
Dr. Budhiraja used different transgenic plant lines expressing tagged SUMO 
moieties and purified SUMO conjugates via Ni-NTA affinity chromatography. 
After separation by SDS-PAGE, SUMO conjugates were identified by the mass 
spectrometric facility of the MPIZ and by Stephan Müller from the University of 
Cologne.  
To verify the SUMOylation of the detected potential in vivo targets, their 
modification with different SUMO isoforms was analyzed in vitro.  
Figure 2.4 shows the in vitro SUMOylation assays for a subset of the identified in 
vivo targets and of other proteins of interest. For a better overview, the results for 
the various proteins are summarized in Table 2.1. 
 
Figure 2.4: In vitro SUMOylation of different proteins 
 Various recombinant tag fusion proteins, carrying either a Flag or a GST epitope 
and a His tag for purification, were analyzed in an in vitro SUMOylation assay. The 
substrate was incubated with the required enzymes and different SUMO isoforms 
and an aliquot was separated by SDS PAGE.  
Candidate proteins were detected by Western blot using anti-Flag or anti-GST 
antibodies. The unmodified substrate is marked with a black dot, while higher 
molecular weight bands, indicating SUMOylated proteins, are highlighted with 
asterisks. 
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Table 2.1: In vitro SUMOylation of different proteins  
 
Gene Protein ΨKxE/D SIM in vivo modified 
by SUMO 
in vitro modified  
by SUMO 
  score  1  3 5 1 3 5 
  ≥ 0.90 ≥ 0.65  Q90A   WT Q90A   
RNA dependent processes         
At2g41060 RRM2 0 2 2 yes   yes nt nt nt 
At3g56860 RRM1 1 0 1 not distinguished 
from RRM2 
yes yes no nt 
At2g43970 LA 0 1 1 yes   ? ? no no 
           
DNA and Chromatin related pathways 
At1g55300 TAF7 0 0 7 yes yes yes yes yes yes nt 
At1g29400 AML5  0 1 0  yes  ? ? no no 
At5g08450 Rxt3 3 7 11    yes  yes yes no no 
At2g19480 NAF 1 1 2 yes   yes yes yes no 
At1g51950 IAA 18 0 4 3    no nt nt nt 
At5g15840 CO  2 2 3    yes yes no no 
At5g12840  Hap2a 0 1 0    no no no no 
At2g22540 SVP 0 0 3    yes yes yes no 
At5g10140 FLC 1 0 7    yes yes no no 
           
Other proteins 
At2g32950 COP1  2 0 3 yes   no nt nt nt 
At5g50870 Ubc27 0 0 1    no no no no 
At3g15355 PFU1 0 1 6    no nt nt nt 
At1g75940 β 
glucosidase 
0 1 4 yes yes yes no nt nt nt 
 
The SUMOylation of various substrates is shown. The data for the in vivo modification were 
obtained by Dr. Ruchika Budhiraja, while the in vitro SUMOylation resulted from this work. 
Unclear results for the in vitro modification are indicated by a question mark (?) and not tested (nt) 
combinations are shown as well.   
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As shown in Figure 2.4 and Table 2.1, the in vitro SUMOylation of various proteins 
was analyzed. 
In general, it can be observed that often proteins involved in RNA dependent 
processes or in DNA and chromatin related pathways are targets for both in vivo 
and in vitro SUMOylation. 
Usually, in vitro SUMOylation led to clear distinct higher molecular weight bands, 
but in case of the protein Rxt3, which contains several potential SUMOylation 
sites, many different higher molecular weight bands occurred. 
Most proteins could be modified in vitro by SUMO1 and SUMO Q90A, while 
SUMOylation with SUMO3 was only observed for the proteins NAF, SVP and 
TAF7 and resulted in weaker bands compared to the other two isoforms. In 
contrast to SUMOylation by SUMO1 or SUMO1 Q90A, only a single slower 
migrating band was detected, indicating mono-SUMOylation. 
SUMO5 modification was not observed at all during in vitro experiments, although 
Dr. Budhiraja had identified some potential substrates for this isoform in 
Arabidopsis. SUMO1 and SUMO Q90A are two nearly identical proteins, which 
differ only in one amino acid at position -4 from the carboxyl terminus. A 
substrate that could be modified with one variety could also be SUMOylated by 
the other one with an identical pattern.  
For some substrates, the in vitro results differed from the in vivo prognosis. The Rtx 
protein for example, an in vivo candidate for SUMOylation with SUMO3, could 
not be modified with SUMO 3, but with SUMO1 and SUMO1 Q90A during in vitro 
experiments. In contrast to this, the Nucleosome Assembly Factor NAF was 
supposed to be only a target of SUMO1 Q90A, but could be modified in vitro also 
with SUMO3.  
The results for in vivo targets AML5 and LA are not clear. In the samples positive 
for modification by SUMO1 and SUMO1 Q90A the amount of unmodified 
substrate is slightly less compared to the negative controls. This might be a hint 
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for SUMOylation that leads to uptake of the substrate into higher molecular 
weight bands that are too weak to be detected by the used antibody. 
It should also be mentioned that candidates containing at least one high 
probability SUMOylation consensus motif with a score above 0.90 
(http://www.abgent.com/tools/sumoplot_login) could be SUMOylated with 
SUMO1, while none of the unmodified proteins contains such a high scoring 
consensus sequence. 
Nevertheless, proteins that had no SUMOylation consensus motif at all like the 
TAF7, a TATA binding protein associated factor, or the transcription factor SVP, 
which only possesses consensus sequences with a low probability, were modified 
in vitro. 
Both proteins contain so-called SUMO interacting motifs (SIMs), which consist of a 
four residues long hydrophobic stretch that can interact with the SUMO moiety. In 
contrast to this, the AML5 protein that has neither a high probability consensus 
site nor a SIM is not clearly positive for in vitro SUMOylation. The protein Hap2a, 
that was not SUMOylated at all during in vitro experiments, is lacking any SIM or 
consensus sequence as well. 
 
 
2.1.2.1 Determination of SUMOylation sites 
 
Due to the fact that attempts to identify SUMOylation sites of RRM1, SVP, NAF 
and an N-terminal fragment of CONSTANS (CO) via mass spectrometric analysis 
by the service unit of the MPIZ were not successful, we tried to identify the 
SUMOylated residues of the TAF7 protein by generating different mutant 
proteins, in which candidate lysine residues are exchanged. Previous MALDI-TOF 
analysis allowed the exclusion of a number of residues as SUMOylation sites, so 
that we could focus on seven lysine residues to be mutagenised. 
  
 
Figure 2.5: SUMOylation of mutated TAF7 proteins
 To determine the residue within the TAF7 protein, to which the SUMO moiety is 
attached, several mutated variants with amino acid changes of lysine to arginine 
were generated. The proteins were analyzed for their 
SUMO1 using human recombinant E1 and E2 (BostonBiochem) and a functional 
fragment of the Arabidopsis
 
As shown above, TAF7 proteins that are mutated in the lysine residues K328, K337 
or K369 do not differ significantly
type protein. TAF7 variants TAF7(K373R), TAF7(K423,424R) and TAF7(K435) that 
are mutated in the lysine residues closer to the amino terminus, show a weaker 
modification by SUMO1, but are SUMOylated nevertheless.
To investigate the role of these residues further, triple or quadruple mutants were 
created. The proteins TAF7 (K373,423,424R) and the TAF7(K373,423,424,435R) 
were SUMOylated as efficiently as the wild type protein. For TAF7(K423,424,435R) 
no SUMOylation was detected in the shown experiment, but in this case less 
substrate was used. 
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2.2 SUMO1 Q90A, a mutant variant differing in a 
conserved residue 
Usually, SUMO isoforms have a conserved glutamine residue at position -4 from 
the carboxyl terminus. The Arabidopsis SUMO3 and SUMO5 differ from this 
consensus and have a methionine and a leucine at this position, respectively, as 
demonstrated below (Figure 2.6).  
 
 
 
 
 
Figure 2.6: Arabidopsis SUMO isoforms differ in a conserved residue. 
 Above, the carboxyl termini of Arabidopsis SUMO isoforms, which are significantly 
expressed, as well as the mutant variant SUMO1 Q90A are shown. 
Amino acids that are generally conserved in the SUMO core, are highlighted in 
yellow. Differences from the conserved glutamine residue at position -4 from the 
carboxyl terminus are depicted in red. 
 
Although SUMO3 and SUMO5 lack this conserved residue, these SUMO variants 
are significantly expressed and seem to be conjugated to substrates in vivo 
(Budhiraja, 2005). To further investigate the role of the glutamine residue at this 
position, several mutant plants, in which this residue was mutated in the 
background of SUMO1, were created in our laboratory and investigated by 
Dr. Ruchika Budhiraja and Dr. Andreas Bachmair. They demonstrated similar 
effects of the exchange of the conserved glutamine to a hydrophobic residue 
(leucine) or to the small amino acid alanine. The mutation led to poor growth and 
early senescence, finally resulting in premature death of the plant, if expressed 
under a constitutive promoter. Under an inducible promoter, this phenotype was 
less severe and an accumulation of SUMO conjugates for SUMO1 Q90A was 
observed compared to plants overexpressing wild type SUMO1.  
SUMO1        LDMEDGDEIDAMLHQTGG/SGGGATA 
SUMO1 Q90A   LDMEDGDEIDAMLHATGG/SGGGATA 
SUMO2        LEMEDGDEIDAMLHQTGG/GAKNGLKLFCF 
SUMO3        LDMEDGDVIDACRAMSGG/LRANQRQWSYMLFDHNGL 
SUMO5        LHMEEEDEICMVMELGGG/GPYTP 
  
Therefore, I further investigated the features of SUMO1 Q90A.
 
 
2.2.1 SUMOylation by SUMO1 Q90A
First of all, the ability of SUMO1 Q90A to modify different substrates 
analyzed. As shown in Figure 
SUMOylated by SUMO1, were also modified by SUMO1 Q90A to a similar extent 
and in an identical pattern. Both SUMO1 varieties did also not differ during 
vitro SUMO chain formation as presented in 
already presented the formation of SUMO1 Q90A in plants (Budhiraja, 2005) and I 
analyzed the incorporation of this mutant variety after heat shock treatment of 
seedlings demonstrated in Figure 
 
 
Figure 2.7: Incorporation of SUMO1 Q90A after heat shock
 Col0 WT or seedlings carrying the construct pHi
SUMO1 Q90A with a hexa
expressed under control of the 35S promoter, were analyzed prior and after heat 
shock treatment of 1 h at 37°C. Plant extracts were analyzed by Western blot using 
anti-HA primary antibody and secondary anti
peroxidase. Free SUMO is indicated by a dot.
 
As shown above in Figure 
HA-tagged SUMO1 Q90A incorporated this mutant SUMO1 variant into higher 
molecular weight bands after hea
Results
 
 
2.4 and Table 2.1, all targets, which could be 
Figure 2.2. Dr. Ruchika Budhiraja 
2.7. 
 
-SUMO1 Q90A, from which 
-Histidine tag and three HA epitopes is 
-rat antibody coupled to horse radi
 
2.7, seedlings that were constitutively expressing the 
t shock treatment. Prior to the stress treatment 
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only the mono-SUMO moiety but no conjugates were observed. Analysis of 
Col0 WT control plants showed no signals with the antibodies used.
 
 
2.2.2 De-SUMOylation of SUMO1 Q90A conjugates
Similar to the behavior dur
regarding de-SUMOylation were analyzed. Therefore the activity of the SUMO 
protease ESD4 towards a SUMO1 and SUMO1 Q90A conjugate was monitored as 
shown in Figure 2.8. 
Figure 2.8: Cleavage of SUMO1 and SUMO1 Q90A conjugates by ESD4
 The activity of a functional fragment of the SUMO protease ESD4 torwards SUMO1 
and SUMO1 Q90A modified NAF was analyzed. Therefore a SUMOylation assay
was carried out and modified and unmodified NAF were co
with ESD4. Aliquots of the protease reaction were separated by SDS
monitored by Western blot with antibodies against the Flag epitope.
In the upper panel, a time cours
coupled antibody was used.
In the lower panel, less protease was utilized and the usage of secondary IR
coupled antibody allowed quantification of the experiment.
In both cases reactions were stopped by
 
As shown above, the model substrate NAF, carrying a Flag tag, was either 
SUMOylated with SUMO1 or SUMO1 Q90A. Afterwards modified and 
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unmodified substrate were co-purified via the Flag epitope and incubated with a 
functional fragment of the SUMO protease Early in Short Days 4 (ESD4). In the 
upper panel, the activity of ESD4 against SUMO1-NAF and SUMO1 Q90A-NAF is 
shown. Over the analyzed time course of one hour, ESD4 is able to cleave all of the 
SUMO1 modified protein, but this reaction can be prevented by addition of the 
cysteine protease inhibitor N-ethylmaleimide (NEM). Under the same conditions, 
SUMO1 Q90A cleavage is far slower, but takes place nevertheless. 
In the lower panel, a similar experiment is shown, but the use of IR-dye coupled 
secondary antibody allowed quantitative analysis of conjugate cleavage and less 
ESD4 was used. In this case, SUMO1 Q90A-NAF was not degraded within 30 min, 
while during this time approximately 70% of the applied SUMO1-NAF conjugate 
was cleaved. 
 
 
 
2.3 PIAS-like SUMO ligases in Arabidopsis 
In this work, not only in vitro experiments were conducted, but different plants 
mutated in SUMO ligases were analyzed as well. 
The Arabidopsis genome encodes three potential SUMO ligases of the SIZ/PIAS 
family, SIZ1 (At5g60410), PIAS-Like1 (PIL1, At1g08910) and PIAS-Like2 (PIL2, 
At5g41580) (Novatchkova et al., 2004). 
These types of proteins are known SUMO ligases in yeast and animals and are 
characterized by their SP-RING domain (Johnson & Gupta, 2001). They show 
similarity to Ubiquitin ligases of the RING type and can interact with the SCE-
SUMO conjugate via their SP-RING domain.  
While the importance of SIZ1 for various developmental traits and responses to 
biotic and abiotic factors of Arabidopsis is clear, the role of PIAS-Like1 and PIAS-
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Like2 has not yet been analyzed. Therefore we investigated these two potential 
SUMO ligases further. 
 
 
2.3.1 PIAS-Like1 and PIAS-Like2 differ from SIZ1 in their domain  
structure 
SIZ1, PIL1 and PIL2 all belong to the SIZ/PIAS protein family and show some 
sequence homology as shown in the alignment in Figure 2.9. 
 
Figure 2.9: Alignment of Arabidopsis SUMO ligases of the SIZ/PIAS family 
 The protein sequence of the three members of the Arabidopsis SIZ/PIAS SUMO 
ligases is shown. The SAP and PHD domains of SIZ1 (At5g60410) are indicated by a 
black and a grey line, respectively. The zf-MIZ finger (SP-RING) common to all 
three proteins is underlined in red. Domains were detected with the PFAM 
webservice (http://pfam.sanger.ac.uk). 
In panel A, identical residues are highlighted in yellow while conservative amino 
acid exchanges are marked in blue. To show the similarity between PIL1 
(At1g08910) and PIL2 (At5g41580), residues identical or conserved only in these two 
proteins are also colored (yellow).  
Below in panel B, SUMOylation consensus motifs with a score ≥ 0.90 are shown in 
red letters, those with a probability of ≥ 0.65 in blue. Potential SUMO interaction 
motifs (SIMs) with the sequence V/I/L x V/I/L V/I/L or V/I/L V/I/L x V/I/L are 
indicated by green letters. SUMO consensus motifs were determined with the 
SUMOplot tool (http://www.abgent.com/tools/sumoplot). 
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A: Conserved residues of Arabidopsis SUMO ligases of the PIAS family 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SIZ1  MDLEANCKEKLSYFRIKELKDVLTQLGLSKQGKKQELVDRILTLLSDEQAARLLSKKNTVAKEAV 
PIL1                   MVIPATSRFGFRAEFNTKEFQASCISLANFTENFTPGFGECSEID--- 
PIL2                 MSTAAAARPVAGTGLREKTAASLVNSFRLASVTQRLRYHIQDGAKVDPKE 
 
SIZ1  AKLVDDTYRKMQVSGASDLASKGQVSSDTSNLKVKGEPEDPFQPEIKVRCVCGNSLETDSMIQCE 
PIL1  -------------AAIGRNEVPGNIQELALILNN----------------------------VCR 
PIL2  FQICCISFAKGIDFAIANNDIPKKVEEFPWLLKQ----------------------------LCR 
 
SIZ1  DPRCHVWQHVGCVILPDKPMDGNPPLPESFYCEICRLTRADPFWVTVAHPLSPVRLTATTIPNDG 
PIL1  RKCDDYQTRAVVMALMISVKSACQLGWFPERETQELLAIIDLMWNGFSCPEN----VTSCVNSPV 
PIL2  -HGTDVYTKTALMVLMISVKHACHLGWFSDSESQELIALADEIRTCFGSSGS----TSPGIKSPG 
 
SIZ1  ASTMQSVERTFQITRADKDLLAKPEYDVQAWCMLLNDKVLFRMQWPQYADLQVNGVPVRAINRPG 
PIL1  TLISQVIERFYPCVKLGHILVS---FEAKPESKMMMKDFHISKKMPHSPKQKVGLFVVRTEDISR 
PIL2  STFSQIMERFYPFVKLGHVLVS---FEVKAGYTMLAHDFYISKNMPHSLQEKIRLFVAQTDNIDT 
 
SIZ1  GQLLGVNGRDDGPIITSCIRDGVNRISLSGGDVRIFCFGVRLVKRRTLQQVLNLIPEEGKGETFE 
PIL1  SNCIVHPQGVSFLLNGKGIDKRVNISMESGPQLPTNVTALLNLGANLLQAIGCFGGSYLIAIAFM 
PIL2  SACISNPPEVSFLLNGKGVEKRVNIAMDTGPQLPTNVTAQLKYGTNLLQVMGNFKGNYIIIIAFT 
 
SIZ1  DALAR-VRRCIGGGGGDDNADSDSDIEVVADFFGVNLRCPMSGSRIKVAGRFLPCVHMGCFDLDV 
PIL1  DVIPLPNKPLLKDYVHPEVVGSNSDCDIIEGPSRISLSCPISRTRIKLPVKGHVCKHLQCFDFWN 
PIL2  GLVVPPEKPVLKDYLQSGVIEASPDSDIIEGPSRVSLSCPISRKRIKLPVKGQLCKHLQCFDFSN   
 
SIZ1  FVELNQRSRKWQCPICLKNYSVEHVIVDPYFNRITSKMKHCDEEVTEIEVKPDGSWRVKFKRESE 
PIL1  YVNMNTR------------------RHHGAARIILEEVGRN---AADVVISADGTWMVETENDED 
PIL2  YVHINMRNPTWRCPHCNQPVCYPDIRLDQNMAKILKDVEHN---AADVIIDAGGTWKVTKNTGET 
 
SIZ1  RRELGELSQWHAPDGSLCPSAVDIKRKMEMLPVKQEGYSDGPAPLKLGIRKNRNGIWEVSKPNTN 
PIL1  VELVPETTHDHGDPNSFINLGPTVKNPARD---ENEMETSTQVEEHNPCLSEIQGPSN----DTH 
PIL2  PEPVREIIHDLEDPMSLLNSGPVVFDLTGDDDAELEVFGDNKVEDRKPCMSDAQGQSNNNNTNKH 
 
SIZ1  GLSSSNRQEKVGYQEKNIIPMSSSATGSGRDGDDASVNQDAIGTFDFVANGMELDSISMNVDSGY 
PIL1  RPASDYTMLNQS-----------HTSTNTLPQLPRTLNAFDGQQFVNLPQVINTRDSPASQALPM 
PIL2  PSNDDYSSIFDISDVIALDPEILSALGNTAPQPHQASNTGTGQQYSNLSQIPMSIDP---MPVPV 
 
SIZ1  NFPDRNQSGEGGNNEVIVLSDSDDENDLVITPGPAYSGCQTDGGLTFPLNPPGIINSYNEDPHSI 
PIL1  TFSPTPSPQDILATNAANFGTSMPAAQSSQFQGSHVTSLGNCEGRTSDLMAR-WNHIYGRVQTQF 
PIL2  PFSQTPSPRDRPATTSTVFTIPNPSPQYSQVHASPVTPTGTYLGRT--TSPR-WNQTY-----QS 
 
SIZ1  AGGSSGLGLFNDDDEFDTPLWSFPSETPEAPGFQLFRSDADVSGGLVGLHHHSPLNCSPEINGGY 
PIL1  PPAPLSHHHYSMQNQSPSPAQQRPVPSYIAHPQTFHVNYGENADQRWMPSSIAHPQTLPVNYGGN 
PIL2  QAPPMTTPYTSRKVSVPVTSQS------------------------------------PANVSSF 
 
SIZ1  TMAPETSMASVPVVPG-----------------STGRSEANDGLVDNPLAFGRDDPSLQIFLPTK 
PIL1  TNQRPIPSSIAHPQTLPVNYRGNTDHRSTPYSITHLQTLLNYGGNADQRPMPSSITNLQTLPATY 
PIL2  VQSQHVPRVLSQPN--------------------------NYG--------------VRGLTSSH 
 
SIZ1  PDASAQSGFKNQADMS--------------------------------------------NGLRS 
PIL1  GGYAHQRPMSSSITHPRTSPVNYGGTPDQRPMPSSITHPQTLPVSYGGTTDQILNPGGAMGQFSS 
PIL2  ASTSRQHPSGPTVQS--------------------------------------------VSRLSD 
 
SIZ1  EDWISLRLGDSASGNHGDPATTNGINSSHQMSTREGSMDTTTETASLLLGMNDSRQDKAKKQRSD 
PIL1  REFMNLTPANTENWRPQSRMRGSVAPG---TGYDHMIIHPTRPVHPQAQTPPAPLSTSYDGADEI 
PIL2  LVDVDLTVPDTSNWRP--RMRGSLVPGSHSTALDHMIIRPSQ--QSQTSTRLNSSQPVQTPSVQT 
 
SIZ1  NPFSFPRQKRSVRPRMYLSIDSDSETMNRIIRQDTGV------ 
PIL1  QAFIGHPSYPVSNNETQAGTSSLPVAEGLGYSGSFWSMPPETW 
PIL2  SQAQSPFTTAAYRTETVLGNRNHPVPAPPGIVRPTGPTS---- 
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B: SUMOylation consensus sites and potential SUMO interaction motifs 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
SIZ1  MDLEANCKEKLSYFRIKELKDVLTQLGLSKQGKKQELVDRILTLLSDEQAARLLSKKNTVAKEAV 
PIL1                   MVIPATSRFGFRAEFNTKEFQASCISLANFTENFTPGFGECSEID--- 
PIL2                 MSTAAAARPVAGTGLREKTAASLVNSFRLASVTQRLRYHIQDGAKVDPKE 
 
SIZ1  AKLVDDTYRKMQVSGASDLASKGQVSSDTSNLKVKGEPEDPFQPEIKVRCVCGNSLETDSMIQCE 
PIL1  -------------AAIGRNEVPGNIQELALILNN----------------------------VCR 
PIL2  FQICCISFAKGIDFAIANNDIPKKVEEFPWLLKQ----------------------------LCR 
 
SIZ1  DPRCHVWQHVGCVILPDKPMDGNPPLPESFYCEICRLTRADPFWVTVAHPLSPVRLTATTIPNDG 
PIL1  RKCDDYQTRAVVMALMISVKSACQLGWFPERETQELLAIIDLMWNGFSCPEN----VTSCVNSPV 
PIL2  -HGTDVYTKTALMVLMISVKHACHLGWFSDSESQELIALADEIRTCFGSSGS----TSPGIKSPG 
 
SIZ1  ASTMQSVERTFQITRADKDLLAKPEYDVQAWCMLLNDKVLFRMQWPQYADLQVNGVPVRAINRPG 
PIL1  TLISQVIERFYPCVKLGHILVS---FEAKPESKMMMKDFHISKKMPHSPKQKVGLFVVRTEDISR 
PIL2  STFSQIMERFYPFVKLGHVLVS---FEVKAGYTMLAHDFYISKNMPHSLQEKIRLFVAQTDNIDT 
 
SIZ1  GQLLGVNGRDDGPIITSCIRDGVNRISLSGGDVRIFCFGVRLVKRRTLQQVLNLIPEEGKGETFE 
PIL1  SNCIVHPQGVSFLLNGKGIDKRVNISMESGPQLPTNVTALLNLGANLLQAIGCFGGSYLIAIAFM 
PIL2  SACISNPPEVSFLLNGKGVEKRVNIAMDTGPQLPTNVTAQLKYGTNLLQVMGNFKGNYIIIIAFT 
 
SIZ1  DALAR-VRRCIGGGGGDDNADSDSDIEVVADFFGVNLRCPMSGSRIKVAGRFLPCVHMGCFDLDV 
PIL1  DVIPLPNKPLLKDYVHPEVVGSNSDCDIIEGPSRISLSCPISRTRIKLPVKGHVCKHLQCFDFWN 
PIL2  GLVVPPEKPVLKDYLQSGVIEASPDSDIIEGPSRVSLSCPISRKRIKLPVKGQLCKHLQCFDFSN   
 
SIZ1  FVELNQRSRKWQCPICLKNYSVEHVIVDPYFNRITSKMKHCDEEVTEIEVKPDGSWRVKFKRESE 
PIL1  YVNMNTR------------------RHHGAARIILEEVGRN---AADVVISADGTWMVETENDED 
PIL2  YVHINMRNPTWRCPHCNQPVCYPDIRLDQNMAKILKDVEHN---AADVIIDAGGTWKVTKNTGET 
 
SIZ1  RRELGELSQWHAPDGSLCPSAVDIKRKMEMLPVKQEGYSDGPAPLKLGIRKNRNGIWEVSKPNTN 
PIL1  VELVPETTHDHGDPNSFINLGPTVKNPARD---ENEMETSTQVEEHNPCLSEIQGPSN----DTH 
PIL2  PEPVREIIHDLEDPMSLLNSGPVVFDLTGDDDAELEVFGDNKVEDRKPCMSDAQGQSNNNNTNKH 
 
SIZ1  GLSSSNRQEKVGYQEKNIIPMSSSATGSGRDGDDASVNQDAIGTFDFVANGMELDSISMNVDSGY 
PIL1  RPASDYTMLNQS-----------HTSTNTLPQLPRTLNAFDGQQFVNLPQVINTRDSPASQALPM 
PIL2  PSNDDYSSIFDISDVIALDPEILSALGNTAPQPHQASNTGTGQQYSNLSQIPMSIDP---MPVPV 
 
SIZ1  NFPDRNQSGEGGNNEVIVLSDSDDENDLVITPGPAYSGCQTDGGLTFPLNPPGIINSYNEDPHSI 
PIL1  TFSPTPSPQDILATNAANFGTSMPAAQSSQFQGSHVTSLGNCEGRTSDLMAR-WNHIYGRVQTQF 
PIL2  PFSQTPSPRDRPATTSTVFTIPNPSPQYSQVHASPVTPTGTYLGRT--TSPR-WNQTY-----QS 
 
SIZ1  AGGSSGLGLFNDDDEFDTPLWSFPSETPEAPGFQLFRSDADVSGGLVGLHHHSPLNCSPEINGGY 
PIL1  PPAPLSHHHYSMQNQSPSPAQQRPVPSYIAHPQTFHVNYGENADQRWMPSSIAHPQTLPVNYGGN 
PIL2  QAPPMTTPYTSRKVSVPVTSQS------------------------------------PANVSSF 
 
SIZ1  TMAPETSMASVPVVPG-----------------STGRSEANDGLVDNPLAFGRDDPSLQIFLPTK 
PIL1  TNQRPIPSSIAHPQTLPVNYRGNTDHRSTPYSITHLQTLLNYGGNADQRPMPSSITNLQTLPATY 
PIL2  VQSQHVPRVLSQPN--------------------------NYG--------------VRGLTSSH 
 
SIZ1  PDASAQSGFKNQADMS--------------------------------------------NGLRS 
PIL1  GGYAHQRPMSSSITHPRTSPVNYGGTPDQRPMPSSITHPQTLPVSYGGTTDQILNPGGAMGQFSS 
PIL2  ASTSRQHPSGPTVQS--------------------------------------------VSRLSD 
 
SIZ1  EDWISLRLGDSASGNHGDPATTNGINSSHQMSTREGSMDTTTETASLLLGMNDSRQDKAKKQRSD 
PIL1  REFMNLTPANTENWRPQSRMRGSVAPG---TGYDHMIIHPTRPVHPQAQTPPAPLSTSYDGADEI 
PIL2  LVDVDLTVPDTSNWRP--RMRGSLVPGSHSTALDHMIIRPSQ--QSQTSTRLNSSQPVQTPSVQT 
 
SIZ1  NPFSFPRQKRSVRPRMYLSIDSDSETMNRIIRQDTGV------ 
PIL1  QAFIGHPSYPVSNNETQAGTSSLPVAEGLGYSGSFWSMPPETW 
PIL2  SQAQSPFTTAAYRTETVLGNRNHPVPAPPGIVRPTGPTS---- 
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As demonstrated above in Figure 2.9, SIZ1 has in contrast to PIL1 and PIL2 two 
additional domains: a SAP domain and a PHD finger. It is also striking that SIZ1 
possesses different high probability SUMOylation consensus motifs that are 
absent in the two other proteins.  
Nevertheless, all three proteins contain SP-RING domains. This domain type is 
also called zf-MIZ and confers SUMO ligase activity and shows similarity to the 
RING domain found in Ubiquitin ligases (Cheng et al., 2007; Wu et al., 1997; Zhao 
& Blobel, 2005). The occurrence of this domain indicates a SUMO ligase function. 
In contrast to the other two proteins, the potential zf-MIZ domain of PIL1 is 
slightly shorter and lacks two cysteines and a proline residue close to the end of 
the domain that are conserved in SIZ1 and PIL2. To investigate the potential 
SUMO ligase function of PIL1 and PIL2, the amount of SUMO conjugates in the 
respective mutants was analyzed. 
 
 
2.3.2 SUMO conjugates of SUMO ligase mutants 
The SP-RING domain of the PIAS-Like family suggests a SUMO ligase function of 
these proteins. To analyze this hypothesis, the amount of SUMO conjugates of 
different PIAS-like mutant plants was analyzed as shown in Figure 2.10, because 
the knockout of a SUMO ligase could lead to a decrease in SUMO conjugates. 
  
  
 
Figure 2.10: SUMO1 conjugates of different SUMO ligase candidate mutants
 The total protein amount of plant extracts 
detected by Coomassie stain (panel A). Afterwards, equal protein amounts were 
tested for SUMO conjugates 
plant extract prepared under denaturing conditions was separated 
SUMO1 conjugates were detected with anti
secondary anti rabbit antibody coupled to alkaline phosphatase (upper
horse radish peroxidase (lower panel). The experiment with horse radish 
peroxidase coupled ant
MPIZ, and signals were detected with the LumiImager system. Untreated plants 
were compared to those that were heat shocked for an hour at 37°C.
Results
of different SUMO ligase mutants was 
as demonstrated in panel B. Therefore an aliquot of 
via SDS
-SUMO1 antibody (ABCAM) and 
ibody was performed together with Dr. Kishore Panigrahi, 
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In Figure 2.10, the detection of SUMO1 conjugates of different SUMO ligase 
mutants is shown. Untreated plants and those that underwent a heat shock 
treatment for an hour at 37°C were compared. In wild type plants under normal 
conditions few higher molecular weight bands were detected, indicating a low 
level of SUMO conjugates. The amount of these conjugates increased strongly after 
heat shock treatment. Siz1 mutant plants show fewer conjugates and do not 
respond to heat shock as strongly as wild type. The weaker allele siz1f shows a 
higher amount of SUMO conjugates after stress treatment compared to the siz1a 
mutant that has a stronger phenotype.  
In the pil1 mutant the overall amount of SUMO conjugates is slightly decreased 
compared to the untreated wild type and the level of conjugates does not differ 
significantly with and without heat shock treatment. In contrast to this, the pil2 
mutant shows an accumulation of SUMO conjugates under normal conditions that 
equals the amount after heat shock treatment both in pil2 and the wild type control 
plant. The pil1pil2 double mutants have slightly reduced SUMO conjugates under 
normal conditions and show an increase of SUMO modified proteins after stress 
treatment that is weaker than those observed in wild type but significantly 
stronger than in the siz1 mutants. 
 
 
2.3.3 Phenotypic analysis of pil mutant plants 
To investigate the role of PIL proteins in plant development, the growth and 
flowering phenotype of different pil single and double mutants was monitored. 
Figure 2.11 shows plants grown under long day and short day conditions. 
 
  
Figure 2.11: SUMO ligase mutant plants grown under different light 
 Above different SUMO ligase 
conditions (16 hours light) or short day conditions (eight hours light), are shown.
As demonstrated in Figure 
described before. In contrast to this, the 
two analyzed lines of pil1pil2
wildtype control under both long day and short day conditions.
Additionally, the flowering time of the different ligase mutants was monitored 
under different light conditions, because it was already known that s
flower early (Jin et al., 2008). The results of these experiments are listed below.
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mutants that were grown either under long day 
 
2.11, siz1 mutant plants are dwarfish and bushy as 
pil1 and pil2 single mutants as well as the 
 double mutants cannot be distinguished from the 
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iz1 mutants 
 
  
Table 2.2: Flowering time analysis of different SUMO ligase mutants
 
 
light genotype mean 
 LD Col 0 WT 11,29
 siz1a 11,11
 siz1c 9,33
 siz1f nt
 pil1apil2b 10,95
 pil1cpil2a 11,00
 LD Col 0 WT 28,57
 siz1a 9,77
 siz1c 10,00
 siz1f 20,94
 pil1apil2b 25,77
 pil1cpil2a 25,82
 ex SD Col 0 WT 42,33
 siz1a 28,14
 siz1c 30,86
 siz1f nt
 pil1apil2b 36,52
 pil1cpil2a 45,52
 SD Col 0 WT 63,14
 siz1a 52,47
 siz1c 61,94
 siz1f 92,06
 pil1apil2b 86,94
 pil1cpil2a 92,18
 
The results of a one way comparison conducted with SigmaPlot 10 and SigmaStat 3 are shown. An 
overall significance level of 0.01 was chosen. 
Results
rosette leaves cauline leaves
st dev significance mean st dev 
 1,45  1,62 0,81
 1,69 no 1,67 1,00
 1,33 yes 1,72 0,58
 nt nt nt nt
 1,64 no 2,20 0,52
 1,58 no 6,04 0,50
 10,55  3,86 1,23
 3,46 yes 3,29 0,77
 4,62 yes 3,06 0,75
 5,41 no 4,00 0,08
 6,92 no 4,18 0,95
 7,33 no 6,14 0,09
 5,09  6,00 1,00
 8,24 yes 4,38 1,88
 7,33 yes 4,33 1,24
 nt nt nt nt
 5,21 no 5,91 1,04
 4,71 no 6,25 0,66
 23,08  6,71 2,27
 21,21 no 5,60 1,55
 20,18 no 5,31 1,20
 11,63 yes 9,44 2,31
 11,09 yes 8,59 1,00
 12,44 yes 6,36 0,95
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For an easier overview, the results of these flowering time experiments are shown 
graphically in Figure 2.12. 
Figure 2.12: Flowering time of different SUMO ligase mutants
 The flowering time of different 
was analyzed under various light conditions as indicated. Rosette and cauline 
leaves were counted at the time of opening of the first flower bud. A one way 
comparison of the data was carried out with an overall significance level of 0.01. 
Bars represent mean numbers of leaves for different light regimes, 
deviation indicated as arrow bars. Values that differed significantly from wild 
type are marked by an asterisk above the respective bar.
 
The flowering time of the different S
various light conditions. Two experiments were performed under long day 
conditions with 16 hours of light per day and single data sets were available for 
extended short day (10 hours of light) and short day conditions 
light per day. 
Under long day condition, an early flowering of 
of siz1a in one experiment was observed. In contrast to these two lines, 
not flower significantly earlier compared to the Columbia 
At ten hours of light per day (extended short day), the tested 
mutants also flowered earlier and had on average two cauline leaves less 
compared to wild type. These differences were not observed under eight hours 
Results
 
siz1 mutant lines and the pil1pil2 double mutants 
 
UMO ligase mutants was analyzed under 
with eight hours 
siz1c line in both experiments and 
wild type in long day. 
siz1a
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with standard 
siz1f did 
 and siz1c 
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light per day (short day) but in this case, the siz1f plants flowered later as the wild 
type by nearly thirty rosette leaves. Additionally, siz1f produced more cauline 
leaves during this experiment.(Jin et al., 2008b)  
The pil1pil2 double mutants differed only significantly in short day from the 
Columbia wild type. On average, the pil1apil2b and pil1cpil2a possessed from more 
than twenty up to nearly thirty rosette leaves more under this condition and the 
pil1cpil2a line produced excess cauline leaves as well. 
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2.4 The Arabidopsis SUMO protease Early in Short Days- 
Like 1 (EL1) 
Not only SUMO ligases play an important role during SUMOylation. Another 
class of proteins regulating SUMOylation are the SUMO proteases, because they 
control the abundance of mature SUMO moieties and can de-SUMOylate 
substrates. 
In Arabidopsis several genes encoding potential SUMO proteases are found (Colby 
et al., 2006; Novatchkova et al., 2004). Three of them show similarity to the yeast 
SUMO protease Ulp1. One of these, named Early in Short Days 4 (ESD4, 
At4g15880) has already been described (Murtas et al., 2003; Reeves et al., 2002). It is 
involved in flowering time control and is located mainly at the inner side of the 
nuclear envelope (Murtas et al., 2003; Reeves et al., 2002). 
The other two members with similarity to the yeast SUMO protease Ulp1, the 
Ulp1b (At4g00690) and Ulp1a (At3g06910) are less well described. However, a 
close homology of Ulp1a to ESD4 was shown, so it is also named Early in Short 
Days 4 –Like 1 (EL1) and Dr. Yong Fu-Fu in the laboratory of Prof. George 
Coupland demonstrated in vitro SUMO protease activity for this protein (Yong Fu-
Fu, unpublished data). 
In this work, the role of EL1 (Ulp1a) was further investigated. 
 
 
2.4.1 Domain structure of El1 
EL1 and Ulp1b are the closest homologs of ESD4 in Arabidopsis. 
In Figure 2.13, an alignment of all three Ulp1-related open reading frames of 
Arabidopsis is shown. 
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A: Residues, conserved in the Ulp1a type SUMO proteases of Arabidopsis  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
ESD4   --MGAVAINRKRSDESFNFINQQSTNPLRNSPYFQ------ASKKRRFSFAMSEDSGKPA  
Ulp1b  ------------------------------------------------------------ 
EL1    MKNQSRVLNSELGDFDLSVLWDQILNFEGYGSYCFRPMDMDGYHKRSAGLNPCKHSGFSH                                                          
 
ESD4   SSNPTISRISRYPDAKAPLRREIHAPSRGILRYGKAKSNDYCEKDAN--FFVRKYDDAKR  
Ulp1b  ------------------------------------------------------------ 
EL1    SSRPMAPGIYRYPEVKSSLRRQVHAPVR-ILNSGRDRSTRQGSGNVLGTFLTRNNDMWKR  
                                                                            
ESD4   SALEALRFVNKGKDFVDLGDEVEKEEVVSDDSSVQAIE--VIDCDDDEEKKNLQPSFSSG  
Ulp1b  ------------------------------------------------------------ 
EL1    NALDSSLRYRTDREVIDVDDELGDVEMISDDTSREGVENVAMEVDEVEEKAEMGNGLFSE  
                                                                            
ESD4   VTDVKKGENFRVEDTSMMLDSLSLDRDVDNDASSLEAYRKLMQSAEKRNSKLEALGFEIV  
Ulp1b  ----------------MFVD--------------------AMQDLALVNS----------
EL1    VASLKNG-SLRVGECSKANSSSLVVNRPVTDVTSFEAYRKVLESAVNRTSKLKDRGFVDF  
 
ESD4   LNEKKLSLLRQSR---PKTVEKRVEVPREPFIPLTEDEEAEVYRAFSGRNRRKVLATHEN  
Ulp1b  --------------------------------------------ALSKRNRKKILVSHKN  
EL1    FKERGRALLRSLSSFWRQDEEPVEVVQREAFVPLSREEETAVRRAFSAND-SNILVTHKN  
 
ESD4   SNIDITGEVLQCLTPSAWLNDEVINVYLELLKERETREPKKYLKCHYFNTFFYKKLVS-D  
Ulp1b  SNIDISGETLQCLRPNQWLNDDVTNLYLELLKERQTRDPQKYFKCHFFNTFFYVKLVS-G  
EL1    SNIDITGKILRCLKPGKWLNDEVINLYMVLLKEREAREPKKFLKCHFFNTFFFTKLVNSA  
 
ESD4   SGYNFKAVRRWTTQRKLGYALIDCDMIFVPIHRGVHWTLAVINNRESKLLYLDSLN-GVD  
Ulp1b  SGYNYKAVSRWTTKRKLGYDLIDCDIIFVPIHIDIHWTLGVINNRERKFVYLDSLFTGVG  
EL1    TGYNYGAVRRWTSMKRLGYHLKDCDKIFIPIHMNIHWTLAVINIKDQKFQYLDSFK-GRE  
 
ESD4   PMILNALAKYMGDEANEKSGKKIDANSWDMEFVEDLPQQKNGYDCGMFMLKYIDFFSRGL 
Ulp1b  HTILNAMAKYLVDEVKQKSQKNIDVSSWGMEYVEERPQQQNGYDCGMFMLKYIDFYSRGL  
EL1    PKILDALARYFVDEVRDKSEVDLDVSRWRQEFVQDLPMQRNGFDCGMFMVKYIDFYSRGL  
 
ESD4   GLCFS-------QEHMPYFRLRTAKEILRLRAD  
Ulp1b  SLQFSQVIRDVIKKDMPYFRLRTAKEILRLRAD  
EL1    DLCFT-------QEQMPYFRARTAKEILQLKAE  
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B: SUMOylation consensus sites and potential SUMO interaction motifs 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.13: Alignment of Arabidopsis SUMO proteases of the Ulp1 type 
 
 An alignment of the protein sequences of the three members of the Arabidopsis 
SUMO proteases of the Ulp1 type is shown. Identical residues are highlighted in 
yellow while conservative amino acid changes are marked in blue in panel A.  
In panel B, SUMOylation consensus motifs with a score ≥ 0.90 are shown with red 
letters, those with a probability of ≥ 0.65 in blue. Potential SUMO interaction motifs 
(SIMs) with the sequence V/I/L x V/I/L V/I/L or V/I/L V/I/L x V/I/L are indicated by 
green letters. SUMO consensus motifs were determined with the SUMOplot tool 
(http://www.abgent.com/tools/sumoplot). 
The conserved Peptidase_C48 domain in all three proteins is highlighted in red in 
both panels and was detected with the PFAM webservice (http://pfam.sanger.ac.uk).  
 
 
 
ESD4   --MGAVAINRKRSDESFNFINQQSTNPLRNSPYFQ------ASKKRRFSFAMSEDSGKPA  
Ulp1b  ------------------------------------------------------------ 
EL1    MKNQSRVLNSELGDFDLSVLWDQILNFEGYGSYCFRPMDMDGYHKRSAGLNPCKHSGFSH                                                                       
 
ESD4   SSNPTISRISRYPDAKAPLRREIHAPSRGILRYGKAKSNDYCEKDAN--FFVRKYDDAKR  
Ulp1b  ------------------------------------------------------------ 
EL1    SSRPMAPGIYRYPEVKSSLRRQVHAPVR-ILNSGRDRSTRQGSGNVLGTFLTRNNDMWKR  
                                                                            
ESD4   SALEALRFVNKGKDFVDLGDEVEKEEVVSDDSSVQAIE--VIDCDDDEEKKNLQPSFSSG  
Ulp1b  ------------------------------------------------------------ 
EL1    NALDSSLRYRTDREVIDVDDELGDVEMISDDTSREGVENVAMEVDEVEEKAEMGNGLFSE  
                                                                            
ESD4   VTDVKKGENFRVEDTSMMLDSLSLDRDVDNDASSLEAYRKLMQSAEKRNSKLEALGFEIV  
Ulp1b  ----------------MFVD--------------------AMQDLALVNS----------
EL1    VASLKNG-SLRVGECSKANSSSLVVNRPVTDVTSFEAYRKVLESAVNRTSKLKDRGFVDF  
 
ESD4   LNEKKLSLLRQSR---PKTVEKRVEVPREPFIPLTEDEEAEVYRAFSGRNRRKVLATHEN  
Ulp1b  --------------------------------------------ALSKRNRKKILVSHKN  
EL1    FKERGRALLRSLSSFWRQDEEPVEVVQREAFVPLSREEETAVRRAFSAND-SNILVTHKN  
 
ESD4   SNIDITGEVLQCLTPSAWLNDEVINVYLELLKERETREPKKYLKCHYFNTFFYKKLVS-D  
Ulp1b  SNIDISGETLQCLRPNQWLNDDVTNLYLELLKERQTRDPQKYFKCHFFNTFFYVKLVS-G  
EL1    SNIDITGKILRCLKPGKWLNDEVINLYMVLLKEREAREPKKFLKCHFFNTFFFTKLVNSA  
 
ESD4   SGYNFKAVRRWTTQRKLGYALIDCDMIFVPIHRGVHWTLAVINNRESKLLYLDSLN-GVD  
Ulp1b  SGYNYKAVSRWTTKRKLGYDLIDCDIIFVPIHIDIHWTLGVINNRERKFVYLDSLFTGVG  
EL1    TGYNYGAVRRWTSMKRLGYHLKDCDKIFIPIHMNIHWTLAVINIKDQKFQYLDSFK-GRE  
 
ESD4   PMILNALAKYMGDEANEKSGKKIDANSWDMEFVEDLPQQKNGYDCGMFMLKYIDFFSRGL 
Ulp1b  HTILNAMAKYLVDEVKQKSQKNIDVSSWGMEYVEERPQQQNGYDCGMFMLKYIDFYSRGL  
EL1    PKILDALARYFVDEVRDKSEVDLDVSRWRQEFVQDLPMQRNGFDCGMFMVKYIDFYSRGL  
 
ESD4   GLCFS-------QEHMPYFRLRTAKEILRLRAD  
Ulp1b  SLQFSQVIRDVIKKDMPYFRLRTAKEILRLRAD  
EL1    DLCFT-------QEQMPYFRARTAKEILQLKAE  
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As shown in the alignment above, all three proteins contain a so called 
Peptidase_C48 domain, which is typical for cysteine proteases involved in 
cleavage of SUMO precursors or SUMOylated conjugates (Mossessova & Lima, 
2000). Although the catalytic domains of ESD4 and Ulp1b show a high similarity, 
the Ulp1b protein is far smaller and lacks the amino terminal extension that is 
found in both ESD4 and EL1. Therefore ESD4 and EL1 have overall a higher 
similarity to each other than to Ulp1b and subsequent experiments focused on EL1 
rather than on Ulp1b. Both ESD4 and El1 have a conserved SUMOylation 
consensus motif on the amino terminal side of the peptidase domain 
(TDVKKGEN, VASLKNGSL), and ESD4 has an additional high probability 
SUMOylation site (PDAKAPLR) closer to the amino terminus that is not found in 
the other two proteases. EL1 differs from the other two proteins in its SUMO 
interaction motifs (SIMs). While in Ulp1b and ESD4 only a single potential SIM is 
found at the amino terminal side of the catalytic domain, EL1 has four potential 
interaction motifs in this region. 
 
 
2.4.2 Localization of EL1 
After attempts to express EL1 as a GFP-fusion protein in Arabidopsis failed, EL1-
GFP constructs were transiently expressed in Nicotiana benthamiana leaves and 
their localization was detected by confocal microscopy with the help of the CeMic 
group at the MPIZ. The results of these experiments are shown in Figure 2.14. 
 
  
Figure 2.14: Localization of El1
 Carboxyl and amino terminal fusion of El1 to GFP were transiently expressed in 
Nicotiana benthamiana
panel, the nucleus was stainend with propidium iodide. The experiments were 
conducted by Dr. Elmon Schmelzer and Rainer Franzen 
MPIZ.  
 N: Nucleus 
V: Vesicels 
 
As demonstrated above, the localization of both EL1
analyzed in Nicotiana benthamiana
completely absent from the nucleus, but found in vesicular structures that might 
be connected to cytoplasmic 
protein. The aggregates observed in case of GFP
protein expression. The propidium iodide stain in the lower panel shows clearly 
that the EL1-GFP is not nuclear or at the nuclear
the nucleus in a structure that may be part of the ER.
 
 
2.4.3 Phenotypic analysis of 
Different el1 mutant lines were analyzed for their growth and flowering 
phenotype, because it is known that mutants of the 
extremely early under short days and are dwarfish and bushy.
Results
 
 leaves and detected by confocal microscopy. In the
at the CeMic fac
A: Aggregates 
C: Cytoplasmic strands 
-GFP and GFP
 leaves. Both fusion proteins were almost 
strands as observed for the carboxy terminal fusion 
-EL1 might be due to strong 
 envelope, but partially surrounds 
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Figure 2.15 shows various el1 
Figure 2.15: Different el1 mutants grown under short day conditions
 Comparison of the growth habit of different 
conditions (eight hours light
wild type plants and a 
 
In short days with eight hours light per day, a condition that leads to an extremely 
bushy and dwarfish phenotype of 
not differ strongly from wild type. All three lines reach a similar height as the 
Wassilewskija wild type control, and show a number of side shoots in between 
those of Columbia and Wassilewskija wild type. The 
serrated leaves, which were already observed by Dr. Yong Fu
mutant line in the background of Wassilewskija. In case of this line, which carries 
a mutation in the first exon of the el1 gene, slightly thinner stems compared to 
wild type were observed. In contrast to this, the other lines 
both in the background of the ecotype Columbia did not differ in stem thickness 
from wild type. To further investigate this observation, the tissue composition of 
stems of the el1a was investigate
Results
mutant lines grown under SD.  
el1 mutants, grown under short day 
 per day). As controls, Columbia and Wassilewskija 
siz1 mutant plant are shown as well. 
esd4 mutants, the different tested
el1 mutants have slightly 
-Fu for the 
el1b and 
d as demonstrated in Figure 2.16 . 
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 el1 lines do 
el1a 
el1c that are 
  
Figure 2.16: Altered tissue composition of 
 Comparison of the stem thickness and tissue composition of 
Wassilewskija (WS) 
utilized. The main 
stained either with Astralblue and Safranin T or
All pictures are shown with the sam
 
In Figure 2.16, the stems of 
type. Stems of plants of the same developmental state that just begun to flower, 
were cut and stained with Safranin T or Safranin T and Astralblue. The 
combination of the two dyes Astrablue and Safranin T (lef
el1a shoots have less mark compared to Wassilewskija wild type main shoots.
To rule out that the proportional thicker vascular tissue is due to the overall size of 
the stem, a wild type side shoot with similar diameter was analyzed as well. In the 
wild type side shoot, the area of the vasculature, which is stained brightly blue by
the Astralblue/ Safranin T stain, is thinner than that of the 
thickness. 
The stain with Safranin T (right panel) confirmed that the vascular tissue of the 
el1a main shoot is far thicker compared to the stem of the wild type plant,
although overall the stem of 
wild type one. Again, this observation cannot be explained by the total size of the 
shoot, because a thinner wild type side shoot possesses a significantly slimmer 
Results
el1 line 1 stems 
el1a and 
wild type plants. Plants that just started to flower were 
stems were cut above the first cauline leaf and slices were 
 only with Safranin T
e magnification. 
el1a mutant plants are shown in comparison to wild 
t panel) indicates that 
el1 shoot with a similar 
el1a has approximately only half the diameter of the 
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 as indicated. 
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outer layer compared to the el1a. In the main shoot of Wassilewskija, a pink ring is 
visible after the Safranin T staining that could be interfascicular cambium 
indicating secondary radial growth. A similar structure could not be observed in 
the analyzed el1a shoot. 
The flowering time of the different el1 lines was also monitored. The results of two 
experiments under long day conditions and a single experiment under eight hours 
of light are summarized in Table 2.3. 
  
  
Table 2.3: Flowering time analysis of different
 
 
light genotype mean 
 LD Col 0 WT 12,18
 WS WT 8,82
 el1a 9,58
 el1b 12,33
 el1c 11,09
 siz1f 10,18
 LD Col 0 WT 14,36
 WS WT 9,60
 el1a 10,83
 el1b 15,83
 el1c 15,33
 siz1f 13,25
 SD Col 0 WT 72,13
 WS WT 63,00
 el1a 48,91
 el1b 64,33
 el1c 78,80
 siz1f 44,00
 
The results of a one way comparison conducted with SigmaPlot 10 and SigmaStat 3 are shown. An 
overall significance level of 0.01 was chosen. 
type (WS WT) and the other two lines to Columbia 0, because the mutations are in the respective 
background. 
 
 
 
 
Results
 el1 lines 
rosette leaves cauline leaves
st dev significance mean st dev 
 1,60  2,64 0,51
 1,99  3,00 0,78
 0,79 no 6,50 1,09
 1,72 no 2,58 0,67
 1,92 no 2,73 0,47
 1,08 no 2,82 0,75
 4,46  2,82 0,60
 1,43  3,30 0,48
 0,84 no 2,67 0,49
 3,27 no 3,50 0,52
 3,23 no 3,50 0,80
 3,39 no 3,25 0,62
 26,65  10,88 2,80
 31,71  7,64 0,81
 24,28 no 5,82 1,60
 26,19 no 11,00 4,30
 23,34 no 11,30 3,20
 16,54 no 10,67 2,18
The el1 line1 was compared to the Wassilewskija wild 
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For a better overview, these data are graphically presented in 
 
Figure 2.17: Flowering time of different 
 The flowering time of different 
short day conditions, with sixteen or eight hours light per day, respectively. 
Rosette and cauline leaves were counted at the opening time of 
bud. A one way comparison of the data was conducted with an overall 
significance level of 0.01
and the according standard deviation (arrow bars)
differed significantly from the wild type under the same condition are indicated 
by an asterisk. As the 
el1b and c are in the background of the ecotype Columbia, the li
compared to the respective wild type.
The analysis of the flowering time of different 
above in Table 2.3 and summarized in 
different ecotypes were monitored as control, because the 
background of Wassilewskija while the 
background.  
All three analyzed el1 mutant lines did not differ significantly from the respective 
wild type in their number of rosette leaves at the opening of the first flower. Only 
the number of cauline leaves of 
Wassilewskija during one experiment under long day conditions. Nevertheless, 
Results
Figure 2
el1 lines 
el1 mutant lines was monitored under long and 
the first flower 
 Above the mean number of leaves during that time point 
 are shown and values that 
el1a line is in the background of Wassilewskija and the lines 
 
 
el1 mutant lines is demonstrated 
Figure 2.17. In these experiments, two 
el1a line is in the 
el1b and el1c are in the Columbia 
el1a was significantly increased in comparison to 
50  
.17. 
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this was not observed in a second experiment under long day, in which the 
number of cauline leaves of el1a and the wild type control equaled.  
Furthermore, siz1f was analyzed in parallel, but this mutant line did not differ 
significantly from wild type (Columbia) in any experiment. 
Additionally it has to be mentioned that the standard deviation (st dev) in the 
experiment with short day conditions is extremely high and that this experiment 
was conducted with a different batch of soil. 
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2.5 Early in Short Days 4 (ESD4), a SUMO protease  
involved in flowering time control 
As mentioned before, Early in Short Days 4 (ESD4, At4g15880) is a SUMO protease 
of the Ulp1 type, which is involved in the control of flowering time (Murtas et al., 
2003; Reeves et al., 2002). Probably, ESD4 can delay flowering via control of FLC, a 
floral repressor, and mutants of this SUMO protease flower extremely early under 
short day conditions (Murtas et al., 2003; Reeves et al., 2002). This protein is mainly 
nuclear and enriched at the inner side of the nuclear envelope. It contains the 
Peptidase_C48 domain (Figure 2.13) that is typical for SUMO proteases of the 
Ulp1 type, and its SUMO protease activity has already been demonstrated (Murtas 
et al., 2003; Reeves et al., 2002).  
The esd4 mutants do not only flower early, but have a reduced apical dominance 
and growth. This observation resembles the phenotype of the bushy and dwarfish 
siz1 mutant plants. As it is known that the growth defect of siz1 is at least partly 
due to an increased level of salicylic acid in those mutant plants, it was assumed 
that an exaggerated amount of this phyto hormone in esd4 might (partly) cause the 
observed growth phenotype. Therefore esd4 mutant plants were crossed with sid2 
plants that are defective in salicylic acid biosynthesis. The offspring of this cross 
was monitored for rescue of the esd4 induced growth effect due to decreased 
salicylic acid levels by the introduced sid2 mutation.  
Figure 2.18 shows the growth phenotype of those plants. 
  
 
Figure 2.18: Phenotype of esd4 sid2 
 Wild type, sid2 and 
grown under LD conditions are shown in the upper panel. Below, different crosses 
of esd4 to sid2 are shown. The plants were grown in summer time during a rather 
warm period. 
 
As already mentioned, esd4
bushy even under long day conditions. This extreme growth phenotype is not so 
pronounced in the heterozygous 
the homozygous mutants and less arborescent.
Results
plants 
esd4 homozygous (hom) and heterozygous (het) mutants 
 homozygous mutants are dwarfish and extremely 
esd4 plants, which are significantly bigger than 
 
53  
 
 
  
54 Results 
A similar result was obtained for the cross of esd4 plants with a sid2 line. The 
resultant esd4(hom)sid2(hom) and esd4(het)sid2(het) offspring showed a similar 
growth phenotype as the esd4 homo- or heterozygous plants, respectively.  
 
 
 
2.6 The bacterial effector protein Factor X 
It is known that some pathogens try to undermine the resistance system of their 
host by modulating post-translational protein modification in the host cell 
(Janjusevic et al., 2006; Orth et al., 2000). Some of these bacterial virulence factors 
possess Ubiquitin or SUMO protease activity towards host proteins (Angot et al., 
2007; Orth et al., 2000). It has been demonstrated that plant pathogens produce 
different virulence factors, which are secreted into plant cells via a bacterial type 
III secretion system. Some of these effectors possess SUMO protease activity 
(Gurlebeck et al., 2006; Hotson et al., 2003; Roden et al., 2004). 
In cooperation with Prof. Ulla Bonas and Robert Szczesny from the Martin-Luther-
University in Halle, Germany, the bacterial effector Factor X from the pathogen 
Xanthomonas campestris was tested for in vitro SUMO and Ubiquitin protease 
activity.  
 
 
2.6.1 In vitro protease activity of Factor X 
To test the ability of Factor X to cleave Ubiquitin and SUMO conjugates, this 
potential protease was produced as a recombinant protein in E. coli and its activity 
against different fusion proteins was tested. The results of this experiment are 
shown in Figure 2.19.  
  
  
 
Figure 2.19: Test for protease activity of Factor X 
 Recombinant Factor X, a mutant variant of Factor X, in which the potential 
catalytic Cysteine is mutated, or a fragment of the SUMO protease ESD4 were 
incubated with SUMO1 or SUMO3 fu
lower panel shows incubations to probe the ability of Factor X to cleave a 
recombinant Rub1 (Nedd8) fusion protein or commercially available Ubiquitin 
chains with a K48 or mixed linkages (BostonBiochem). As controls
recombinant proteases NEDP1 (a Nedd8 protease), A20 and USP7
proteases) were used (BostonBiochem). The samples were incubated in ATP and 
zinc containing buffer overnight at 30°C. Reactions were stopped by adding the 
cysteine protease 
2 mM, in negative controls (upper panel) the inhibitor was added prior to 
incubation. An aliquot of the reaction mixture was separated by SDS
analyzed via Western blot with antibody aga
Ubiquitin serum (A. Bachmair). Secondary antibody coupled to horse radish 
peroxidase was used for visualization of substrates.
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As shown above, the ability of Factor X to cleave SUMO fusion proteins was 
tested. In case of the SUMO1 fusion protein, the sample with potentially active 
Factor X does not differ significantly from the control with Factor X mut, in which 
the proposed catalytically active cysteine residue is mutated, or from the negative 
control in which protease inhibitor (NEM) was added prior to incubation. In 
contrast to this, a functional fragment of ESD4 was able to cleave the SUMO1 
fusion protein. This reaction could be inhibited by the cysteine protease inhibitor 
N-ethylmaleimide. Similar results were obtained for SUMO3. Again no protease 
activity was observed for Factor X, while the ESD4 fragment cleaved the SUMO3 
fusion protein. 
The activity of Factor X towards other protein modifiers was analyzed as well. 
Factor X showed no activity against fusion proteins with Rub1, the Arabidopsis 
orthologue to the mammalian Nedd8. Whereas commercially available, human 
recombinant Nedd8 protease NEDP1 cleaved this construct, indicated by the 
occurrence of a smaller molecular weight band representing the fusion protein 
without Rub1. 
Different Ubiquitin chains were also tested. Factor X was not able to cleave K48-
linked Ubiquitin chains, which were degraded by NEDP1 and human 
recombinant A20 as indicated by the occurrence of a band with smaller molecular 
weight. In case of USP7 no smaller weight band occurred, but in general this lane 
stained less intense indicating lower substrate input. The activity against 
Ubiquitin chains with a mixed K48 and K63 linkage was tested as well. Factor X 
showed no cleavage of these constructs. In case of the human recombinant 
Ubiquitin ligase A20 and USP7 and the Nedd8 specific NEDP1 no breakdown 
products could be observed but the bands with a molecular weight of 49 kDa, 
indicating di-Ubiquitin, are significantly weaker. 
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3 DISCUSSION 
As during this work several aspects of SUMOylation were investigated, they are 
discussed separately in the following part. Later on, a conclusion gives an 
overview and integration of all achievements. 
 
 
 
3.1 In vitro SUMOylation assays – a handy technique 
In this work an in vitro SUMOylation assay system was established based on plant 
recombinant proteins that allows quick analysis of various proteins for their in 
vitro modification with different SUMO isoforms. 
 
 It turned out to be highly difficult to express and purify the Arabidopsis SUMO 
conjugating enzyme (SCE) in a stably active form from E. coli. Nevertheless it 
might be worth the effort, because the comparison of the plant recombinant 
enzyme to human recombinant SCE, which is commercially available, indicates 
that the Arabidopsis protein can utilize the SUMO isoform 3 with higher efficiency 
(Figure 2.1). Still, for SUMO1 such a difference was not detected. Due to this 
observation and the fact that the production of stably active plant recombinant 
SAE and SCE is quite challenging, commercially available human recombinant 
enzymes (BostonBiochem) were used in some subsequent experiments. Maybe 
human recombinant proteins have a lesser ability to use plant SUMO3, because 
this SUMO isoform differs rather significantly from the known mammalian SUMO 
variants. In contrast to this, Arabidopsis SUMO1 and SUMO2 show higher 
similarity to human SUMO2 and SUMO3, not only in their sequence, but also 
biologically in the formation of SUMO conjugates after stress treatment (Dohmen, 
2004; Kurepa et al., 2003; Novatchkova et al., 2005). It might therefore be possible 
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that human recombinant enzymes can utilize Arabidopsis SUMO1 and SUMO2 
with moderate efficiency, while the more distinct isoforms like SUMO3 are 
conjugated to a lesser extent. 
 
The ability of the different SUMO moieties to form chains in vitro was analyzed as 
shown in Figure 2.2. SUMO1 and SUMO1 Q90A, in which a residue at position -4 
from the carboxyl terminus is mutated, form chains in an identical pattern and to a 
similar extent. The differences in band intensity in the shown experiment are 
easily explained by the unequal amount of SUMO1 versus SUMO1 Q90A protein 
used. Both varieties form constructs with a molecular weight according to tetra-
SUMO chains. In contrast to this, chain formation of SUMO3 and SUMO5 leads to 
only a single higher migrating band that agrees with a di-SUMO conjugate.  
The ability of SUMO1 and SUMO1 Q90A to form chains with high efficiency 
might be due to lysine residues at position nine and ten in both proteins. These 
amino acids are conserved in SUMO2, where the second lysine at position ten is 
part of a typical SUMOylation consensus motif, and Colby et al. demonstrated 
chain formation of SUMO2 via those residues (Colby et al., 2006). SUMO3 has a 
lysine and a proline residue at this position, which might lead to weaker in vitro 
chain formation, because the lysine moiety is no longer part of a canonical 
consensus motif. 
SUMO5 has at position nine and ten a serine and a proline, respectively. These 
residues might constrain chain formation and in case of the in vitro experiment, it 
cannot be ruled out that not only SUMO chains but other conjugates are detected 
that are stable during the gel electrophoresis under denaturing conditions. For 
example, stable SIZ-dependent SUMOylation of the SCE or the SIZ1 ligase itself 
was recently observed during in vitro SUMOylation assays with Arabidopsis 
proteins (Garcia-Dominguez et al., 2008). For the yeast and mammalian ortholog of 
the SCE, SUMOylation was reported as well, and it cannot be ruled out that 
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conjugates of SUMO and the conjugating enzyme are detected (Knipscheer et al., 
2008). 
The in vitro chain formation of various SUMO isoforms was also used to analyze 
the impact of the different enzymes. Comparison of the two different subunits of 
the activating enzyme, SAE1a and SAE1b, showed that the latter had a higher 
activity during in vitro experiments. Due to this, the SAE1b isoform was used later 
on. 
It was also demonstrated that addition of a functional fragment of the SUMO 
ligase SIZ1 increases in vitro SUMOylation or SUMO chain formation and 
therefore this protein was added during in vitro SUMOylation experiments. SIZ1 
might enhance the SUMOylation of different proteins in vitro, because in vivo a 
role for SIZ1 in many different pathways was shown, indicating a broad variety of 
substrates for this ligase (Catala et al., 2007; Jin et al., 2008). Low substrate 
selectivity was also detected for related yeast ligases of the SIZ/PIAS family, 
leading to the assumption that SIZ ligases can modify different substrates (Catala 
et al., 2007; Jin et al., 2008a; Reindle et al., 2006).  
 
Different tags, commonly used for protein purification from E. coli, were 
monitored for their in vitro SUMOylation with SUMO1 (Figure 2.3). As SUMO1 is 
the most promiscuous of the tested SUMO isoforms, the analysis of this isoform 
was considered sufficient to gain information about the potential SUMOylation of 
tags. Neither the Flag tag, which was present in a fusion to the (in vitro) non-
SUMOylatable protein UBC27 nor the GST-S construct, were modified. A 
combination of the three tags, the GST-S-Flag, was modified by SUMO1 in vitro. 
As only a single higher molecular weight band occurred, it can be assumed that 
this construct is mono-SUMOylated at a single residue. Mutation of a likely 
SUMOylation site close to the carboxyl terminus of the GST moiety, creating the 
GST (K217R)-S-Flag, did not abolish SUMOylation. Therefore it was assumed that 
a Lysine residue within the S peptide, which is part of a high probability SUMO 
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consensus motif might be SUMOylated. A combination of the GST(K217R) moiety 
and the Flag peptide lacking the S peptide was analyzed. The GST(K217R)-Flag 
construct showed no modification by SUMO1, indicating that a residue within the 
S peptide is likely to be SUMOylated. The modification seems to be context 
specific, because the GST-S protein remained unmodified. It can be hypothesized 
that the GST-S construct was not SUMOylated because the high probability 
SUMOylation site of the S peptide lies rather close to the carboxyl terminus of this 
protein. This might lead to a decreased interaction of the SUMOylating enzymes 
with the SUMO consensus motif.  
The finding that the fusion protein Hap2a-GST could not be modified by any 
tested SUMO isoform during later experiments, strengthens the idea that the GST 
moiety itself is not SUMOylated (Figure 2.3). Therefore GST or Flag fusion 
proteins were used in subsequent experiments. 
 
 
3.1.1 In vitro SUMOylation of different substrates 
The in vitro SUMOylation system developed in this work was used to analyze the 
modification of various proteins, and to verify the results from 
Dr. Ruchika Budhiraja, who identified several potential in vivo SUMO targets. The 
results of these experiments are listed in Table 2.1 and in Figure 2.4. 
Many of the identified SUMO substrates are proteins involved in either RNA-
dependent or in DNA- or chromatin-related processes. This is concordant with the 
data for other organisms such as yeast or mammals, for which it was shown that 
many proteins from these pathways are modified by SUMO (Dohmen, 2004; Gill, 
2005; Hay, 2005; Watts, 2004). 
 
The efficiency of in vitro SUMOylation differed for the tested SUMO isoforms. 
Most proteins could be modified by SUMO1 and the mutant variety 
SUMO1 Q90A, which is lacking a conserved glutamine residue at position -4 from 
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the carboxyl terminus but is otherwise identical to SUMO1. A small subset of 
proteins was SUMOylated by SUMO3, but proteins modified with SUMO5 were 
not observed in vitro. 
This is similar to the observations for the in vitro chain formation and might have 
different reasons. On the one hand only the b isoform of the activating enzyme 
was used, and this protein might not be able to activate SUMO3 and SUMO5 with 
the same efficiency as SUMO1. On the other hand, the same can be true for the 
added functional fragment of the SUMO ligase SIZ1, which might interact less 
efficiently with conjugates of the SCE and either SUMO3 or SUMO5.  
The activity of SUMO1 and its mutant version SUMO1 Q90A agrees with the 
observation that SUMO1 and SUMO2 conjugates of different sizes increase 
strongly in Arabidopsis after heat shock or other stress treatments, leading to the 
assumption that these SUMOs have a broad range of substrates and can be quickly 
transferred onto targets (Kurepa et al., 2003). For SUMO3 and SUMO5 an 
accumulation of conjugates after heat shock was not observed and their 
abundance is far lower, so that they might have only few substrates or might 
modify targets only under very distinct conditions.  
In case of modification by SUMO1 or SUMO1 Q90A, respectively, all proteins that 
contained high probability SUMOylation consensus motifs were modified. In 
these cases, the SUMOylation might proceed efficiently with SCE alone, which can 
interact directly with consensus sequences. Nevertheless, proteins such as TAF7, 
which lacked a consensus motif, could be SUMOylated as well. Interestingly, all 
substrates without high probability consensus motif contained several SUMO 
interacting motifs that may permit the interaction of the SCE-SUMO conjugate 
with the substrate via binding to the SUMO moiety. The SIZ1 ligase might also be 
necessary for modification of substrates without consensus sequence, but this was 
not further investigated. 
The low efficiency for in vitro SUMOylation by SUMO3 and SUMO5 might occur, 
because some of the tested substrates are actually no targets of these isoforms. 
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However, candidate proteins that were identified as targets of SUMO5 in vivo, 
such as TAF7, could not be modified with this SUMO moiety in vitro. So it seems 
to be more likely that the lack of SUMO5 conjugation is rather due to an inability 
of the tested enzymes to efficiently interact with this SUMO isoform.  
SUMOylation with SUMO3 was far less effective than modification by SUMO1 or 
SUMO1 Q90A, but could be observed for the proteins TAF7, SVP and NAF. It is 
striking that these three proteins contain several SIM motifs but not necessarily a 
high probability SUMOylation consensus motif. Their SUMOylation might be 
facilitated by interaction of the SIM motifs with the second beta sheet of the SUMO 
moiety, because the SUMO3 sequence is rather conserved in this structural motif 
except for one amino acid exchange that supposedly does not alter the interaction 
with hydrophobic amino acids, and it can safely be assumed that the change does 
not lead to a different secondary structure (Novatchkova et al., 2004). SUMO3 
modification led only to one slower migrating band, indicating mono-
SUMOylation by a single SUMO moiety. This agrees with the low ability of this 
SUMO isoform to form poly-SUMO chains. In contrast to this, the occurrence of 
several bands during SUMOylation by SUMO1 or SUMO1 Q90A might be partly 
due to modification with SUMO chains and is therefore not necessarily the result 
of SUMOylation of different residues within the substrate. However, in case of 
Rtx3, a protein with many SUMOylation consensus sites, a multitude of higher 
molecular weight bands occurred, indicating SUMOylation of several Lysine 
residues within the same substrate protein. 
 
 
3.1.2 Determination of SUMOylation sites 
After our attempts to detect the SUMOylation sites of several proteins by mass 
spectrometry failed, we decided to take a different approach for the TAF7 protein 
that is part of the TFIID complex, a basic transcription factor in RNA-
Polymerase II dependent transcription. 
  
63 Discussion 
Several mutant varieties of TAF7 were created, in which the lysine residue that is 
the potential acceptor of the SUMO moiety is mutated to arginine that cannot be 
SUMOylated. 
As shown in Figure 2.5, the mutation of single lysine residues or the double 
exchange of the two neighbouring amino acids K423 and K424 did not abolish 
SUMOylation with SUMO1. Still the experiment indicated less efficient 
modification of TAF7 varieties lacking the lysine residues K373, K423, K424 or 
K435 close to the C-terminus. Therefore the according triple and quadruple 
mutants were generated and analyzed for their in vitro SUMOylation. The proteins 
TAF7(K373,423,424R) and TAF7(K373,423,424,435R) were modified with the same 
efficiency as wild type protein. For TAF7(K423,424,435R), no SUMOylation was 
detected, but because of the strong modification of the quadruple mutant 
TAF7(K373,423,424,435R), it has to be assumed that the failure to detect modified 
triple mutant protein in this particular experiment is not representative. In this 
experiment, less TAF7(423,424,435R) substrate was used, so that the SUMOylation 
of this protein might be below the threshold of detection.  
The combined results with mutant TAF7 proteins indicate that the previously 
observed weaker higher molecular weight bands during SUMOylation of the 
TAF7 varieties mutated in lysine residues close to the carboxyl terminus are more 
likely due to unequal staining of the according part of the Western blot, than to 
differences in the SUMOylation reaction. For these experiments it cannot be ruled 
out completely that the use of human recombinant conjugating enzyme during 
these experiments might influence the results, but this is highly unlikely because 
the TAF7 lacks a SUMO consensus motif that would interact directly with this 
enzyme. In addition, the Arabidopsis SUMO ligase SIZ1 was added, which most 
likely facilitates the modification of proteins lacking a consensus sequence. The 
findings should therefore not differ from those obtainable with plant recombinant 
SCE. 
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It is striking that TAF7 modification does not differ for mutated proteins. 
Nevertheless it may not be forgotten that not all lysine residues were mutated. A 
subset was chosen regarding preliminary mass spectrometry results, indicating 
the mutated amino acids as probable SUMOylation sites. Therefore it cannot be 
ruled out that the mutated amino acids were not chosen carefully enough. This 
would have to be proven by subsequent experiments, in which the other lysine 
residues are mutated as well. Another option is that SUMOylation is not restricted 
to a single residue within the protein, but can switch between different amino 
acids. 
SUMOylation of unaltered TAF7 led to a single distinct higher molecular weight 
band that indicates mono-SUMOylation at a single residue. Modification of 
several lysine residues within the proteins would rather result in a pattern with 
several less strong bands as found for the target Rtx3 which has multiple high 
probability SUMOylation sites. 
The analysis of TAF7 demonstrated that the in vitro SUMOylation may not be 
restricted to a certain residue within this protein, but seems to occur at multiple 
sites. Nevertheless the overall SUMOylation does not exceed one SUMO moiety. 
Maybe structural restrictions prohibit the attachment of more than one SUMO 
protein. Whether this happens, because second site SUMOylation is generally rare 
or because SUMOylation triggers conformational changes that inhibit further 
modification, remains speculative.  
In Arabidopsis SUMOylation of TAF7 might be involved in transcriptional control. 
TAFs, TBP-association factors, are able to interact with a TATA-box binding 
protein to form the basic TFIID transcription factor. This protein complex is 
involved in RNA Polymerase II dependent transcription, and TAFs confer TFIID 
ability to recognize TATA-less promoters (Thomas & Chiang, 2006). Modification 
by SUMO1 was demonstrated for human TAF5 and TAF12 (Boyer-Guittaut et al., 
2005). While TAF12 SUMOylation had no obvious effect, modification of TAF5 
interfered with TFIID binding to promoter regions indicating a regulatory role for 
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SUMOylation in TFIID mediated transcription. Additionally, a role for 
SUMOylation during assembly and disassembly of protein complexes in general 
was discussed, and the TFIID consists of several subunits that can exist in different 
combinations. 
A similar role for TAF SUMOylation in Arabidopsis has not been demonstrated yet, 
but seems likely regarding our results for the TAF7 protein.  
 
 
 
3.2 SUMOylation by SUMO1 Q90A 
Most SUMO isoforms carry a glutamine residue at position -4 from the C-
terminus. This is conserved throughout several organisms, but the natural 
isoforms SUMO3 and SUMO5 have a leucine and a methionine at this position, 
respectively, nevertheless they are expressed and conjugated in vivo (Novatchkova 
et al., 2004; Saracco et al., 2007).  
We investigated the role of this residue further. Therefore Dr. Ruchika Budhiraja 
and Dr. Andreas Bachmair generated transgenic plants, which over-express 
SUMO1 variants, in which this residue was exchanged. The results of Dr. 
Budhiraja suggested similar effects, when this residue was mutated to leucine or 
to alanine. The amino acid exchange led to growth retardation and premature leaf 
senescence, which resulted in plant death if the construct was constitutively 
expressed. Under an inducible promoter, this phenotype was less severe and an 
accumulation of SUMO conjugates for SUMO1 Q90A was observed compared to 
SUMO1 conjugates in transgenic plants. 
Therefore I investigated the role of the Glutamine residue situated at position -4 
from the C-terminus further. 
During in vitro SUMOylation assays, no difference between SUMO1 wild type and 
the mutant variety SUMO1 Q90A was observed. Both SUMO variants modify the 
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same substrate to a similar extent and with an identical pattern of higher 
molecular weight bands (Figure 2.4). This is most likely due to modification of 
identical sites within the protein, because otherwise the migration and pattern of 
SUMOylated species would differ.  
In Figure 2.7, it was also demonstrated that SUMO1 Q90A is incorporated into 
slower migrating bands after heat shock treatment of seedlings. The accumulation 
of conjugates after diverse stress treatments is a typical feature of SUMO1 as 
shown by Richard Vierstra and his co-workers (Kurepa et al., 2003). So it seems 
that both, wild type SUMO1 and SUMO1 Q90A, do not differ in this respect. 
However, the natural isoforms SUMO3 and SUMO5, which lack the conserved 
glutamine at position -4, do not form more conjugates in response to stress. The 
lack of SUMO conjugates with SUMO1 Q90A prior to stress treatment is rather 
surprising, because SUMO1 conjugates are also found in unstressed plants. Maybe 
the amount of conjugates is too low for detection with the used antibody. Apart 
from that, the untagged natural SUMO1 that is also present in the seedlings could 
be preferred to the tagged mutant SUMO1 Q90A during conjugate formation. 
Only under stress conditions, when the amount of natural SUMO moieties might 
be insufficient, the mutant SUMO1 Q90A conjugates increase to a detectable level. 
Nevertheless it can be assumed that both, SUMO1 and SUMO1 Q90A, do not 
differ in their conjugation properties. 
 
 
3.2.1 De-SUMOylation of SUMO1 Q90A 
After it became clear that the SUMO1 Q90A variant does not seem to differ in 
conjugation from the SUMO1 wild type, its features during in vitro de-
SUMOylation were analyzed. As shown in Figure 2.8, both SUMO1-NAF and 
SUMO1 Q90A-NAF conjugates are cleaved by a functional fragment of the SUMO 
protease ESD4 during a time course of one hour, but degradation of the SUMO1 
Q90A conjugate is far slower and after sixty minutes SUMO1 Q90A-NAF is still 
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observed, while the SUMO1 conjugate was no longer detectable after 15 min 
incubation with ESD4. The SUMO1 Q90A conjugate is therefore degraded at least 
four times slower than the respective SUMO1 wild type conjugate. A similar 
experiment was repeated with less protease and secondary antibody coupled to IR 
dye, which allowed quantification of the conjugates. Again, SUMO1 Q90A 
conjugates showed a higher resistance against the SUMO protease ESD4. After 30 
min, 70% of the employed SUMO1-NAF was cleaved while SUMO1 Q90A de-
conjugation was not detected. 
The increased stability of SUMO1 Q90A conjugates against ESD4 in vivo agrees 
with the results of Dr. Budhiraja. She postulated that plants over-expressing 
SUMO1 Q90A accumulate more SUMO conjugates than plants producing SUMO1 
under an inducible promoter (Budhiraja, 2005). In vitro only a single protease, 
ESD4, was tested for its ability to cleave conjugates with SUMO1 Q90A, but it 
seems that this enzyme is a major SUMO protease in Arabidopsis nuclei, and up to 
now no other Arabidopsis SUMO protease with a similar effect on plant 
development was described (Colby et al., 2006; Murtas et al., 2003; Reeves et al., 
2002). Therefore the resistance of SUMO1 Q90A conjugates against the functional 
fragment of ESD4 might be sufficient to explain the increased stability of SUMO1 
Q90A conjugates in vivo. 
The model that the amino acid exchange in SUMO1 Q90A can stabilize conjugates 
is supported by structural data from Lima and co-workers, who demonstrated that 
SUMO proteases interact with this region of the SUMO moiety during cleavage of 
SUMO conjugates and that residues C-terminal of the Gly-Gly motif are important 
for protease specificity towards different SUMO isoforms (Mossessova & Lima, 
2000; Reverter & Lima, 2004). In our experiments, only mature SUMO moieties 
were expressed either as recombinant proteins or in Arabidopsis. So we did not 
address the question whether differences occur only during de-conjugation of 
substrates or might affect maturation of the SUMO precursor as well. It is very 
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likely that the residues in close proximity to the di-glycine motif affect the 
maturation rate of different SUMO isoforms in vivo. 
Our observations for the variant SUMO1 Q90A imply also an increased stability of 
SUMO3 and SUMO5 conjugates, which might coincide with slower maturation 
rates. This could explain, why under stress conditions a quick increase of SUMO1 
and SUMO2 conjugates, but not off SUMO3 or 5, is observed. 
As SUMO1 and SUMO1 Q90A showed no differences in conjugation, but the 
SUMO1 Q90A conjugates are more stable, the mutant variety might turn out to be 
a valuable tool to detect SUMO1 substrates. The modified proteins should not 
differ in vitro and likely in vivo for both SUMO1 variants. Nevertheless, the 
increased stability of SUMO1 Q90A conjugates allows easier purification and 
handling of substrates during subsequent experiments. 
 
 
 
3.3 PIAS-like SUMO proteases in Arabidopsis 
In this work, not only in vitro experiments were conducted, but several plants 
mutated in enzymes of the SUMOylation cycle were analyzed as well. One class of 
proteins, whose role in plants was further studied, are the SUMO ligases of the 
SIZ/PIAS family. 
Arabidopsis has three genes potentially coding for SUMO ligases of the SIZ/PIAS 
family, SIZ1 (At5g60410), PIAS-Like1 (At1g08910) and PIAS-Like2 (At5g41580) 
(Novatchkova et al., 2004). These types of proteins are known SUMO ligases in 
yeast and animals and are characterized by their SP-RING also called zf-MIZ 
domain (Johnson & Gupta, 2001). They show similarity to Ubiquitin ligases of the 
RING type and can interact with the SCE-SUMO conjugate via their SP-RING 
domain.  
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While the role of PIAS-Like1 (PIL1) and PIAS-Like2 (PIL2) remains unknown, 
SIZ1 is already well described. This SUMO ligase plays a regulatory role in the 
response to various stresses like cold, drought or phosphate starvation and is 
involved in regulation of flowering time and salicylic acid signalling (Catala et al., 
2007; Jin et al., 2008b; Lee et al., 2007; Miura et al., 2007; Miura et al., 2005; Yoo et al., 
2006). SIZ1 seems to be able to SUMOylate the transcription factors ICE1, PHR1, 
FLD and the bromo domain containing protein GTE3 (Garcia-Dominguez et al., 
2008; Jin et al., 2008b; Miura et al., 2007; Miura et al., 2005).  
Whereas the involvement of SIZ1 in many different developmental traits and 
responses to biotic and abiotic factors is clear, nothing is yet known about the role 
of the other two members of this protein family. We therefore investigated the two 
potential SUMO ligases PIAS-Like1 (PIL1) and PIAS-Like2 (PIL2). 
 
 
3.3.1 PIAS-Like1 and PIAS-Like2 differ from SIZ1 in their domain  
structure 
As shown in Figure 2.9, the domain structure of SIZ1 differs from PIL1 and PIL2. 
All three proteins contain a zf-MIZ domain that shows similarity to the U-box of 
Ubiquitin ligases and is responsible for SUMO ligase activity. Nevertheless, in 
SIZ1, two additional domains are found: a SAP domain and a PHD finger. The 
SAP domain is involved in interactions with RNA and DNA and is often found in 
nuclear and cytoplasmic proteins (Aravind & Koonin, 2000; Iida et al., 2006). The 
PHD is a C4HC3 Zn-finger-like motif with similarities to the RING finger. It is 
typically found in nuclear proteins that are involved in chromatin-mediated 
transcriptional regulation, and interactions of this domain with methylated 
histone H3 were shown. The occurrence of those regulatory domains in SIZ1 
might explain its various regulatory roles in different pathways. 
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Recently it was also demonstrated that the PHD finger can interact with the 
SUMO conjugating enzyme and contributes together with the SP-RING (zf-MIZ) 
domain to the SUMO ligase activity (Garcia-Dominguez et al., 2008).  
Furthermore, SIZ1 contains several high probability SUMOylation consensus 
motifs that can explain the observed SUMO modification of this enzyme during in 
vitro experiments (Garcia-Dominguez et al., 2008). As those motifs are absent in 
PIL1 and PIL2, their auto-SUMOylation seems rather unlikely. 
In contrast to SIZ1, PIL1 and PIL2 have only a zf-MIZ domain, which might enable 
these proteins to function as SUMO ligases. In PIL1 the SP-RING is lacking two 
conserved cysteine residues and a proline close to the C terminus of the domain. It 
is therefore unclear whether this protein contains a functional zf-MIZ finger, 
because it was suggested that those residues, which are conserved throughout zf-
MIZ domains of several organisms, are integral part of the RING motif and 
coordinate the co-factor zinc (Cheng et al., 2006). To investigate whether PIL1 and 
PIL2 have indeed SUMO ligase function, the amount of SUMO conjugates in the 
according mutant plants was analyzed. 
 
 
3.3.2 SUMO conjugates of SUMO ligase mutants 
To analyze the potential role of the PIL proteins as SUMO ligases, the amount of 
SUMO1 conjugates of different SUMO ligase mutants was analyzed, because this 
SUMO isoform is highly expressed and seems to target various proteins. It is likely 
that the used antibody (ABCAM) might interact with the nearly identical SUMO2 
as well (Kurepa et al., 2003). 
 As shown in Figure 2.10, the wild type plants have a relatively low level of 
SUMO1 conjugates during normal growth conditions that increases strongly after 
heat shock treatment as described before by Richard Vierstra and his co-workers 
(Kurepa et al., 2003). Interestingly, although for seedlings significant SUMO1 
expression was assumed, free SUMO was detected in no case, which might be due 
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to a relatively low expression level of SUMO in the tested plants, (Saracco et al., 
2007). 
The tested siz1 mutants have a decreased amount of SUMO conjugates under 
standard conditions compared to wild type, and do not show an increase of 
SUMO modified proteins after heat shock treatment. The siz1a line, which has in 
general a stronger growth defect than mutants with the siz1f allele, shows a lower 
level of SUMO1 conjugates also upon heat shock.  
This is consistent with previous work that links the SIZ1 SUMO ligase to various 
stress-related pathways like drought tolerance, phosphate starvation or cold 
adaptation (Catala et al., 2007; Miura et al., 2007; Miura et al., 2005; Yoo et al., 2006). 
SIZ1 also seems to play a role in the response to biotic stresses (Lee et al., 2007) and 
so far all substrates targeted by this ligase seemed to be modified by SUMO1. SIZ1 
is also able to increase SUMO1 modification during in vitro SUMOylation assays 
as reported in the literature and demonstrated in this work (Garcia-Dominguez et 
al., 2008; Jin et al., 2008; Miura et al., 2007; Miura et al., 2005). These results strongly 
indicate a role for SIZ1 in modification of different proteins by SUMO1 and maybe 
SUMO2 and also a function in the general increase of SUMO conjugates during 
stress response. 
The results from the pil mutants diverge, although the two potential SUMO ligases 
are highly similar. In case of the pil1 mutant, the overall amount of SUMO1 
modified proteins is slightly less compared to wild type under standard 
conditions and does not increase after heat shock. In contrast to this, the pil2 
mutant has an increased level of SUMO conjugates prior to and after stress 
treatment. The according double mutants show slightly less SUMO conjugates 
under both tested conditions compared to the wild type. 
The slightly lower level of SUMO1 conjugates in the pil1 mutant seedling is 
surprising, because this transgenic plant line has no obvious phenotype. This 
contrasts with the siz1 mutants that display a similarly disturbed SUMOylation 
pattern, but have a severe growth defect. As only a single plant was analyzed for 
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each tested condition, this observation might be due to variation among 
individuals. Therefore it cannot be ruled out that the weak difference of pil1 
compared to wild type is indeed due to a SUMO ligase function of PIL1. With 
respect to the aberrations in the SP-RING of PIL1 it is possible that this domain is 
not functional and that PIL1 cannot act as a SUMO ligase by itself. However, it 
might be a subunit in a SUMO ligase complex, or regulate other SUMO ligases like 
SIZ1.  
The pil2 mutants have an increased amount of SUMO1 modified proteins under 
standard conditions and a level comparable to those of wild type plants after 
stress treatment. Maybe the knockout of the PIL2 protein is stressful to plants at 
this developmental stage and leads to an accumulation of SUMO1 conjugates 
under normal conditions. The mutation seems to have no severe effect on growth, 
because adult plants do not have an obvious phenotype and cannot easily be 
distinguished from wild type.  
Both tested lines of pil1pil2 double mutants have less SUMO conjugates under 
standard and stress conditions compared to wild type in the experiment with 
horse radish peroxidase-coupled antibody, but the results of the Western blot with 
alkaline phosphatase-coupled secondary antibody do not confirm this 
observation. Nevertheless both experiments show a strongly reduced level of 
SUMO conjugates in pil1pil2 under standard conditions compared to the pil2 
single mutant. The reduced level of SUMO modified proteins indicates a SUMO 
ligase function of at least one of the PIL proteins. The present conjugates might be 
formed by the prominent SUMO ligase SIZ1, which is present in pil1pil2 mutants. 
The findings that the amount of SUMO conjugates is only slightly reduced and 
that the plants have no severe phenotype compared to siz, indicates only a minor 
role for PIL1 and PIL2 in Arabidopsis SUMO1 conjugation. The single mutants of 
the PIL ligases gave no clear results and it cannot be ruled out that these highly 
similar proteins are functionally redundant or might be co-regulated. In this case, 
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the knockout of PIL2 might lead to an up-regulation of PIL1 or SIZ1 that can 
explain the increase of SUMO1 conjugates under standard conditions.  
Taken together, these experiments suggest a SUMO ligase function for the PILs, 
but it may not be forgotten that they were only performed with a single individual 
for each condition and have to be repeated with another set of biological 
replicates. It is also of great interest to verify the SUMO ligase function of PIL2 and 
PIL1 in vitro by creating recombinant PIL proteins for subsequent SUMOylation 
assays. As the Western blot data indicate a minor role for PIL1 and PIL2 in 
SUMO1 conjugation, their relevance for SUMO3 and SUMO5 conjugation should 
be analyzed, because so far no role of the third PIAS family member in Arabidopsis, 
the SIZ1, on SUMO3 and SUMO5 modification has been demonstrated, but these 
two SUMO isoforms seem to be conjugated nevertheless (Budhiraja, 2005). 
 
 
3.3.3 Phenotypic analysis of pil mutant plants 
The growth and the development of pil1 and pil2 single and pil1pil2 double 
mutants was analyzed but no difference from wild type under either long day or 
short day conditions was observed (Figure 2.11).  
 In contrast to this, the siz1 mutants showed a strongly reduced growth and 
decreased apical dominance as already described in the literature (Catala et al., 
2007; Miura et al., 2007; Miura et al., 2005; Yoo et al., 2006).  
The flowering time of the different mutants was also monitored (Figure 2.12). 
The pil1pil2 plants did not differ significantly from wild type under long day 
(sixteen hours light per day) or extended short day conditions. Under these 
conditions, earlier flowering of siz1a and siz1c was observed, while the siz1f that 
has an overall weaker phenotype, did not differ from the wild type. Nevertheless, 
under a light regime with only eight hours light per day, the siz1f and the pil1pil2 
mutants flowered later compared to the wild type, but the siz1a and siz1c plants 
did not differ significantly compared to Columbia 0 plants. This observation is 
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rather striking, because in the literature early flowering for siz1 knockout lines has 
been described (Jin et al., 2008; Miura et al., 2005) and the later flowering of siz1f 
could not be confirmed in another experiment under short day conditions (Figure 
2.17). 
It has to be kept in mind that only a single experiment under short day conditions 
was performed and that the standard deviation is rather high and adds up to a 
quarter of the total leaf number (for several lines more than twenty leaves). 
Additionally, the two pil1pil2 lines differ in their cauline leaf number. While the 
line pil1cpil2a has less cauline leaves compared to Columbia, pil1apil2b does not 
differ significantly from the wild type. Concerning the observation that the siz1 
lines differ in the discussed experiment from the known literature and that the 
later flowering of siz1f was not observed in another experiment, it has to be 
assumed that the results of the flowering time experiment under short day 
conditions are inconclusive, and that this experiment has to be repeated to give 
clearer information about pil1pil2. However, it can be concluded from these 
experiments that the PIL SUMO ligases have a less important function in 
flowering time control than SIZ1. 
 
Generally, our results indicated only a minor role for PIL1 and PIL2 in SUMO 
conjugation under the tested conditions, and it has to be assumed that SIZ1 is the 
major SUMO ligase in Arabidopsis that is involved in a broad variety of different 
pathways. 
In contrast, our cooperation partner Dr. Holger Hesse from the MPI for Plant 
Physiology, Golm, Germany, analyzed the metabolite content of the tested pil 
mutants, because he investigates a sulfure transporter, which is likely to be 
regulated by SUMOylation (Holger Hesse, personal communication). The 
preliminary data obtained in his laboratory indicate altered levels of different 
metabolites in the pil1pil2 double mutants compared to siz1 mutants or wildtype. 
For example, an upregulation of Serine and a downregulation of different sulfur 
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transporters were observed (data not shown). The results of Dr. Hesse imply a role 
for PIL1 and PIL2 in regulation of sulfur metabolism and uptake. For SIZ1 a role in 
the primary metabolism of Arabidopsis was already demonstrated by showing that 
siz1 plants are more sensitive to phosphate starvation compared to wild type 
(Miura et al., 2005). It is therefore not unlikely that other pathways are also 
regulated via SUMOylation. An involvement of the PIL proteins in sulfur 
metabolism might not lead to an obvious phenotype under the conditions tested 
by us, because sulfur starvation or boosted sulfate levels in the media were not 
tested. Therefore, it would be of great interest to see the results of sulfur starvation 
experiments that are currently carried out by our cooperation partners in Golm, to 
verify a regulatory role of PIL1 and PIL2 in sulfur metabolism. 
 
 
 
3.4 The SUMO protease EL1 
Not only SUMO ligases, but also SUMO proteases were analyzed in this work. 
The Arabidopsis genome encodes several SUMO proteases. One of them, Early in 
Short Days 4 (ESD4, At4g15880), plays an important role in control of flowering 
time by regulation of the floral repressor FLC. Mutants in this SUMO protease 
flower extremely early under short days (Murtas et al., 2003; Reeves et al., 2002). 
In this work, the closest homolog of ESD4, the SUMO protease Early in Short Days 
4-Like 1 (EL1, also called Ulp1a,At3g06910) was further investigated to analyze its 
role in plant development with particular emphasis on flowering time control. 
 
 
3.4.1 Domain structure of EL1 
The domain structure of El1 was compared to its two closest homologs in 
Arabidopsis, ESD4 and Ulp1b (At4g00690) as depicted in Figure 2.13. All three 
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proteins contain a Peptidase_C48 domain. This feature is typical for cysteine 
proteases with activity against SUMO and SUMO conjugates and SUMO protease 
activity has already been reported for ESD4 and EL1 (Colby et al., 2006; Murtas et 
al., 2003; Reeves et al., 2002). 
Although the peptidase domain of ESD4 and Ulp1b is more similar compared to 
EL1, overall similarity is higher between ESD4 and EL1. Both, ESD4 and EL1 
contain an amino terminal extension that is absent from the smaller Ulp1b.  
No domains or obvious structures were found in these areas with PFAM 
webservice (http://pfam.sanger.ac.uk), but the analysis with the SUMOplot tool 
and the search for potential SUMO interaction motifs, revealed some differences in 
the amino terminal regions of ESD4 and EL1. Both share a potential SUMOylation 
motif (TDVKKGEN, VASLKNGSL), but another high probability SUMOylation 
site is exclusively found in ESD4 (PDAKAPLR).  
Strinkingly, in ESD4 and Ulp1b only a single potential SUMO interaction motif is 
found on the amino terminal site of the catalytic domain, while in EL1 four of 
these motifs occur in the amino terminal region before the Peptidase_C48 domain. 
The multiplicity of potential SUMO interaction sites in EL1 indicates an affinity for 
poly-SUMOylated substrates, because they could allow interaction with poly-
SUMO chains. A similar mechanism was already demonstrated for a class of 
SUMO targeted Ubiquitin ligases (Stubls), which contain several SIM domains and 
preferably ubiquitylate poly-SUMOylated targets (Lallemand-Breitenbach et al., 
2008; Perry et al., 2008; Prudden et al., 2007; Tatham et al., 2008; Uzunova et al., 
2007; Weisshaar et al., 2008). 
Therefore it seems likely that the amino terminal SUMO interaction motifs of EL1, 
which are absent in ESD4, play a role in substrate selectivity of these two similar 
proteins. 
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3.4.2 Localization of EL1 
After attempts to express GFP-tagged EL1 in Arabidopsis failed, transient 
expression of EL1 fused to GFP in Nicotiana benthamiana was used. GFP fusions to 
both the carboxyl- and amino-terminal end of EL1 were absent from the nucleus 
and the nuclear membrane, but could be detected in the cytoplasm around the 
nucleus (Figure 2.14). Often vesicle-like structures were observed, which might be 
attached to cytoplasmic strands. The observation of aggregates in case of GFP-EL1 
is most likely due to the strong overexpression of the construct in tobacco cells. 
The localization of EL1 in the cytoplasm and in vesicular structures differs 
completely from ESD4, which was found in the nucleus, predominantly at the 
nuclear periphery, maybe associated to the nuclear inner envelope. It cannot be 
ruled out that the observed vesicles are, like aggregates, an artefact of over-
expression. It might nonetheless be interesting to analyze a connection to the 
Endoplasmatic Reticulum or the Golgi apparatus, two organelles involved in 
membrane trafficking. 
 
 
3.4.3 Phenotypic analysis of el1 mutant plants 
The analysis of the growth phenotype of el1 mutant plants revealed that el1 
mutants do not differ significantly in height and number of side shoots from the 
wild type control (Figure 2.15). In case of el1a, which is in the background of the 
ecotype Wassilewskija, thinner stems compared to the respective wild type were 
observed. This observation was confirmed by an Astralblue/Safranin T and a 
Safranin T stain shown in Figure 2.16. Both staining methods showed that in el1 
stems the ratio of vascular tissue to mesophyll is increased in comparison to 
(thicker) wild type main shoots at the same developmental stage or to side shoots 
of the wild type plant with a similar diameter. In contrast to the el1a in 
Wassilewskija wild type, the other two lines in the background of Columbia did 
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not differ in their stem thickness from the respective wild type. It therefore seems 
that the thinner stems of el1a are dependent on the genetic background and not 
due to a general effect of EL1 independent of the ecotype. 
The flowering time of the different el1 mutants was also monitored (Figure 2.17). 
The number of rosette leaves during the time of the opening of the first flower did 
not differ significantly from the wild type in case of all tested el1 mutant lines. An 
increased number of cauline leaves for el1a was observed in a single experiment 
under a sixteen hours light regime, but could not be confirmed in a second 
experiment with long day conditions. It seems therefore safe to assume that EL1 
plays no role in control of flowering time. 
 
It can be summarized that ESD4 and EL1 differ clearly in their localization and in 
the phenotype of the respective mutants, although the proteins are highly similar. 
Therefore, it has to be concluded that both SUMO proteases differ in their 
substrates. EL1 might have a distinct set of target proteins due to its cytoplasmic 
localization and its many SUMO interaction motifs.  
The analysis of mutant plants showed only a weak effect of the el1 mutation on 
plant growth and development, and indicated that at least in the ecotype 
Wassilewskija, EL1 might play a minor role in the differentiation of stems. In both 
the Columbia and the Wassilewskija background, EL1 seems to play no role in 
flowering time control. Therefore ESD4 seems to be the key SUMO protease of the 
Ulp1 type in Arabidopsis. 
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3.5 Early in Short Days 4 (ESD4), a SUMO protease  
involved in flowering time control 
 Early in Short Days 4 (ESD4, At4g15880) seems to be the key SUMO protease of 
the Ulp1 type in Arabidopsis. It has already been demonstrated that it regulates 
flowering time (Murtas et al., 2003; Reeves et al., 2002). ESD4 presumably controls 
the activity of the floral repressor FLC and mutants of this SUMO protease flower 
extremely early under short day conditions (Murtas et al., 2003; Reeves et al., 2002). 
ESD4 is localized in the nucleus, mainly at the inner side of the nuclear envelope 
and possesses a typical SUMO protease domain (Peptidase_C48 domain,Figure 
2.13), and its SUMO protease activity has already been demonstrated (Murtas et 
al., 2003; Reeves et al., 2002).  
In addition to the early flowering phenotype in short days, esd4 plants differ also 
from wild type in their bushy growth and decreased apical dominance. As it is 
assumed that a similar growth defect of the siz1 mutant is (partly) due to increased 
levels of salicylic acid (Catala et al., 2007; Lee et al., 2007), we investigated whether 
the growth phenotype of esd4 is due to altered levels of this hormone as well. The 
esd4 mutants were crossed to sid2 mutants that are defective in salicylic acid 
biosynthesis and have a lower content of this phyto hormone. Introduction of the 
sid2 allele into esd4 plants should decrease the salicylic acid level in the offspring. 
As shown in Figure 2.18, the resulting esd4sid2 double mutants showed a growth 
defect identical to the esd4 single mutants. The heterozygous mutants esd(het) and 
esd4(het)sid had a less severe growth defect, compared to esd(hom) and 
esd4(hom)sid. Although this result is rather clear, a similar experiment is ongoing, 
in which the esd4 mutants had been crossed to plants carrying the bacterial nahG 
gene coding for a salicylic acid hydroxylase, which reduces the level of salicylic 
acid in plants by degrading the hormone. 
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It seems that the growth defect of the esd4 mutants and their decreased apical 
dominance are independent of salicylic acid signaling, in contrast to the salicylic 
acid dependence of a similar growth phenotype of for siz1 mutants. Therefore, it 
has to be assumed that, although SIZ1 seems to be the major SUMO ligase in 
Arabidopsis and ESD4 the major SUMO protease, both enzymes act in different 
pathways regulating plant growth. 
 
 
 
3.6 The bacterial effector protein Factor X 
The plant pathogen Xanthomonas campestris, which attacks Solanaceae such as 
pepper or tomato, is able to inject so-called type III effectors into host cells 
(Gurlebeck et al., 2006). One of these virulence factors is XopD, a cysteine protease 
with a peptidase_C48 domain, which is characteristic for SUMO proteases 
(Chosed et al., 2007; Hotson et al., 2003; Kim et al., 2008). After delivery into the 
host cell, XopD is located in the nucleus and it is therefore likely to process nuclear 
targets. Its SUMO protease activity has been demonstrated both in vivo and in vitro 
(Chosed et al., 2007; Colby et al., 2006; Hotson et al., 2003).  
Our cooperation partners Prof. Ulla Bonas and Robert Szczesny from the Martin-
Luther-University in Halle identified Factor X, a Xanthomonas type III effector 
protein with similarity to XopD. Therefore, Factor X was tested for protease 
activity against protein modifiers. As the data of our cooperation partners about 
Factor X are not yet published, no further details can be revealed regarding the 
nature of Factor X. 
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3.6.1 In vitro protease activity of Factor X 
The analysis of bacterial proteins for their in vitro protease activity against SUMO1 
is rather difficult, because it was shown that those virulence factors might display 
nonspecific protease activity if the experimental settings are not chosen well, 
although the natural function of the proteins might be different. In case of the 
Yersinia pestis effector YopJ for example, it was first postulated that this protein is a 
SUMO protease (Orth et al., 2000). Later on, it turned out that YopJ has far higher 
activity as an acetyltransferase, and that the observed SUMO protease activity is 
likely restricted to the in vitro experiment (Mukherjee et al., 2006).  
To test the in vitro protease activity of Factor X, the protein was produced and 
purified from E. coli as a His tag fusion (clone received from R. Szczesny). A 
mutant variety, in which the catalytic cysteine residue was exchanged to alanine, 
was used as a negative control. Its activity towards SUMO1, SUMO3 and Rub1 
fusion proteins that were produced as recombinant proteins in our laboratory, as 
well as against the commercially available human recombinant Ubiquitin chains 
with either a K48 or a mixed linkage was tested in Figure 2.19. 
Factor X was not able to cleave a SUMO1 or a SUMO3 fusion protein. A functional 
fragment of ESD4 that was produced in the same way and tested under identical 
conditions showed rather strong activity against both substrates. It can therefore 
be assumed that Factor X has indeed no in vitro SUMO protease activity and the 
lack of activity is not due to deficiencies in the experimental design.  
Similar results were obtained for cleavage of Rub1, the Arabidopsis ortholog of 
Nedd8. Factor X was not able to cleave a Rub1 fusion protein while the 
recombinant human protease NEDP1 was able to cleave Rub1 in this fusion. The 
ability of the human protease to cleave a plant substrate shows that this protein 
modifier is highly conserved throughout the different kingdoms, and that in this 
in vitro experiment high protease activity can be achieved. 
Finally, the activity of Factor X against Ubiquitin chains was analyzed. These 
substrates were not produced during this work, but obtained from BostonBiochem 
  
82 Discussion 
as human recombinant proteins. Factor X was not able to cleave K48 chains or 
chains with mixed K48/K63 linkage. In case of K48 chains, a significant activity of 
NEDP1 and A20 was observed, while the result for recombinant human ubiquitin-
specific protease USP7 is less clear. As in case of USP7 and K48 chains, a low 
amount of protein in these two lanes made interpretation difficult. Nevertheless, 
cleavage by NEDP1 and A20 is documented by occurrence of bands with lower 
molecular weight. This shows again that a strong protease activity was obtained, 
because NEDP1 is actually a Nedd8 (Rub1) protease in contrast to the Ubiquitin-
specific A20 and USP7.  
The results for Ubiquitin chains with a mixed linkage are less clear. Again, Factor 
X was not able to process the substrate. In case of the human recombinant control 
proteases NEDP1, A20 and USP7, no additional bands appeared that indicated 
cleavage, but the bands with a molecular weight of approximately 49 kDa that 
indicate tetra-Ubiquitin are significantly weaker. It might therefore be that these 
proteases did indeed cleave the tetra-Ubiquitin constructs but that it was not 
possible to detect the released mono-Ubiquitin. 
Only human recombinant Ubiquitin chains were tested, but nevertheless it can be 
assumed that Factor X has no activity against Arabidopsis Ubiquitin fusions, 
because Ubiquitin is one of the most conserved proteins throughout all eukaryotic 
kingdoms.  
In summary, Factor X has - at least in vitro - no protease activity against the tested 
protein modifiers, while the recombinant control proteases were active under 
identical conditions. These results agree with the observation that Factor X has 
also no in vivo SUMO protease activity (R. Szczesny, personal communication). 
Weak protease activity of recombinant Factor X that was observed before 
(R. Szczesny, personal communication) might therefore be the result of 
contamination with bacterial proteins.  
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4 CONCLUSION 
In this work, several aspects of Arabidopsis SUMOylation were discussed: 
 
• An in vitro SUMOylation system based on plant recombinant proteins was 
developed, which can be used to study the modification of various 
potential substrates. At a large scale, in vitro SUMOylation allows 
purification of SUMOylated proteins for subsequent experiments. This 
method can also be applied to further investigate the different enzymes 
involved in SUMOylation as well as the differences of the SUMO isoforms. 
 
• A mutant variety of SUMO1, the SUMO1 Q90A was analyzed, in which a 
conserved glutamine at position -4 from the carboxyl terminus is changed 
to alanine. In vitro experiments revealed that this variant leads to conjugates 
with higher resistance against the SUMO protease ESD4, but is identical to 
SUMO1 concerning modification of substrates and SUMO chain formation. 
SUMO1 Q90A is also incorporated into conjugates after heat shock similar 
to SUMO1 wild type. SUMO1 Q90A can therefore be used to enrich 
SUMO1 conjugates in plants: It will presumably lead to an identical subset 
of modified proteins but give more stable conjugates. The insight that an 
alteration of the conserved glutamine close to the carboxyl terminus 
increases conjugate stability leads also to the assumption that the natural 
isoforms SUMO3 and SUMO5, which have leucine and methionine, 
respectively, at this position, form more robust conjugates in vivo. 
 
• The PIAS-Like1 and PIAS-LIKE2 proteins, two potential SUMO ligases of 
the SIZ/PIAS type, were investigated as well. Although they are the closest 
homologes of SIZ1 in Arabidopsis, they seem to play only a minor role in 
plant development. Mutants did not differ in growth from wild type and 
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the majority of data indicate that they do not regulate flowering time. 
Nevertheless, PIL1 and PIL2 seem to be involved in sulfur metabolism, 
because data of our cooperation partner Dr. Holger Hesse from the MPI in 
Golm suggest altered levels of sulfur pathway components in pil1pil2 
double mutants. This preliminary data have yet to be confirmed by sulfur 
starvation experiments of the pil1pil2 plants that are conducted at the 
moment in the laboratory of Holger Hesse. 
 
• The SUMO protease EL1 was investigated. Its localization in the cytoplasm, 
often in vesicular structures, was shown. The flowering time of different el1 
mutants was also analyzed, but did not differ from wild type neither under 
a long day nor under a short day regime. Compared to wild type, an el1 
mutant line in the Wassilewskija background showed thinner stems due to 
an increased ratio of vascular tissue to mesophyll, but this difference in 
shoot thickness was not observed for el1 mutants in the ecotype Columbia. 
It is remarkable that EL1 is the closest homolog of the SUMO protease ESD4 
in Arabidopsis, but has an entirely different localization and no function in 
flowering time control, implying a different subset of substrates for these 
two similar enzymes. 
 
• The growth defect of esd4 mutants was analyzed. It was shown previously 
that a similar phenotype of dwarfish growth with reduced apical 
dominance observable in mutants of the SUMO ligase SIZ1 is due to an 
increased level of salicylic acid. Esd4 mutants were therefore crossed with 
plants defective in salicylic acid biosynthesis. The ensuing esd4sid2 double 
mutants did not differ from the esd4 parent in growth characteristics. This 
implies that the growth defect of esd4 plants is independent of salicylic acid 
signaling. Although ESD4 seems to be the major SUMO protease in 
Arabidopsis, while SIZ is the most important SUMO ligase, both seem to act 
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in different pathways concerning growth control. To verify these results, an 
experiment is on-going in which the esd4 mutants were crossed to plants 
carrying the bacterial nahG gene, coding for salicylic acid hydroxylase, 
which reduces salicylic acid levels by degrading this phytohormone. 
 
• In cooperation with Prof. Ulla Bonas and Robert Szczesny from the Martin-
Luther-University in Halle, Factor X, an effector protein of the bacterial 
plant pathogen Xanthomonas campestris was analyzed for SUMO, Ubiquitin 
and Rub1 protease activity. During in vitro experiments, Factor X was not 
able to cleave any of the tested fusion proteins. It has therefore to be 
assumed that this type III effector does not alter proteins linked to these 
three modifiers the host plant. 
 
The analysis of the PIL1 and PIL2 proteins and the SUMO protease EL1 revealed 
that SUMO ligases and proteases exist in Arabidopsis that have only minor effects 
on plant development while strong effects of their closest homologs were 
reported. This implies on the one hand some redundancy in the SUMOylation 
pathways, because the knockout of these proteins had only weak effects on plant 
development. On the other hand, the existence and expression (ESTs exists) of the 
PILs and EL1 could mean that their influence on SUMOylation might be important 
during certain developmental phases, or in responses to abiotic or biotic factors 
not monitored during our experimental settings. This hypothesis is strengthened 
by the preliminary data of our cooperation partner Holger Hesse, which implicate 
a function of PIL proteins in sulfur metabolism.  
The analysis of ESD4 also showed that, although this protein plays a role in 
flowering time control via regulation of the transcription factor FLC, which is also 
regulated by the SUMO ligase SIZ1, both enzymes seem to act in different 
pathways concerning growth control or hormone signaling. Siz1 mutants have 
increased levels of salicylic acid leading to reduced growth and apical dominance, 
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while an alteration of salicylic acid seems not to be the cause of the similar 
phenotype of esd4 mutants. 
This work demonstrates that SUMOylation plays an important regulatory role in 
many, yet unidentified processes and that, although the involved enzymes are 
often highly similar and might be partly redundant, slight differences exist that 
allow fine regulation of many different developmental processes and responses to 
the environment. Although sometimes mutants of those enzymes might resemble 
each other phenotypically, they might be altered in different pathways. 
It becomes clear that SUMOylation plays a vital role in the regulation of many 
processes in Arabidopsis, but only little is known about the exact regulation and the 
interaction of the different enzymes and substrates. Only the identification of in 
vivo substrates of SUMO as already performed by Dr. Ruchika Budhiraja and their 
further investigation can answer these questions. With the in vitro SUMOylation 
system and the SUMO1 variant SUMO1 Q90A, which were characterized in this 
work, two valuable tools are available, which might help to accomplish this task.
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5 MATERIAL AND METHODS 
5.1 Material 
5.1.1 Chemicals 
Chemicals used in this work were purchased in laboratory quality from the 
companies Sigma, Roth, Duchefa, Amersham, Merck, Fluka, Gibco, Roche and 
Invitrogen. 
 
 
5.1.2  Vectors 
In the following list vectors and plasmids used for the generation of DNA 
constructs are shown. 
 
Table 5.1 : Vectors used in this work 
 
Vector Origin Description 
pET9a-d Novagen The pET-9a-d(+) vectors carry a N-terminal T7-
Tag® sequence and BamH I cloning site. These 
vectors are the precursors to many pET family 
vectors. 
pET19 Novagen The pET-19b vector carries a N-terminal His tag 
sequence followed by an enterokinase site and three 
cloning sites. 
pET-42a,b,c Novagen The pET-42 series was used for cloning and high-
level expression GST fusion proteins. 
pETM30 EMBL protein expression 
and purification unit 
The pETM30 is a vector for expression of proteins 
with a GST moiety and a His tag. 
pDEST17 Invitrogen This vector was used for expression of proteins and 
determines resistance to ampicillin. 
pQE30 Qiagen pQE30 was used for expression of His tagged 
proteins. 
pGEX-4T-2 GE Healthcare pGEX vectors allow the production of GST fusion 
proteins and confer ampicillin resistance. 
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Vector Origin Description 
pLysS, E Novagen These two vectors were constructed by insertion 
of the T7 lysozyme gene into the BamH I site of 
pACYC184. They are no cloning vectors, but are 
used in lDE3 lysogenic hosts to suppress basal 
expression from the T7 promoter by producing T7 
lysozyme, a natural inhibitor of T7 RNA 
polymerase. This allows tight regulation of 
transgene expression. 
pLysSRARE Novagen pLysSRARE contains the genes encoding T7 
lysozyme (lysS), a chloramphenicol resistance gene 
and tRNA genes corresponding to rare codons in 
E. coli. 
pBlueskript II Stratagene This vector was used for routine cloning procedures 
and determines ampicillin resistance. 
pER8 Zuo et al., 2000 pER8 is a binary T-DNA cloning vector that carries 
a β-estradiol inducible promoter. Selection markers 
of this vector are spectinomycin (bacteria) and 
hygromycin (Arabidopsis). 
p3 Yin et al., 2007 This vector combines the pBIB backbone with the 
multiple cloning site of pRT103 (Becker, 1990; 
Topfer et al., 1993) and allows expression under the 
35S promoter with three enhancers. 
pHi Schloegelhofer and 
Bachmair, 2002 
This vector was used for constitutive expression of 
transgenes in Arabidopsis, because it carries the 
CaMV35S promoter with two enhancers.. 
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5.1.3 Oligonucleotides 
Oligonucleotides that were obtained from Isogen Life Science or Operon and used 
in this work are listed in Table 5.2. 
 
Table 5.2 :  Oligonucleotides used in this work 
 
Oligonucleotide Sequence Description 
Primers for the generation of amino acid exchanges in TAF7 
TAF7(K328R)f GTT GTT GAG TCT TTT AGA ACT 
TAT GAT GAT TGT G 
These two primers were utilized 
for site directed mutagenesis of 
TAF7 to exchange lysine 328. TAF7(K328R)r CAA TCA TCA TAA GTT CTA AAA 
GAC TCA ACA AC 
TAF7(K337R)f GAT TGT GCA TTA GTC AGA ACT 
GCT GAT ATT GGG 
Both oligonucleotides were 
generated to exchange lysine 337 in 
TAF7. TAF7(K337R)r CCC AAT ATC AGC AGT TCT GAC 
TAA TGC ACA ATC 
TAF7(K369R)f CTA ACT CCT CCA ATG AGG GAT 
GCT CGA AAG AGG 
With those primers the lysine 369 
in TAF7 was mutated to arginine. 
TAF7(K369R)r CCT CTT TCG AGC ATC CCT CAT 
TGG AGG AGT TAG 
TAF7(K373R)f ATG AAG GAT GCT CGA AGA AGG 
AGA TTT CGT CGA 
To create TAF7(K373R) these two 
oligonucleotides were used. 
TAF7(K373R)r CTC GAC GAA ATC TCC TTC TTC 
GAG CAT CCT TCA T 
TAF7(K423,424R)f GCT AGT AAT GCA AGT AGG AGA 
GTA TCT TCT TCT TC 
These two primes allowed the 
exchange of two neighbouring 
lysine residues in TAF7. TAF7(K423,424R)r GAA GAA GAA GAT ACT CTC CTA 
CTT GCA TTA CTA GC 
TAF7(K435R)f CCZT ACA CCT GTT GAA AGG CCT 
GAA GCT CCT GAG 
These oligonucleotides were 
generated for the mutation of 
lysine 435 close to the carboxyl 
terminus of TAF7. 
TAF7(K435R)r CTC AGG AGC TTC AGG CCT TTC 
AAC AGG TGT AGG 
Oligonucleotides utilized to generated plasmid constructs 
SAE1a fill in 1 CAT GCG AGC ATG GAC GGA GAA 
GAG CCC GGG ATC C 
These oligonucleotides were 
annealed and inserted into a 
construct during the creation of 
pET9d-SAE1aSAE2. 
SAE1a fill in 2 TCG AGG ATC CCG GGC TCT TCT 
CCG TCC ATG CTC G 
GST-S-Flag fill in 
1 
CCA GAA CCA CTA GTT GAA CCA 
TCC GAG CGT GGA GGA T 
These primers were used in the 
generation of pET42c-GST-S-Flag. 
GST-S-Flag fill in 
2 
GCT GAA AAT GTT CGA AGA TCG 
TTT 
GST(K217)R fill in 
1 
GCT GAA AAT GTT CGA AGA TCG 
TTT 
These oligonucleotides were 
utilized to generate the amino acid 
exchange in pET42c-GST(K217R)-
S-Flag. 
GST(K217)R fill in 
2 
CCA GAA CCA CTA GTT GAA CCA 
TCC GAG CGT GGA GGA T 
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Oligonucleotide Sequence Description 
Primers used for sequencing of transgenic plants 
ESD4 start dn CTA ATG GGT GCC GTA GCG ATC 
ATT C 
These primers anneal in the wild 
type allele of esd4. 
 ESD4 up 2 TAT CTG CAG AGG GCA ACA GAC 
TAA GTT 
sid2-1f GCA GTC CGA AAG ACG ACC TCG 
AG 
With these olignucleotides the sid2 
mutation can be detected. They 
were obtained from Dr. J. Parker 
(MPIZ). 
sid2-1r CTA TCG AAT GAT TCT AGA AGA 
AGC 
SALK LBa1 TGG TTC ACG TAG TGG GCC ATC G This primer anneals in T-DNA 
insertions and can therefore be 
used to detect those. 
 
Above the oligonucleotides used in this work are shown in 5´to 3´direction. In case of the primers 
utilized for site directed mutagenesis, the bases encoding the mutated residue are bold.  
 
 
5.1.4 Plasmid Constructs 
The latter enumerations show plasmids used for the overexpression of 
recombinant proteins in E.coli or for in planta protein expression. If not stated 
otherwise, all expressed proteins carry a Histidine tag. 
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Table 5.3 : Plasmid constructs utilized in this work 
 
Plasmid construct Origin Description 
Enzymes and SUMO moieties used for in vitro SUMOylation assays 
pQE30-SCE Dr. A. Bachmair This plasmid allows the overexpression of untagged 
SCE.  
pQE30-SCE(C94S) Dr. A. Bachmair 
Dr. C. Hardtke, 
University of 
Lausanne 
This construct encodes a mutated SCE(C94S) that is 
no longer catalytically active and carries no tag. 
pET9d-SAE1bSAE2 Dr. A. Bachmair This plasmid resembles bacterial di-cistronic 
constructs and allows overexpression of SAE1b and 
SAE2 in equal amounts. 
 
 
 
 
 
 
pET9d-SAE1aSAE2 This work The backbone of this construct is the pET9d-
SAE1bSAE2 plasmid generated by Dr. A. Bachmair. 
To obtain the analogous clone with isoform SAE1a, 
a Pvu II – Sal I fragment of the original plasmid was 
inserted into Ecl 136II – Sal I digested vector pSK. 
The resulting construct was digested with Nco I and 
Sal I, and oligonucleotides CAT GCG AGC ATG 
GAC GGA GAA GAG CCC GGG ATC C (SAE1a fill 
in1) and TCG AGG ATC CCG GGC TCT TCT CCG 
TCC ATG CTC G (SAE1a fill in 2) were annealed 
and inserted. After Sap I and Sma I digest, a Sap I – 
Pme I fragment from the SAE1a cDNA was inserted. 
Finally, a Bsr GI – Bam HI fragment from this 
construct was used to replace the Bsr GI – Bam HI 
fragment of pETSAE1b2, to result in pETSAE1a2. 
pDEST17-SIZ1 Dr. Y. Fu-Fu pDEST17-SIZ1 encodes a functional fragment of the 
SUMO ligase SIZ1 that contains the SP-RING 
domain, but neither the SAP nor the PHD domain. 
pET9d-tag3-SUMO1 Dr. A. Bachmair, 
Dr. R. Budhiraja 
This construct allows the expression of SUMO1 
moieties carrying a triple HA tag. 
pET9d-tag3-SUMO1 
Q90A 
Dr. A. Bachmair, 
Dr. R. Budhiraja 
This construct is identical to pET9d-tag3-SUMO1 
except for an amino acid exchange at postion -4 of 
the SUMO moiety. 
pET9d-tag3-SUMO3 Dr. A. Bachmair, 
Dr. R. Budhiraja 
pET9d-tag3-SUMO3 encodes a SUMO3 fusion 
protein with a triple HA tag. 
pET9d-tag3-SUMO5 Dr. A. Bachmair, 
Dr. R. Budhiraja 
This plasmid is similar to the other pET9d-tag3-
SUMO constructs and encodes a SUMO5 fusion 
protein. 
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Tag fusions analyzed for in vitro SUMOylation 
pET42c-UBC27 Dr. A. Bachmair With this construct not only the UBC27 protein 
could be expressed but it was also used to produce 
the Flag epitope for analysis of in vitro 
SUMOylation. 
pET42c Novagen The commercially available plasmid was used to 
generate a GST-S peptide fusion protein. 
pET42c-GST-S-Flag This work To generate a plasmid for the expression of GST-S-
Flag protein, a fragment (Nde I and Kpn I digested) 
of the vector pET42c was inserted in the vector 
pET42c-UBC27after a Nde I and Kpn I digest.  
 
pET42c-GST(K217R)-S-
Flag 
This work pET42c-GST-S-Flag was changed by insertion of a 
Swa I - Spe I PCR-generated fragment (oligos GCT 
GAA AAT GTT CGA AGA TCG TTT and CCA 
GAA CCA CTA GTT GAA CCA TCC GAG CGT 
GGA GGA T )with the respective K to R mutation 
(AAA to CGC). 
pET42c-GST(K217R)-
Flag 
This work For expression of GST-Flag, vector pET42c-
GST(K217R)-S-Flag was digested with Mfe I and Bgl 
II, treated with Klenow fragment of E. coli DNA 
polymerase to delete the sequence coding for the 
S peptide, and re-ligated to give pET42c-
GST(K217R)-Flag. 
Substrates tested for their in vitro modification by SUMO 
pET42c-RRM1 Dr. A. Bachmair This construct encodes the protein RRM1 
(At3g56860) carrying a Flag epitope. 
pET42c-RRM2 Dr. A. Bachmair This plasmid allows recombinant expression of 
RRM2 (At2g41060) as a GST fusion protein. 
pET-LA Dr. A. Bachmair With the construct pET-LA, the protein LA 
(At2g43970) can be expressed as a GST fusion. 
pET-TAF This work At first, an Nco I – Not I fragment from pUNI clone 
U63389 (Yamada et al., 2003) was inserted into Nco I 
and Not I digested vector pET42c to generate a 
plasmid encoding for version of TAF carrying the S 
peptide. Thereafter, the ensuing vector was digested 
with Bgl II and Mfe I, treated with Klenow fragment 
and relegated to delete the S peptide from this 
construct to retrieve pET42c-TAF 
pET-TAF(K328R) This work This construct, encoding for a mutated variety of 
TAF7, was obtained by site directed mutagenesis of 
pET-TAF. 
pET-TAF(K337R) This work This construct, encoding for a mutated variety of 
TAF7, was obtained by site directed mutagenesis of 
pET-TAF. 
pET-TAF(K369R) This work This construct, encoding for a mutated variety of 
TAF7, was obtained by site directed mutagenesis of 
pET-TAF. 
pET-TAF(K373R) This work This construct, encoding for a mutated variety of 
TAF7, was obtained by site directed mutagenesis of 
pET-TAF. 
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pET-TAF(K423,424R) This work This construct, encoding for a mutated variety of 
TAF7, was obtained by site directed mutagenesis of 
pET-TAF. 
pET-TAF(K435R) This work This construct, encoding for a mutated variety of 
TAF7, was obtained by site directed mutagenesis of 
pET-TAF. 
pET-
TAF(K373,423,424R) 
This work To retrieve triple mutants of the TAF7, the pET-
TAF(K423,424R) plasmid was utilized for further 
mutagenesis. 
pET-
TAF(K423,424,435R) 
This work To retrieve triple mutants of the TAF7, the pET-
TAF(K423,424R) plasmid was utilized for further 
mutagenesis. 
 
 
 
pET-
TAF(K373,423,424,435R) 
This work This plasmid, which allows expression of a 
quadruple mutant of TAF7, was obtained by using 
an already existing construct, encoding for a triple 
mutant, as a template for site directed mutagenesis. 
pET42c-AML5 Dr. A. Bachmair The open reading frame of At1g29400 was inserted 
into pET42c between Sac II and Sac I sites (sequence 
CCG CGG GTC ATA TG ... till stop codon TGA, 
ending at Sca I site of cDNA). 
pET-Rxt3 Dr. A. Bachmair The open reading frame of At5g08450 was inserted 
into pET42c between Mfe I and Bam HI sites 
(sequence CAA TTG GTC ATA TG ... till stop 
codon, ending with Bam HI of cDNA).  
pET42c-NAF Dr. A. Bachmair This construct codes for a fusion protein of NAF 
(At2g19480) and the Flag epitope. 
pET42c-IAA Dr. A. Bachmair 
M. Lehnen 
An Eco NI Klenow – Bsr GI fragment from the 
cDNA of At1g51950 was inserted into Bgl II Klenow 
– Asp 718 treated vector pET42c. 
pET-CO N terminus Dr. A. Bachmair 
M. Lehnen 
An amino-terminal fragment generated by PCR 
from the CO open reading frame (CAT ATG ...TTC 
CCT AAT TCA GGT ACC) Nco I to Kpn I was 
inserted between Nco I and Kpn I sites of vector 
pET42c-GST-S-Flag. The ensuing protein is no GST 
fusion, but has a FLAG tag. 
pET-CO mid Dr. A. Bachmair 
M. Lehnen 
A PCR-generated Spe I Not I fragment 
encompassing the middle part of CO (ACT AGT 
CAT CAG CGA ... CCC TGC AAG CGC GGC CGC) 
was inserted into Spe I - Not I digested vector 
pET42c. 
pET-CO C terminus Dr. A. Bachmair 
M. Lehnen 
A PCR-generated Mfe I Xho I fragment 
encompassing the carboxyl-terminal part of CO 
(CAA TTG CTC AAC AGA ATT ... CCT TCA TTC 
TGA CTC GAG) was inserted into Mfe I Xho I 
digested vector pET42c. 
pET-Hap2a Dr. M. 
Horvarth, 
Dr. C. Koncz 
This construct was obtained from the laboratory of 
Dr. Czaba Koncz and allows the expression of 
Hap2a (At5g12840) fused to the GST moiety. 
  
94 Material and Methods 
pETM30-SVP Dr. P. Huijser The plasmid allows expression of SVP, cloned into 
pETM30 vector to obtain a His tag - GST fusion 
protein. 
pET-FLC Dr. A. Bachmair This plasmid allows the expression of FLC 
(At5g10140) fused to the FLAG epitope. 
pET42c-COP1 frag.   
pET-PFU1 Dr. A. Bachmair, 
K. Eifler 
pET-PFU1 allows expression of the protein PFU1 
(At3g15355). 
pET-β glucuronidase Dr. A. Bachmair 
M. Lehnen 
A fragment from At1g75940 cDNA encompassing 
start ATG to Eco RI after the stop codon (sequence 
CCG CGG GTC ATA TG ... till stop codon TGA, 
ending at Eco RI site of cDNA) was inserted 
between Sac II and Eco RI sites of pET42c. 
Other plasmid constructs 
p3-GFP-EL1 This work To create this construct a GFP-EL1 fragment (Xho I 
/Sfo I) was inserted into Xho I/ Sma I digested 
vector p3. The insert was obtained from the plasmid 
pENSG-GFP DH (from Dr. Yong Fu-Fu). The 
resulting plasmid allowed transient expression of a 
GFP-EL1 fusion protein in N. benthamiana. 
p3-EL1-GFP This work The plasmid 35-S-EL1-GFP (Dr. Yong Fu-Fu) was 
digested with Xho I and Spe I and the resulting 
fragment was inserted into Xho I/ Sma I digested 
vector p3. This construct was used for transient 
expression of EL1-GFP. 
pQE130-Myc-Ub-Rub1 Dr. H.-P. Stuible This plasmid was utilized to express a Rub1 fusion 
protein to test the protease activity of Factor X. 
pET-ESD4 Dr. Y. Fu-Fu This construct allows the expression of a functional 
fragment of the SUMO protease ESD4. 
pET-FLC-SUMO1 Prof. G. 
Coupland 
This fragment allowed the expression of a SUMO1 
fusion protein to test the activity of Factor X. 
pET-FLC-SUMO3 Prof. G. 
Coupland 
pET-FLC-SUMO3 was used, to analyze the ability of 
Factor X to cleave SUMO3 fusions. 
pDEST17-Factor X Prof. U. Bonas 
R. Szczesny 
This construct encodes the potential SUMO 
protease Factor X. 
pDEST17-Factor mut Prof. U. Bonas 
R. Szczesny 
This construct codes for a variant of Factor X, in 
which the catalytic residue is mutated. 
 
 
5.1.5 Escherichia coli strains 
The Escherichia coli strains used in this work are listed in Table 5.4. 
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Table 5.4 : E. coli strains 
 
Strains for plasmid maintenance 
Strain Origin Genotype 
XL1 blue Stratagene recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F´ 
proAB lacIqZΔM15 Tn10 (Tetr)] 
XL10 Gold Stratagene Tetr Δ(mcrA)183 Δ(mcrCB-hsdSMR-mrr)173 endA1 supE44 
thi-1 recA1 gyrA96 relA1 lac Hte [F´ proAB lacIqZΔM15 
Tn10 (Tetr) Tn5 (Kanr) Amy] 
DH5α Invitrogen F- φ80lacZΔM15 Δ(lacZYA-argF)U169 recA1 endA1 
hsdR17(rk
-, mk
+) phoA supE44 thi-1 gyrA96 relA1 λ- 
Strains for protein expression 
BL21 Stratagene F– dcm ompT hsdS(rB– mB–) gal 
BL21 (DE3) Invitrogen 
Statagene 
F– dcm ompT hsdS(rB– mB–) gal λ(DE3) 
BL21 (DE3) pLysS Invitrogen 
Stratagene 
F- ompT hsdSB (rB-mB-) gal dcm (DE3) pLysS (CamR) 
Rosetta(DE3) pLysS Novagen F- ompT hsdSB(rB- mB-) gal dcm (DE3) pLysSRARE (CamR) 
Strains for sexual conjugation 
S17-1 ATTC recA pro hsdR RP4-2-Tc::Mu-Km::Tn7 
(chromosomally integrated tra genes) 
 
 
5.1.6 Agrobacterium tumefaciens strains 
For transient expression of EL1-GFP fusion proteins in Nicotiana benthamiana the 
Agrobacterium tumefaciens strain C58C1 pCV2260 (obtained from D. Staiger, TU 
Zurich, Switzerland) was used. 
 
 
5.1.7 Arabidopsis thaliana Ecotypes 
In this work, the Arabidopsis ecotypes Columbia 0 and Wassilewskija were utilized 
as background for mutations and as controls in different experiments. 
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5.1.8 Arabidopsis thaliana mutant lines 
The Arabidopsis mutants which were described in this work are listed below. 
 
Table 5.5: Arabidopsis thaliana lines 
 
Mutant Origin Description 
siz1a Dr. A. Bachmair 
SALK_065397 
(At5g60410) 
This line is mutated in the siz1 gene, and has 
a rather strong phenotype. 
siz1c Dr. A. Bachmair 
SALK_034008 
(At5g60410) 
This line is mutated in the siz1 gene, with an 
obvious phenotype. 
siz1f Dr. A. Bachmair  
GABI-Kat line 217A09 
(At5g60410) 
This line is mutated in the siz1 gene, but 
confers to a rather mild phenotype in 
comparison to siz1a or siz1c. 
pil1a Dr. A. Bachmair  
GABI-Kat line 339H11 
This mutant line originated of a GABI-Kat 
line and was selected for an insertion within 
the PIL1 (At1g08910). 
pil1b Dr. A. Bachmair  
SALK_147797 
 
This line carries a mutation in the pil1 gene. 
pil1c Dr. A. Bachmair  
SAIL_738_B09 
This line carries a mutation in the pil1 gene. 
pil2a Dr. A. Bachmair  
SALK_043892 
This line carries a mutation in the pil2 gene 
(At5g41580). 
pil2b Dr. A. Bachmair  
GABI-Kat line 712B09  
 
This line carries a mutation in the pil2 gene 
(At5g41580). 
pil1a pil2b Dr. A. Bachmair  
 
This line was generated via crossing the 
respective single mutants. 
pil1c pil2a Dr. A. Bachmair  
 
This line was generated via crossing the 
respective single mutants. 
esd4 Prof. G. Coupland 
esd4-2  SALK_032317 
This line carries a mutation in the esd4 gene 
(Reeves et al., 2002). 
el1a Dr. Y. Fu-Fu 
FLAG 201D11 
(in Ws background) 
The line has an insertion in the first exon of 
esd4 and is in the genetic background of 
Wassilewskija. 
el1b Dr. A. Bachmair  
SAIL_318_C01 N814746 line 1 
This mutant line was generated from the 
homozygous offspring of the SAIL line, 
which carries the T-DNA insertion in an 
intron of the coding region. 
el1c Dr. A. Bachmair  
SAIL_318_C01 N814746 line 2 
This mutant line was generated from the 
homozygous offspring of the SAIL line el1b. 
 
If not stated, all mutations are in the genetic background of the ecotype Columbia. 
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5.1.9 Antibodies 
Antibodies utilized in this work are listed below. 
 
Table 5.6 : Antibodies 
 
Antibody Origin Description 
Primary antibodies 
anti-HA Roche 
(11 867 423 001) 
This antibody was derived from rat. 
anti-GST SIGMA 
(G7781) 
This antibody is directed against the GST moiety and 
was produced in rabbit. 
anti-Flag  SIGMA 
(F3165) 
That monoclonal anti-Flag antibody was isolated from 
mouse. 
anti-Flag alkaline 
phosphatase 
SIGMA 
(A9469) 
That monoclonal anti-Flag antibody was purified from 
a murine cell culture. 
anti-Myc US Biological 
(M9601-31) 
This antibody is directed against the human Myc-tag 
and was generated in mouse. 
anti-SUMO1 ABCAM 
(ab5316) 
The polyclonal anti-SUMO1 antibody by ABCAM 
allows detection of the Arabidopsis protein and was 
generated in rabbit. 
anti-SUMO3 ABCAM 
(ab5317) 
The polyclonal anti-SUMO1 antibody by ABCAM 
allows detection of the Arabidopsis protein and was 
generated in rabbit. 
anti-Ubiquitin Dr. A. Bachmair This is a polyclonal anti-serum from rabbit directed 
against Arabidopsis thaliana Ubiquitin. 
 
Secondary antibodies 
anti-mouse IgG AP SIGMA  
(A3562) 
The anti-mouse secondary antibody coupled to alkaline 
phosphatase was produced in goat. 
anti-rabbit IgG AP SIGMA  
(A3812) 
This antibody was developed in goat using rabbit IgG 
as immunogen. 
-rat IgG AP Promega 
(S3731) 
This antibody was produced in goat. 
anti-rat IgG AP SIGMA  
(A8438) 
This product was developed in goat. 
anti-mouse IgG HRP SIGMA 
(A2304) 
This antibody is labeled with horse radish peroxidase 
and was developed in goat. 
anti-rabbit IgG HRP SIGMA 
(A6154) 
This antibody is labeled with horse radish peroxidase 
and was developed in goat. 
anti-rat IgG HRP SIGMA 
(A9037) 
This antibody is labeled with horse radish peroxidase 
and was developed in goat. 
anti-mouse IR Dye 
800  
Rockland 
(610-132-121) 
This antibody is coupled to a fluorescent marker and 
allows signal detection in the 780 nm to 820 nm range. 
It was developed in goat. 
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5.2 Methods 
5.2.1 Culture and storage of organisms 
5.2.1.1 Culture and storage of Escherichia coli 
Escherichia coli cells were usually grown overnight at 37°C in liquid LB or on LB 
plates. For selection of transgenic bacteria, the medium was supplemented with 
the appropriate antibiotics after autoclaving and cooling down to approx. 60°C. 
E. coli strains were stored as glycerol stocks. Therefore an overnight culture of 
bacteria was mixed with an equal amount of 75% glycerol and stored at -80°C. 
Antibiotics  LB medium 
Ampicillin 100 µg·ml-
1  
 10 g bacto-trypton 
Kanamycin 25 µg·ml-1  5 g yeast extract 
Chloramphenicol (in EtOH) 25 µg·ml-1  10 g NaCl 
   The pH is adjusted to 7.0 with NaOH. 
H2O is added to a final volume of 1 l. 
For plates 15 g·l-1of agar were added 
 
5.2.1.2 TSS competent Escherichia coli  
To introduce plasmids into E. coli, the cells have to be made competent for 
transformation. 
LB medium was inoculated 1:100 from an E.coli culture grown overnight. At an 
OD600 of 0.3 to 0.4, cells were harvested by centrifugation (10 min at 1000x g and 
4°C). The pellet was resuspended in 1/10 volume of chilled TSS solution and 
incubated for 5 to 15 min on ice. Aliquots of 100 µl were frozen rapidly in liquid 
N2 and stored at -80°C for further use. 
TSS solution 
10 % PEG 4000 
50 mM MgCl2 
 in 90 ml LB 
The pH was adjusted to 6.7 and LB medium was added to a final volume of 95 ml. 
After sterile filtration, the TSS solution was stored as 9.5 ml aliquots at -20°C. 
Prior to use, 0.5 ml DMSO was added and the medium was stored on ice. 
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5.2.1.3 Heat shock transformation of Escherichia coli 
Heat shock transformation allows the introduction of plasmids into E. coli. 
An aliquot of TSS competent cells was thawn on ice and incubated with 1 µl 
plasmid DNA or 15 µl ligation for 10 – 30 min on ice. Afterwards cells were 
incubated for 2 min at 37°C and put directly on ice. The bacteria were imbibed in 
0.75 ml LB medium and incubated for 1 h at 37°C and 750 rpm. An aliquot was 
plated on LB plates containing antibiotics for selection of transformants. 
 
5.2.1.4 Culture and storage of Agrobacterium tumefaciens 
Agrobacteria were incubated at 28°C in YEB medium, containing the appropriate 
antibiotics. For the Agrobacterium tumefaciens C58C1, Rifampicin was always 
added, because this strain contains a plasmid providing resistance to that 
antibiotic. 
Antibiotics  YEB medium 
Kanamycin 25 µg·ml-1   5 g beef extract 
Rifampicin 100 µg·ml-1  1 g yeast extract 
Spectinomycin 50 µg·ml-1  5 g peptone 
Carbicillin 100 µg·ml-1  5 g sucrose 
   The pH was adjusted to 7.2 – 7.3 with NaOH. H2O is 
added to a final volume of 1 l; 2 – 10 mM MgSO4 
(sterile filtrated) was added after autoclavation. 
 
5.2.1.5 Heat shock competent Agrobacteria 
Similar to E. coli cells, Agrobacteria have to be made competent for transformation. 
To create heat shock transformation competent Agrobacteria, 10 ml YEB (50 µg·ml-1 
Rifampicin, 2 mM MgSO4) were inoculated with A. tumefaciens and incubated for 
two days at 28°C. The cells were diluted 1:25 in fresh medium and incubated for 
about 3.5 hours. Cells were harvested by centrifugation (5000 rpm, 10 min, 4°C) 
and resuspended in 1 ml precooled YEB (50 µg·ml-1 Rifampicin, 2 mM MgSO4). 
Aliquots of 200 µl were frozen in liquid N2 and stored at -80°C. 
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5.2.1.6 Transformation of Agrobacteria 
Plasmid constructs can be introduced into Agrobacteria by heat shock treatment. 
An aliquot of heat shock competent Agrobacteria was thawn at room temperature 
and then transferred onto ice. After mixing with 2 -5 µg DNA, the cells were 
frozen in liquid N2 for 1 min and then directly transferred to 37°C for 5 min. The 
cells were imbibed in 1 ml YEB medium (50 µg·ml-1 Rifampicin, 2 mM MgSO4) 
and incubated for 2 h at 28°C, before they were spread on YEB plates containing 
the antibiotics necessary for selection of transformation. 
 
5.2.1.7 Sexual transformation of Agrobacteria 
During sexual transformation of Agrobacteria, a plasmid is transferred from E.coli 
into Agrobacteria via sexual conjugation. 
For both microorganisms a liquid culture was inoculated from a preculture grown 
overnight and incubated until an OD540 of approx. 0.5. Then 0.5 ml of each culture 
were carefully mixed. Big drops were set on a YEB plate (2 mM MgSO4, 0.04 mM 
CaCl2) that contained calcium, to promote pili formation. The plate was dried 
under the sterile bench and incubated for 1 day at 28°C. The cells were 
resuspended in 5 ml YEB medium and different dilutions were spread on YEB 
plates, containing the necessary antibiotics for selection of positive transformants 
and Rifampicin to eliminate the E. coli bacteria. 
 
5.2.1.8 Culture of Arabidopsis thaliana plants 
Arabidopsis plants were either grown on 1% ara medium or on soil under long day 
(16 h light) or short day (8 h light) conditions. For selection of transgenic plants, 
Hygromycin was added to the medium, while Claforan was used to inhibit 
growth of Agrobacteria after plant transformation. 
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Antibiotics  1% ara medium 
Hygromycin 25 µg·ml-1   4.3 g MS salt 
Claforan 200 µg·ml-1  10 g sucrose 
   0.5 g MES 
500x Vitamin mix  8 g agar for plates 
5 g myo-inositol  The pH was adjusted to 5.7 with KOH. H2O was 
added to a final volume of 1 l. After autoclaving, the 
medium was supplemented with vitamin mix prior 
to use. 
1 g thiamine  
50 mg nicotinic acid  
10 mg biotin  
H2O was added to a final volume 
of 100 ml and after sterile 
filtration aliquots were stored at  -
20°C. 
 
 
5.2.1.9 Seed sterilization  
Small batches of seeds were shaken in 0.5 ml sterilization solution (3-5% calcium 
hypochlorite and 1/1000 volume of 20% Trition X-100) for 15 min at room 
temperature. They were washed twice with 0.5 ml sterile H2O and once with 
150 µl H2O and then dried in a sterile hood. Up to further use sterilized seeds were 
stored at 4°C. 
 
5.2.1.10 Floral Dip Transformation of Arabidopsis thaliana 
This technique allows the introduction of a DNA construct into plants by using 
Agrobacteria. 
Nine plants per pot were grown on soil. The first shoots were cut to increase the 
total number of shoots. After 7-10 days, plants were ready for transformation. For 
this, 20 ml YEB medium (required antibiotics, 10 mM MgSO4) were inoculated for 
2 days at 28°C with Agrobacteria, which carried the construct to be introduced into 
plants. Afterwards 100 ml fresh medium were inoculated with 2 ml of this 
preculture and incubated overnight. The cells were harvested (5000rpm, 15 min, 
RT) and resuspended in 200 ml 5% sucrose + 0.05% Silvet. Plants were dipped for 
1-2 min in this solution and after drying transferred to the greenhouse. 
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5.2.1.11 Crosses of plants 
To cross plants, the parent plants were grown in the greenhouse. For the mother 
plants, all parts of the flower except the gynoceum were removed before the 
flower opens. Then the free gynoceum was pollinated by running a stamen of the 
father plant over it.  
 
5.2.1.12 Induction of transgene expression by β-estradiol 
To avoid constant expression of harmful constructs, it can be favorable to express 
transgenes in Arabidopsis under control of an inducible promoter. 
To induce transgenes under control of a β-estradiol inducible promoter, plants 
were usually grown on 1% ara plates containing 5 µM β-estradiol. For liquid 
induction, plants were first grown on plates and then either submerged or 
transferred into 24 well plates with medium supplemented with β-estradiol. 
Normally, plants were harvested 1-3 days after induction and analyzed for 
production of transgenic proteins by Western blot. 
 
5.2.1.13 Flowering time measurement 
To analyze the flowering time of different mutants, plants were sown in flat pots 
on soil and vernalized for 2 days. Seedlings were singled in 7x7 cm pots and 
grown in long day or short day growth chambers. When the first flower opened, 
the rosette leafs were counted. 
 
5.2.1.14 Tissue stain 
To detect differences in the tissue compositon of el1 mutant and wild type shoots, 
stains with either only Safranin T or a combination of Astralblue and Safranin T 
were conducted. Shoot sections were cut with a razor blade and stored in water up 
to further use. The slices were incubated in a solution of 1% Astralblue in 0.5 
acidic acid for 20 min at room temperature and then washed with H2O until the 
supernatant stayed clear. Afterwards they were transferred into a dye of 1% 
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Safranin T in 50% EtOH for 10 min. The cuttings were washed with EtOH until the 
supernatant was no longer tinted. Then, they were washed four times with H2O 
and stored in water. If the samples were only stained with Safranin T, only the last 
steps of the procedure were conducted. 
 
 
5.2.2 Working with DNA 
5.2.2.1 Plasmid Preparation (from E. coli) 
Plasmid constructs were purified from transgenic E. coli strains with the kit 
“Nucleospin Plasmid” (Macherey-Nagel) according to the manufacturer´s manual. 
The DNA was eluted with 50 µl sterile H2O and stored at -20°C up to further use. 
 
5.2.2.2 Small scale DNA isolation from Agrobacteria tumefaciens 
After transformation Agrobacteria were tested for the correct plasmid. 
Therefore 5 ml YEB medium (50 µg·ml-1 Rifampicin, 50 µg·ml-1 Kanaymcin or 
Spectinomycin, 2 mM MgSO4) were inoculated with Agrobacteria and incubated at 
28°C until an OD600 of 0.8 was reached. After cell harvest, DNA was isolated using 
a DNA Minikit (“Nucleospin Plasmid”, Macherey-Nagel; “Plasmid Mini Kit”, 
Peqlab) according to the manual. 
 
5.2.2.3 Quick DNA purification from Arabidopsis 
Using this method, DNA can be manually purified from Arabidopsis. 
A leaf was frozen in liquid N2 and grinded with sand and 200 µl Quick DNA 
purification buffer. After centrifugation (14000 rpm, 5 min, RT), the supernatant 
was transferred to a fresh tube and mixed with 200 µl isopropanol by shaking for 
5 min at room temperature. After a second centrifugation step (14000 rpm, 5 min, 
RT), the pellet was washed with 0.5 ml 70% EtOH. The dried pellet was 
resuspended in 70 µl H2O. After boiling for 5 min at 65°C, it was stirred with a 
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pipet tip and again heated for 5 min. After centrifugation (14000 rpm, 2 min, RT), 
the supernatant was transferred to a fresh tube. 
 
5.2.2.4 DNA isolation from Arabidopsis thaliana 
If several DNA samples from Arabidopsis were prepared, the DNA was isolated 
with the BioSprint96 and the according “BioSprint 96 DNA Plant Kit” (Qiagen). 
The program P_100, during which the sample is eluted in 100 µl H2O, was used, to 
get highly concentrated total plant DNA. 
 
5.2.2.5 Agarose gels 
Agarose gels were used to separate DNA fragments or strands according to their 
size and to quantify DNA by visualization with UV light after staining with 
ethidium bromide.  
Dependent on the size of the fragments concentrations of 0.8-2% agarose were 
melted in 1x TAE. After cooling down, ethidium bromide was added to a final 
concentration of 0.1 µg·ml-1 and the gel was poured. Prior to loading, the samples 
were mixed with 1/6 volume of 6x DNA loading buffer. 
50x TAE stock  6x DNA loading buffer 
242 g Tris base  50% glycerol 
57.1 ml glacial acetic acid  0.2 M EDTA pH 8.0 
37.2 g Na2EDTA x 2 H2O  0.005% Orange G 
ad 1 l H2O    
 
5.2.2.6 Extraction of DNA from agarose gels or purification of PCR products 
The DNA was separated on an agarose gel and the desired fragments were cut out 
or a certain fragment was amplified via PCR. In both cases the DNA of interest 
was purified with the kit “Nucleospin Extract II” (Macherey-Nagel) according to 
the manual. In most cases, the DNA was eluted in 15 µl elution buffer. 
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5.2.2.7 DNA Restriction 
DNA was digested to use it in subsequent experiments e.g. ligation or to search for 
correct transformants. 
Restriction analysis of DNA was performed with DNA endonucleases of the 
companies New England Biolabs and Fermentas. If possible, digestions with more 
than one enzyme were carried out in parallel. Otherwise double digests were 
performed stepwise and the DNA was precipitated and resolved in another buffer 
if necessary. 
For partial digest, samples were taken at different time points and monitored by 
agarose gels.  
 
5.2.2.8 Precipitation of DNA 
DNA was precipitated to receive higher concentrations or to change buffer 
conditions. Therefore the DNA was mixed with 1/10 volume 3 M KoAC (pH 4.9 – 
5.3) and 2-3 volumes 96% EtOH and incubated at -20°C for at least 30 min, but 
preferably over night. The DNA was pelleted by centrifugation (14000 rpm, 15 
min, 4°C) and washed with 70°C EtOH. Afterwards, the DNA was pelleted again 
(14000 rpm, 5 min, 4°C) and the supernatant was carefully removed. The dried 
pellet was resolved in sterile H2O. 
 
5.2.2.9 Ligation of DNA fragments 
Ligases facilitate the assembly of e.g. vector backbone and insert. 
Usually, ligations were performed with 1-2 U T4 ligase (Roche) at 16°C over night 
or at least 3 h. Insert and vector backbone were used in a ratio of approx. 3:1. 
 
5.2.2.10 Polymerase chain reactions (PCR) 
PCR, Polymerase chain reaction, was used to amplify distinct DNA fragments. 
According to the length of fragments and further use, different DNA polymerases 
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and PCR programs were used. Primers were obtained from Isogen Life Science or 
Operon. 
 
PCR with Brown-Taq polymerase 
For general PCR reaction, home-made Taq polymerase and buffer, provided by 
Dr. Ian Searle, was used. 
 
PCR mix for Brown-Taq  10x Brown-Taq buffer 
4 µl Template (genomic DNA)  500 mM KCl 
5 µl Brown-Taq buffer  100 mM Tris-HCl pH 8.3 
5 µl 2.5 mM dNTPs  0.1% gelatin 
1 µl 100 pmol·µl-1 primer 1  0.5% Tween 20 
1 µl 100 pmol·µl-1 primer 2  250 µg·ml-1 BSA 
0.5 µl Brown-Taq  After sterile filtration aliquots were stored at -20°C. 
ad 50 µl H2O   
 
PCR with commercially available Taq polymerase  
In some reactions, LA-Taq polymerase provided by TaKaRA Bio Inc., Japan, or 
GoTaq polymerase (Promega) were used with the supplied buffers. 
PCR mix for LA-Taq  PCR mix for GoTaq 
4 µl template  4 µl template 
5 µl LA-Taq buffer  5 µl GoTaq buffer green 
5 µl 25 mM MgCl2  4 µl 2.5 mM dNTPs 
8 µl 2.5 mM dNTPs  0.5  µl 100 pmol·µl-1 primer 1 
1 µl 100 pmol·µl-1 primer 1  0.5 µl 100 pmol·µl-1 primer 2 
1 µl 100 pmol·µl-1 primer 2  0.25 µl GoTaq 
0.5 µl LA-Taq  ad 50 µl H2O 
ad 50 µl H2O    
 
Colony-PCR 
Colony-PCR is a quick method to test many different clones after transformation. 
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As a template a colony was picked with a pipette tip and dissolved in 10 µl H2O. 
The following PCR reaction was performed using BrownTaq polymerase and an 
elongated denaturing step of 10 min in the beginning. 
 
PCR programs 
PCR programs were chosen according to the length of the fragment and the used 
DNA polymerase. 
 
Short programm  Long programm 
94°C 4 min   95°C 5  min  
94°C 30 s  
x 34 repeats 
 95°C 30 s  
x 31 repeats 
54°C 30 s  55°C 30 s 
72°C 1 min  68°C 8  min 
72°C 10 min   68°C 10 min  
8°C for ever  8°C for ever 
 
5.2.2.11 Site directed mutagenesis 
Site directed mutagenesis is a valuable tool to introduce base pair exchanges into 
plasmids via PCR with misannealing primers to obtain proteins with single amino 
acid exchanges later on. 
To perform site directed mutagenesis the kit “Quik Change II XL Site directed 
Mutagenesis” (Stratagene) was used according to the manual. 
PCR mix for site directed mutagenesis  Mutagenesis Program 
5 µl 10 ng·µl-1 template  95°C 1 min  
5 µl buffer  95°C 50 s  
x 18 repeats 
3 µl Q solution  60°C 50 s 
1 µl dNTPs  68°C 20 min 
4 µl 10 µM primer 1  68°C 7 min  
4 µl 10 µM primer 2  6°C for ever 
1 µl polymerase    
ad 50 µl H2O    
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5.2.2.12 Sequencing 
DNA was sequenced by the “Automatic DNA Isolation and Sequencing (ADIS)” 
service unit of the MPIZ, Cologne. 
DNA sequences were determined on Applied Biosystems (Weiterstadt, Germany) 
Abi Prism 377, 3100 and 3730 sequencers using BigDye-terminator v3.1 chemistry. 
Premixed reagents were from Applied Biosystems. Oligonucleotides were 
purchased from Isogen Life Science or Operon. 
 
5.2.2.13 Detection of the sid2 mutation in Arabidopsis 
To test, whether plants carried the sid2 mutation, a PCR was performed with the 
sid2-1 primers using a PCR program with 40 cycles. The resulting fragment was 
digested with Mun I to detect the loss of a restriction site in the mutants. This 
method and the sid2 mutants were kindly given to our group by Dr. Jane Parker. 
 
 
5.2.3 Working with proteins 
5.2.3.1 Expression of recombinant proteins in Escherichia coli 
For further experiments with recombinant proteins those were produced in 
transgenic E. coli cells.  
LB medium supplemented with the necessary antibiotics was inoculated with a 
preculture grown overnight and incubated at 37°C or room temperature up to an 
OD600 of 0.6 – 0.8. After an aliquot was taken for later comparison, production of 
proteins was induced by adding IPTG to a final concentration of 1 mM. The cells 
were harvested after 3 h and stored at -20°C or -80°C prior to further use. 
 
5.2.3.2 Protein purification of recombinant proteins via His tag 
His tag-fusion proteins were preferably purified via Ni-NTA agarose (Qiagen), 
because this is a rather quick and cheap method. 
  
109 Material and Methods 
In general, the purification was performed as suggested by the manufacturer´s 
manual, but a final concentration of 1 mM PMSF was added to the lysis buffer and 
0.5 mM PMSF to the wash buffer. In case of recombinant SUMO activating 
enzyme all buffers were additionally supplemented with 1 mM ATP to increase 
the interaction of the two enzyme subunits. 
 
5.2.3.3 Protein purification of recombinant proteins via FLAG tag 
This method was used to purify potential substrates carrying a FLAG tag from in 
vitro SUMOylation reactions prior to mass spectrometric analysis. 
For protein purification via FLAG tag, the Anti-Flag M2 Affinity Gel provided by 
SIGMA was used. First, the resin was treated twice with 1x TBS. Binding was 
performed either for 2 h or overnight at 4°C in batch with FLAG tag binding 
buffer. After the resin was washed three times with TBS, the proteins were eluted 
by boiling 3 min at 98°C in protein loading sample buffer. 
The amount of resin was dependent on the amount of protein solution, e.g. for 
100 µl of protein sample 20 µl of resin were used. 
FLAG tag binding buffer  1x TBS pH 7.5 
50 mM Tris-HCl pH 7.5  50 mM Tris-HCl pH 7.5 
150 mM  NaCl  150 mM NaCl 
1 mM EDTA     
1% Triton X-100     
 
5.2.3.4 Purification of recombinant SUMO conjugating enzyme 
The SUMO conjugating enzyme (SCE) was produced in E.coli without any tag, 
because it was impossible to express this enzyme as a stably active fusion protein. 
The recombinant SCE was produced in a 2 l culture. After harvesting the cells, the 
pellet was resuspended in 25 ml 50 M Na phosphate buffer pH 6.5/50 mM NaCl 
and stored at -80°C for at least 1 d. As the SCE is a highly soluble protein, this 
procedure was sufficient to let the protein leak out of the cells. After thawing, the 
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suspension was centrifuged at 29000rpm for 1 h at 8°C and the supernatant was 
transferred to a fresh tube. 
First, the SCE was purified via ion exchange. Therefore an SP-Sepharose column 
was prepared by washing 10 ml SP-Sepharose Fast Flow (Sigma) with 0.5 M Na 
phosphate buffer pH 6.5, two times with 50 M Na phosphate buffer pH 6.5/50 mM 
NaCl and finally with 50 M Na phosphate buffer pH 6.5/50 mM NaCl 
supplemented with 1 mM DTT and Proteinase Inhibitor (1/4 tablette of Proteinase 
Inhibitor Cocktail, Roche, per 500 ml). The equilibrated matrix was transferred 
into plastic column (Biorad). The column was loaded with the lysate by gravity 
flow and later on washed, using a Minipuls 3 pump (Gibson) at a speed that 
corresponds to a flow of approx. 1.2 ml/min. The system was washed with approx. 
100 ml M Na phosphate buffer pH 6.5/50 mM NaCl supplemented with 1 mM 
DTT and Proteinase Inhibitor, before proteins were eluted with high salt buffer 
(50 M Na phosphate buffer pH 6.5/300 mM NaCl, 1 mM DTT and Proteinase 
Inhibitor). Fractions were collected and analyzed via polyacrylamide 
gelelectrophoresis and subsequent Coomassie stain. 
In a second purification step fractions containing the SCE were first pooled and 
concentrated with a dialysis column (Vivaspin 15 R, 5000 MWCO HY, Sartorius 
group). The concentrated solution was further purified with the Äkta FPLC 
System (Amersham Biosciences) and injected onto a S-200 column. Proteins were 
eluted with FPLC buffer and those containing SCE were concentrated. This 
purification step was not always performed because it proofed to increase the 
purity not much.  
 
5.2.3.5 Storage of purified proteins 
To store proteins for a longer period of time and to conserve their enzymatic 
activity, a final glycerol concentration of 15% was added and aliquots, small 
enough to avoid freeze-thaw cycles were frozen in liquid N2 and stored at -80°C. 
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5.2.3.6 Dialysis of proteins 
Proteins were dialyzed to change their buffer and to increase their concentration if 
necessary. 
For protein dialysation of small sample amounts, Vivaspin Columns (Sartorius) 
were used. Bigger volumes were dialyzed using the dialysis cassettes (Slide-A-
Lyzer Dialysis Cassette, Extra Strength, 10000 MWCO, 0.5-3 ml capacity, Pierce). 
The buffer volume exceeded the sample volume at least five times. 
 
5.2.3.7 SDS-Polyacrylamide gel electrophoresis (SDS-PAGE) 
SDS-Polyacrylamide gels were used to separate proteins according to size under 
denaturing conditions. 
Prior to gel loading, the proteins were denatured by heating (5 min, 98°C) in SDS-
containing protein loading sample buffer to negatively charge them. Proteins were 
separated on 10% to 15% polyacrylamide gels using the Biorad “Mini Protean 3” 
system. Gels were run at 100 V in 1x electrophoresis buffer. 
 
Stacking gel  2x Protein loading sample buffer 
330 µl 30% acrylamide mix 29:1 (SERVA)  50% glycerine 
250 µl 1.5 M Tris-HCl pH 6.8  20 mM DTT 
20 µl 10% SDS  2% SDS 
20 µl 10% ammoniumpersulfate  125 mM Tris-HCl pH 6.8 
2 µl TEMED  0.003%  bromphenolblue 
ad 2 ml H2O    
 
Separating gel 
10% 12% 15%  
1,7 ml 2 ml 2.5 ml 30% acrylamide mix 29:1 (SERVA) 
1,3 ml 1,3 ml 1,3 ml 1.5 M Tris-HCl pH 8.8 
50 µl 50 µl 50 µl 10% SDS 
50 µl 50 µl 50 µl 10% ammoniumpersulfate 
 4 µl 4 µl 4 µl TEMED 
ad 5 ml H2O 
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5x Electrophoresis buffer 
7.55 g Tris 
36 g glycine 
.5 g SDS 
 
5.2.3.8 Bis-Tris protein gels 
For better resolution, 4-12% NuPAGE Novex Bis-Tris Mini Gels from Invitrogen 
were used according to the manual with the provided buffers. Gels were run at 
200 V. 
 
5.2.3.9 Coomassie stain 
To visualize proteins in gels, the gels were stained with commercially available 
Coomassie stain (Rotiblue, Roth; Imperial Protein Stain, Pierce; PageBlue Protein 
Staining Solution, Fermentas) as recommended by the manufacturers. 
 
5.2.3.10 Western blot 
For detection of proteins by antibodies, Western blots were performed. 
The conditions during these experiments were chosen according to the used 
antibodies. In general, the proteins were separated on a protein gel and then 
transferred to a membrane by blotting for 1 h with 50 V at 4°C. To block the 
membrane afterwards, it was incubated for 1.5 h at room temperature or overnight 
at 4°C in blocking buffer. Incubation with the first antibody was usually 
performed overnight at 4°C. After three wash steps, the membrane was incubated 
with secondary antibody for usually 2 h. Before protein detection, it was washed 
again three times. The antibodies were dissolved in the solution used for the 
blocking step, while the wash steps were performed with a buffer not 
supplemented with proteins. 
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Western blot with alkaline phosphatase-coupled secondary antibodies 
Alkaline phoshatase-coupled antibodies process their substrate BCIP to a stable 
colored product, which allows the detection of signals with the naked eye, but this 
stain is not quantitative. 
If this type of antibodies was used, the proteins were usually transferred onto a 
PVDF membrane (Immobilon-P, pore size 0.45 µm, Millipore). The membrane was 
blocked by either 20% new born calf serum/ANT or by 5% or 10% milk 
powder/PBS. The wash steps were then performed with 1x ANT or 1x PBS, 
respectively. If necessary, the buffers were supplemented with 0.002% natrium 
azide to inhibit bacterial growth or with 0.05% Tween 20 for more stringent 
conditions. The membrane was stained with 10 ml TE buffer pH 8.0 containing 
100 µl 110 mM NBT (in 70% DMF) and 120 µl 90 mM BCIP (in DMF) in the dark. 
 
Western blot with horse radish peroxidase-coupled secondary antibodies 
Horse radish peroxidase-coupled antibodies can process their substrates to 
chemiluminescent products that can blacken X-ray films. This method is semi-
quantitative depending on the exposure time. 
For Western blots with horse radish peroxidase-coupled secondary antibodies, 
nitrocellulose membrane (Protran BA85, pore size 0.45 µm, Schleicher&Schuell) 
was used. The membrane was blocked with 5% or 10% milk powder in 1x PBS, 
ANT or TBS. Signals were detected with the “SuperSignal West Pico 
Chemiluminescent Substrate” provided by PIERCE on KODAK Biomax XAR 
films. Alternatively, the signals were detected with the LumiImager system 
(BioRAD) that allows digital measurement of the signals. 
 
Western blot with IR-Dye-coupled secondary antibodies 
The use of IR-Dye-coupled antibodies allows quantitative detection of protein 
bands.  
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This technique was performed with the “Odyssey Infrared Imaging System” 
(Licor Biosciences) according to the manual with the provided blotting buffer and 
nitrocellulose membrane. Signals were detected by the “Odyssey Infrared Imager” 
(Licor Biosciences). Applying this technique, it was possible to quantify the 
cleavage of SUMOylated products by the SUMO protease ESD4. Therefore 
different samples were separated via Western blot and the substrate protein was 
detected with IR-Dye-coupled antibody. As a reference, three background signals 
of the membrane were measured and the ratio of modified to unmodified 
substrate was calculated, setting the amount of SUMOylated sample in the 
negative control to 1.0 (or 100%). 
1x ANT  10x PBS 
150 mM NaCl  80 g NaCl 
50 mM Tris-HCl pH 8.0  2 g KCl 
   26.8 g Na2HPO4 x 7H2O 
1x TE pH 8.0  2.4 g KH2PO4 
10 ml Tris-HCl pH 8.0  ad 1l H2O 
2 ml 0.5 mM Na2EDTA pH 8.0  adjust pH to 7.4 with HCl 
ad 1l H2O   
   Blotting buffer 
1x TBS  190 mM glycine 
50 mM glycine  25 mM Tris  
150 mM Tris  20% methanol 
   0.05% SDS 
 
5.2.3.11 In vitro SUMOylation assays 
In vitro SUMOylation assays are a valuable tool to test the modification of 
potential substrates by SUMO quickly and easily. 
In a typical in vitro SUMOylation reaction, 100 µg recombinant SUMO, 4 µg SAE, 
0.6 µg SCE and 0.15 µg SIZ1 fragment were incubated in an ATP containing buffer 
at 30°C for 4 h or overnight. 1–10 µg substrate protein, either carrying a FLAG or a 
GST tag, were added to the reaction. Aliquots of 10 µl were separated by SDS-
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PAGE and analyzed by Western blot using antibodies specific for the substrate´s 
tag.  
SUMOylation buffer 
20 mM Tris-HCl pH 7.5 
5 mM MgCl2 
5 mM ATP 
 
5.2.3.12 Mass spectrometry analysis 
To identify the lysine residue, to which SUMO was covalently attached, 
SUMOylated proteins were purified and analyzed by Dr. Jürgen Schmidt, Dr. 
Thomas Colby and Anne Harzen of the mass spectrometry facility of the MPIZ, 
Cologne. Prior to mass spectrometry analysis, the samples were digested with 
trypsin. 
 
In-gel tryptic digest 
For the tryptic digest, samples were separated by SDS-PAGE. Coomassie-stained 
bands were excised and treated as described by Shevchenko et al., except that the 
tryptic digest was performed without adding CaCl2. Peptides were extracted with 
100 µl 1% trifluoroacectic acid for 30 min at 37°C. The extraction was repeated 
once with 100 µl 0.1% trifluoroacectic acid/ acetonitrile (1:2). The supernatants 
were combined and the volume was reduced to 5 µl in a vacuum centrifuge and 
20 µl 0.1% trifluoroacectic were added. 
 
LC-MS/MS analysis 
Liquid chromatography (LC)-MS data were acquired on a quadrupole-TOF mass 
spectrometer (Q-Tof II, Micromass, Manchester, United Kingdom) equipped with 
a Z spray source. Samples were introduced by an Ultimate nano-LC system 
(LC Packings) equipped with the Famos autosampler and a Switchos column 
switching module. The column setup comprises a 0.3 mm x 1 mm trapping 
column and a 0.075 mm x 150 mm analytical column, both packed with 3 µm 
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Atlantis dC18 (Waters). A sample volume of 10 µl was injected onto the trap 
column and desalted for 1 min with 0.1% trifluoroacetic acid at a flow rate of 
10 µl/min. Peptides were eluted onto the analytical column by a gradient of 2% 
acetonitrile in 0.1% formic acid to 40% acetonitrile in 0.1% formic acid over 55 min 
at a flow rate of ca. 200 nl/min, resulting from a 1:1000 split of the 200 µl/min flow. 
The electrospray ionization interface comprised an uncoated 10 µm i.d. PicoTip 
spray emitter (New Objective) linked to the HPLC flow path using a 7 µl dead 
volume stainless mounted onto the PicoTip holder assembly (New Objective). 
Stable nanospray was established by the application of 1.7 to 2.4 kV to the stainless 
steel union. The data-dependent acquisition of MS and tandem MS (MS/MS) 
spectra was controlled by the Masslynx 4.0. Survey scans of 1 s covered the range 
from m/z 360 to 1,200. Doubly and triply charged ions rising above a given 
threshold were selected for MS/MS experiments. In MS/MS mode the mass range 
from m/z 50 to 1,200 was scanned in 1 s, and 3 scans were added up for each 
experiment. Micromass-formatted peak-lists were generated from the raw data by 
using the Proteinlynx software module. Proteins were identified by searching the 
NCBI nr public database (National Center for Biotechnology Information) using a 
local installation of MASCOT 1.9. (Matrix Science). A mass deviation of 0.5 Da was 
allowed for peptide and fragment ions. 
 
5.2.3.13 Localization studies of GFP fusion proteins 
Localization of GFP fusion proteins was determined by the local Central 
Microscopy (CeMic) facility of the MPIZ, Cologne, with the help of Dr. Elmon 
Schmelzer and Rainer Franzen. 
Nicotiana benthamiana leaves were transformed with Agrobacterium tumefaciens 
C58C1  pCV2260 carrying the p3-El1-GFP or the p3-GFP-El1 plasmid, respectively. 
Images were taken in the 505-520 nm emission range after exiting with an Argon 
laser (488 nm) and under transmissible light. 
 
 
 
 
117 
6 LITERATURE 
 
Adamson AL, Kenney S (2001) Epstein-barr virus immediate-early protein BZLF1 
is SUMO-1 modified and disrupts promyelocytic leukemia bodies. J Virol 75(5): 
2388-2399 
 
Anckar J, Hietakangas V, Denessiouk K, Thiele DJ, Johnson MS, Sistonen L (2006) 
Inhibition of DNA binding by differential sumoylation of heat shock factors. 
Molecular and Cellular Biology 26(3): 955-964 
 
Angot A, Vergunst A, Genin S, Peeters N (2007) Exploitation of eukaryotic 
ubiquitin signaling pathways by effectors translocated by bacterial type III and 
type IV secretion systems. PLoS Pathogens 3(1): 1-13 
 
Aravind L, Koonin EV (2000) SAP - a putative DNA-binding motif involved in 
chromosomal organization. Trends Biochem Sci 25(3): 112-114 
 
Bachmair A, Novatchkova M, Potuschak T, Eisenhaber F (2001) Ubiquitylation in 
plants: a post-genomic look at a post-translational modification. Trends Plant Sci 
6(10): 463-470 
 
Bailey D, O'Hare P (2002) Herpes simplex virus 1 ICP0 co-localizes with a SUMO-
specific protease. J Gen Virol 83(Pt 12): 2951-2964 
 
Becker D (1990) Binary vectors which allow the exchange of plant selectable 
markers and reporter genes. Nucleic Acids Res 18(1): 203 
 
Boggio R, Chiocca S (2006) Viruses and sumoylation: recent highlights. Curr Opin 
Microbiol 9(4): 430-436 
 
Bossis G, Melchior F (2006) Regulation of SUMOylation by reversible oxidation of 
SUMO conjugating enzymes. Molecular Cell 21(3): 349-357 
 
Boyer-Guittaut M, Birsoy K, Potel C, Elliott G, Jaffray E, Desterro JM, Hay RT, 
Oelgeschlager T (2005) SUMO-1 modification of human transcription factor (TF) 
IID complex subunits: inhibition of TFIID promoter-binding activity through 
SUMO-1 modification of hsTAF5. J Biol Chem 280(11): 9937-9945 
 
Budhiraja (2005) Post-translational modification of proteins by SUMO in Arabidopsis 
thaliana , PhD thesis, http://deposit.ddb.de/cgi-bin/dokserv?idn=978110773 
  
118 Literature 
Catala R, Ouyang J, Abreu IA, Hu Y, Seo H, Zhang X, Chua NH (2007) The 
Arabidopsis E3 SUMO ligase SIZ1 regulates plant growth and drought responses. 
Plant Cell 19: 2952-2966 
 
Cheng CH, Lo YH, Liang SS, Ti SC, Lin FM, Yeh CH, Huang HY, Wang TF (2006) 
SUMO modifications control assembly of synaptonemal complex and 
polycomplex in meiosis of Saccharomyces cerevisiae. Genes Dev 20(15): 2067-2081 
 
Cheng J, Kang X, Zhang S, Yeh ET (2007) SUMO-specific protease 1 is essential for 
stabilization of HIF1alpha during hypoxia. Cell 131(3): 584-595 
 
Chosed R, Tomchick DR, Brautigam CA, Mukherjee S, Negi VS, Machius M, Orth 
K (2007) Structural analysis of Xanthomonas XopD provides insights into 
substrate specificity of ubiquitin-like protein proteases. Journal of Biological 
Chemistry 282(9): 6773-6782 
 
Colby T, Matthai A, Boeckelmann A, Stuible HP (2006) SUMO-conjugating and 
SUMO-deconjugating enzymes from Arabidopsis. Plant Physiology 142(1): 318-332 
 
David G, Neptune MA, DePinho RA (2002) SUMO-1 modification of histone 
deacetylase 1 (HDAC1) modulates its biological activities. J Biol Chem 277(26): 
23658-23663 
 
Dieckhoff P, Bolte M, Sancak Y, Braus GH, Irniger S (2004) Smt3/SUMO and Ubc9 
are required for efficient APC/C-mediated proteolysis in budding yeast. Molecular 
Microbiology 51(5): 1375-1387 
 
Dohmen RJ (2004) SUMO protein modification. Biochimica Et Biophysica Acta-
Molecular Cell Research 1695(1-3): 113-131 
 
Dorval V, Fraser PE (2007) SUMO on the road to neurodegeneration. Biochim 
Biophys Acta 1773(6): 694-706 
 
Duprez E, Saurin AJ, Desterro JM, Lallemand-Breitenbach V, Howe K, Boddy MN, 
Solomon E, de The H, Hay RT, Freemont PS (1999) SUMO-1 modification of the 
acute promyelocytic leukaemia protein PML: implications for nuclear localisation. 
J Cell Sci 112 ( Pt 3): 381-393 
 
Gao M, Karin M (2005) Regulating the regulators: Control of protein 
ubiquitination and ubiquitin-like modifications by extracellular stimuli. Molecular 
Cell 19(5): 581-593 
 
Garcia-Dominguez M, March-Diaz R, Reyes JC (2008) The PHD domain of plant 
pias proteins mediates sumoylation of bromodomain GTE proteins. J Biol Chem 
  
119 Literature 
Gill G (2004) SUMO and ubiquitin in the nucleus: different functions, similar 
mechanisms? Genes & Development 18(17): 2046-2059 
 
Gill G (2005) Something about SUMO inhibits transcription. Current Opinion in 
Genetics & Development 15(5): 536-541 
 
Gurlebeck D, Thieme F, Bonas U (2006) Type III effector proteins from the plant 
pathogen Xanthomonas and their role in the interaction with the host plant. J Plant 
Physiol 163(3): 233-255 
 
Harder Z, Zunino R, McBride H (2004) Sumo1 conjugates mitochondrial substrates 
and participates in mitochondrial fission. Curr Biol 14(4): 340-345 
 
Hay RT (2005) SUMO: A history of modification. Molecular Cell 18(1): 1-12 
 
Hayashi T, Seki M, Maeda D, Wang W, Kawabe Y, Seki T, Saitoh H, Fukagawa T, 
Yagi H, Enomoto T (2002) Ubc9 is essential for viability of higher eukaryotic cells. 
Exp Cell Res 280(2): 212-221 
 
Hecker CM, Rabiller M, Haglund K, Bayer P, Dikic I (2006) Specification of 
SUMO1 and SUMO2 interacting motifs. J Biol Chem 
 
Hietakangas V, Anckar J, Blomster HA, Fujimoto M, Palvimo JJ, Nakai A, Sistonen 
L (2006) PDSM, a motif for phosphorylation-dependent SUMO modification. Proc 
Natl Acad Sci U S A 103(1): 45-50 
 
Hotson A, Chosed R, Shu H, Orth K, Mudgett MB (2003) Xanthomonas type III 
effector XopD targets SUMO-conjugated proteins in planta. Mol Microbiol 50(2): 
377-389 
 
Huang TT, Wuerzberger-Davis SM, Wu ZH, Miyamoto S (2003) Sequential 
modification of NEMO/IKKgamma by SUMO-1 and ubiquitin mediates NF-
kappaB activation by genotoxic stress. Cell 115(5): 565-576 
 
Huang WC, Ko TP, Li SSL, Wang AHJ (2004) Crystal structures of the human 
SUMO-2 protein at 1.6 angstrom and 1.2 angstrom resolution - Implication on the 
functional differences of SUMO proteins. European Journal of Biochemistry 271(20): 
4114-4122 
 
Iida T, Kawaguchi R, Nakayama J (2006) Conserved ribonuclease, Eri1, negatively 
regulates heterochromatin assembly in fission yeast. Curr Biol 16(14): 1459-1464 
 
  
120 Literature 
Janjusevic R, Abramovitch RB, Martin GB, Stebbins CE (2006) A bacterial inhibitor 
of host programmed cell death defenses is an E3 ubiquitin ligase. Science 
311(5758): 222-226 
 
Janssen K, Hofmann TG, Jans DA, Hay RT, Schulze-Osthoff K, Fischer U (2007) 
Apoptin is modified by SUMO conjugation and targeted to promyelocytic 
leukemia protein nuclear bodies. Oncogene 26(11): 1557-1566 
 
Jin JB, Jin YH, Lee J, Miura K, Yoo CY, Kim WY, Van Oosten M, Hyun Y, Somers 
DE, Lee I, Yun DJ, Bressan RA, Hasegawa PM (2008) The SUMO E3 ligase, AtS1Z1, 
regulates flowering by controlling a salicylic acid-mediated floral promotion 
pathway and through affects on FLC chromatin structure. Plant Journal 53(3): 530-
540 
 
Johnson ES, Gupta AA (2001) An E3-like factor that promotes SUMO conjugation 
to the yeast septins. Cell 106(6): 735-744 
 
Kang H, Kim ET, Lee HR, Park JJ, Go YY, Choi CY, Ahn JH (2006) Inhibition of 
SUMO-independent PML oligomerization by the human cytomegalovirus IE1 
protein. J Gen Virol 87(Pt 8): 2181-2190 
 
Kim JG, Taylor KW, Hotson A, Keegan M, Schmelz EA, Mudgett MB (2008) XopD 
SUMO Protease Affects Host Transcription, Promotes Pathogen Growth, and 
Delays Symptom Development in Xanthomonas-Infected Tomato Leaves. Plant 
Cell 
 
Kim KI, Baek SH (2006) SUMOylation code in cancer development and metastasis. 
Mol Cells 22(3): 247-253 
 
Knipscheer P, Flotho A, Klug H, Olsen JV, van Dijk WJ, Fish A, Johnson ES, Mann 
M, Sixma TK, Pichler A (2008) Ubc9 sumoylation regulates SUMO target 
discrimination. Mol Cell 31(3): 371-382 
 
Kurepa J, Walker JM, Smalle J, Gosink MM, Davis SJ, Durham TL, Sung DY, 
Vierstra RD (2003) The small ubiquitin-like modifier (SUMO) protein modification 
system in Arabidopsis - Accumulation of SUMO1 and -2 conjugates is increased 
by stress. Journal of Biological Chemistry 278(9): 6862-6872 
 
Lallemand-Breitenbach V, Jeanne M, Benhenda S, Nasr R, Lei M, Peres L, Zhou J, 
Zhu J, Raught B, de The H (2008) Arsenic degrades PML or PML-RARalpha 
through a SUMO-triggered RNF4/ubiquitin-mediated pathway. Nat Cell Biol 10(5): 
547-555 
 
  
121 Literature 
Lee HR, Kim DJ, Lee JM, Choi CY, Ahn BY, Hayward GS, Ahn JH (2004) Ability of 
the human cytomegalovirus IE1 protein to modulate sumoylation of PML 
correlates with its functional activities in transcriptional regulation and infectivity 
in cultured fibroblast cells. J Virol 78(12): 6527-6542 
 
Lee J, Nam J, Park HC, Na G, Miura K, Jin JB, Yoo CY, Baek D, Kim DH, Jeong JC, 
Kim D, Lee SY, Salt DE, Mengiste T, Gong QQ, Ma SS, Bohnert HJ, Kwak SS, 
Bressan RA, Hasegawa PM, Yun DJ (2007) Salicylic acid-mediated innate 
immunity in Arabidopsis is regulated by SIZ1 SUMO E3 ligase. Plant Journal 49: 
79-90 
 
Lois LM, Lima CD, Chua NH (2003) Small ubiquitin-like modifier modulates 
abscisic acid signaling in Arabidopsis. Plant Cell 15(6): 1347-1359 
 
Makhnevych T, Ptak C, Lusk CP, Aitchison JD, Wozniak RW (2007) The role of 
karyopherins in the regulated sumoylation of septins. J Cell Biol 177(1): 39-49 
 
Meulmeester E, Melchior F (2008) Cell biology: SUMO. Nature 452(7188): 709-711 
 
Miura K, Jin JB, Lee J, Yoo CY, Stirm V, Miura T, Ashworth EN, Bressan RA, Yun 
DJ, Hasegawa PM (2007) SIZ1-mediated sumoylation of ICE1 controls 
CBF3/DREB1A expression and freezing tolerance in Arabidopsis. Plant Cell 19(4): 
1403-1414 
 
Miura K, Rus A, Sharkhuu A, Yokoi S, Karthikeyan AS, Raghothama KG, Back D, 
Koo YD, Jin JB, Bressan RA, Yun DJ, Hasegawa PM (2005) The Arabidopsis SUMO 
E3 ligase SIZ1 controls phosphate deficiency responses (vol 102, pg 7760, 2005). 
Proceedings of the National Academy of Sciences of the United States of America 102(27): 
9734-9734 
 
Mo YY, Moschos SJ (2005) Targeting Ubc9 for cancer therapy. Expert Opin Ther 
Targets 9(6): 1203-1216 
 
Mossessova E, Lima CD (2000) Ulp1-SUMO crystal structure and genetic analysis 
reveal conserved interactions and a regulatory element essential for cell growth in 
yeast. Mol Cell 5(5): 865-876 
 
Mukherjee S, Keitany G, Li Y, Wang Y, Ball HL, Goldsmith EJ, Orth K (2006) 
Yersinia YopJ acetylates and inhibits kinase activation by blocking 
phosphorylation. Science 312(5777): 1211-1214 
 
Mullen JR, Brill SJ (2008) Activation of the SLX5-SLX8 ubiquitin ligase by poly-
SUMO conjugates. J Biol Chem 
 
  
122 Literature 
Muller S, Dejean A (1999) Viral immediate-early proteins abrogate the 
modification by SUMO-1 of PML and Sp100 proteins, correlating with nuclear 
body disruption. J Virol 73(6): 5137-5143 
 
Murtas G, Reeves PH, Fu YF, Bancroft I, Dean C, Coupland G (2003) A nuclear 
protease required for flowering-time regulation in Arabidopsis reduces the 
abundance of SMALL UBIQUITIN-RELATED MODIFIER conjugates. Plant Cell 
15(10): 2308-2319 
 
Nacerddine K, Lehembre F, Bhaumik M, Artus J, Cohen-Tannoudji M, Babinet C, 
Pandolfi PP, Dejean A (2005) The SUMO pathway is essential for nuclear integrity 
and chromosome segregation in mice. Dev Cell 9(6): 769-779 
 
Novatchkova M, Bachmair A, Eisenhaber B, Eisenhaber F (2005) Proteins with two 
SUMO-like domains in chromatin-associated complexes: the RENi (Rad60-Esc2-
NIP45) family. BMC Bioinformatics 6(1): 22 
 
Novatchkova M, Budhiraja R, Coupland G, Eisenhaber F, Bachmair A (2004) 
SUMO conjugation in plants. Planta 220(1): 1-8 
 
Orth K, Xu Z, Mudgett MB, Bao ZQ, Palmer LE, Bliska JB, Mangel WF, Staskawicz 
B, Dixon JE (2000) Disruption of signaling by Yersinia effector YopJ, a ubiquitin-
like protein protease. Science 290(5496): 1594-1597 
 
Perry JJ, Tainer JA, Boddy MN (2008) A SIM-ultaneous role for SUMO and 
ubiquitin. Trends Biochem Sci 33(5): 201-208 
 
Pichler A, Knipscheer P, Oberhofer E, van Dijk WJ, Korner R, Olsen JV, Jentsch S, 
Melchior F, Sixma TK (2005) SUMO modification of the ubiquitin-conjugating 
enzyme E2-25K. Nature Structural & Molecular Biology 12(3): 264-269 
 
Prudden J, Pebernard S, Raffa G, Slavin DA, Perry JJ, Tainer JA, McGowan CH, 
Boddy MN (2007) SUMO-targeted ubiquitin ligases in genome stability. EMBO J 
26(18): 4089-4101 
 
Reeves PH, Murtas G, Dash S, Coupland G (2002) early in short days 4, a mutation 
in Arabidopsis that causes early flowering and reduces the mRNA abundance of 
the floral repressor FLC. Development 129(23): 5349-5361 
 
Reindle A, Belichenko I, Bylebyl GR, Chen XL, Gandhi N, Johnson ES (2006) 
Multiple domains in Siz SUMO ligases contribute to substrate selectivity. J Cell Sci 
119(Pt 22): 4749-4757 
 
  
123 Literature 
Reverter D, Lima CD (2004) A basis for SUMO protease specificity provided by 
analysis of human Senp2 and a Senp2-SUMO complex. Structure 12(8): 1519-1531 
 
Roden J, Eardley L, Hotson A, Cao Y, Mudgett MB (2004) Characterization of the 
Xanthomonas AvrXv4 effector, a SUMO protease translocated into plant cells. Mol 
Plant Microbe Interact 17(6): 633-643 
 
Saitoh H, Hinchey J (2000) Functional heterogeneity of small ubiquitin-related 
protein modifiers SUMO-1 versus SUMO-2/3. J Biol Chem 275(9): 6252-6258 
 
Sampson DA, Wang M, Matunis MJ (2001) The small ubiquitin-like modifier-1 
(SUMO-1) consensus sequence mediates Ubc9 binding and is essential for SUMO-
1 modification. J Biol Chem 276(24): 21664-21669 
 
Saracco SA, Miller MJ, Kurepa J, Vierstra RD (2007) Genetic analysis of 
SUMOylation in arabidopsis: Conjugation of SUMO1 and SUMO2 to nuclear 
proteins is essential. Plant Physiology 145(1): 119-134 
 
Shen TH, Lin HK, Scaglioni PP, Yung TM, Pandolfi PP (2006) The mechanisms of 
PML-nuclear body formation. Mol Cell 24(3): 331-339 
 
Shiio Y, Eisenman RN (2003) Histone sumoylation is associated with 
transcriptional repression. Proc Natl Acad Sci U S A 100(23): 13225-13230 
 
Steffan JS, Agrawal N, Pallos J, Rockabrand E, Trotman LC, Slepko N, Illes K, 
Lukacsovich T, Zhu YZ, Cattaneo E, Pandolfi PP, Thompson LM, Marsh JL (2004) 
SUMO modification of Huntingtin and Huntington's disease pathology. Science 
304(5667): 100-104 
 
Tatham MH, Geoffroy MC, Shen L, Plechanovova A, Hattersley N, Jaffray EG, 
Palvimo JJ, Hay RT (2008) RNF4 is a poly-SUMO-specific E3 ubiquitin ligase 
required for arsenic-induced PML degradation. Nat Cell Biol 10(5): 538-546 
 
Thomas MC, Chiang CM (2006) The general transcription machinery and general 
cofactors. Crit Rev Biochem Mol Biol 41(3): 105-178 
 
Topfer R, Maas C, Horicke-Grandpierre C, Schell J, Steinbiss HH (1993) Expression 
vectors for high-level gene expression in dicotyledonous and monocotyledonous 
plants. Methods Enzymol 217: 67-78 
 
Ulrich HD (2004) How to activate a damage-tolerant polymerase: consequences of 
PCNA modifications by ubiquitin and SUMO. Cell Cycle 3(1): 15-18 
 
  
124 Literature 
Ulrich HD (2007) Conservation of DNA damage tolerance pathways from yeast to 
humans. Biochem Soc Trans 35(Pt 5): 1334-1337 
 
Uzunova K, Gottsche K, Miteva M, Weisshaar SR, Glanemann C, Schnellhardt M, 
Niessen M, Scheel H, Hofmann K, Johnson ES, Praefcke GJ, Dohmen RJ (2007) 
Ubiquitin-dependent proteolytic control of SUMO conjugates. J Biol Chem 282(47): 
34167-34175 
 
Watts FZ (2004) SUMO modification of proteins other than transcription factors. 
Seminars in Cell & Developmental Biology 15(2): 211-220 
 
Weisshaar SR, Keusekotten K, Krause A, Horst C, Springer HM, Gottsche K, 
Dohmen RJ, Praefcke GJ (2008) Arsenic trioxide stimulates SUMO-2/3 
modification leading to RNF4-dependent proteolytic targeting of PML. FEBS Lett 
 
Wu L, Wu H, Ma L, Sangiorgi F, Wu N, Bell JR, Lyons GE, Maxson R (1997) Miz1, 
a novel zinc finger transcription factor that interacts with Msx2 and enhances its 
affinity for DNA. Mech Dev 65(1-2): 3-17 
 
Yang SH, Galanis A, Witty J, Sharrocks AD (2006) An extended consensus motif 
enhances the specificity of substrate modification by SUMO. EMBO J 25(21): 5083-
5093 
 
Yates JL, Nomura M (1980) E. coli ribosomal protein L4 is a feedback regulatory 
protein. Cell 21(2): 517-522 
 
Yin XJ, Volk S, Ljung K, Mehlmer N, Dolezal K, Ditengou F, Hanano S, Davis SJ, 
Schmelzer E, Sandberg G, Teige M, Palme K, Pickart C, Bachmair A (2007) 
Ubiquitin lysine 63 chain forming ligases regulate apical dominance in 
Arabidopsis. Plant Cell 19(6): 1898-1911 
 
Yoo CY, Miura K, Jin JB, Lee J, Park HC, Salt DE, Yun DJ, Bressan RA, Hasegawa 
PM (2006) SIZ1 small ubiquitin-like modifier E3 ligase facilitates basal 
thermotolerance in Arabidopsis independent of salicylic acid. Plant Physiology 
142(4): 1548-1558 
 
Zhang YQ, Sarge KD (2008) Sumoylation of amyloid precursor protein negatively 
regulates Abeta aggregate levels. Biochem Biophys Res Commun 374(4): 673-678 
 
Zhao XL, Blobel G (2005) A SUMO ligase is part of a nuclear multiprotein complex 
that affects DNA repair and chromosomal organization (vol 102, pg 4777, 2005). 
Proceedings of the National Academy of Sciences of the United States of America 102(25): 
9086-9086 
 
  
125 Literature 
Zunino R, Schauss A, Rippstein P, Andrade-Navarro M, McBride HM (2007) The 
SUMO protease SENP5 is required to maintain mitochondrial morphology and 
function. J Cell Sci 120(Pt 7): 1178-1188 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
126 
7 ABBREVIATIONS 
Commonly used abbreviations derived from the SI or IUPAC nomenclature as 
well as the single letter code for amino acids are not explained separately. The 
other abbreviations are listed below. 
 
Table 7.1: Abbreviations used in this work 
A. thaliana Arabidopsis thaliana  NDSM negatively charged amino 
acid-dependent 
SUMOylation motif 
A. 
tumefaciens 
Agrobacterium 
tumefaciens 
 PCNA Proliferating Cell Nuclear 
Antigen 
AP  alkaline phosphatase  PDSM phosphorylation-
dependent SUMOylation 
motif 
CO CONSTANS  PIL PIAS-Like 
Col Columbia  PML promyelocytic leukemia 
protein 
E. coli Escherichia coli  S. 
cerevisae 
Saccharomyces cerevisae 
EL1 Early in Short Days 4 –
Like 1 (homolog of 
ESD4) 
 SAE SUMO activating enzyme 
ESD4 Early in Short Days 4 
(a SUMO protease) 
 SCE SUMO conjugating 
enzyme 
FLC Flowering Locus C  SD short day (8 h light per 
day) 
FLD Flowering Locus D  SIM SUMO interacting motif 
HDAC histone deacetylases  StUbls SUMO-targeted Ubiquitin 
ligases 
HRP horse radish 
peroxidase 
 SUMO  Small Ubiquitin related 
modifier protein 
Hs Homo sapiens  Ubl Ubiquitin-like protein 
LD long day (16 h light 
per day) 
 WS Wassilewskija 
NAF  nucleosome assembly 
factor 
 WT wild type 
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Table 7.2: Amino acid code 
A alanine Ala  M methionine Met 
C cysteine Cys  N asparagines  Asn 
D aspartic acid Asp  P proline Pro 
E glutamic acid Glu  Q glutamine Gln 
F phenylalanine Phe  R arginine Arg 
G glycine Gly  S serine Ser 
H histidine His  T threonine Thr 
I isoleucine Ile  V valine Val 
K lysine Lys  W tryptophan Trp 
L leucine Leu  Y tyrosine Tyr 
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8 SUPPLEMENTARY 
8.1 Sequences and SUMOplot results of different proteins 
Below the protein sequences and the results of the SUMOplots of tested potential 
SUMO substrates are shown. Potential SIMs are indicated as well in Table 8.1. 
 
Table 8.1: SUMOplot results of various proteins 
SIMs are shown in bold. 
 
gene: At2g41060 protein: RRM2 
 
  1 MTKKRKLESE SNETSEPTEK QQQQCEKEDP EIRNVDNQRD DDEQVVEQDT  
 51 LKEMHEEEAK GEDNIEAETS SGSGNQGNED DDEEEPIEDL LEPFSKDQLL  
101 ILLKEAAERH RDVANRIRIV ADEDLVHRKI FVHGLGWDTK ADSLIDAFKQ  
151 YGEIEDCKCV VDKVSGQSKG YGFILFKSRS GARNALKQPQ KKIGTRMTAC  
201 QLASIGPVQG NPVVAPAQHF NPENVQRKIY VSNVSADIDP QKLLEFFSRF  
251 GEIEEGPLGL DKATGRPKGF ALFVYRSLES AKKALEEPHK TFEGHVLHCH  
301 KANDGPKQVK QHQHNHNSHN QNSRYQRNDN NGYGAPGGHG HFIAGNNQAV  
351 QAFNPAIGQA LTALLASQGA GLGLNQAFGQ ALLGTLGTAS PGAVGGMPSG  
401 YGTQANISPG VYPGYGAQAG YQGGYQTQQP GQGGAGRGQH GAGYGGPYMG  
451 R  
 
SUMOylation consensus motifs (http://www.abgent.com/tools/sumoplot): 
No. Pos. Group Score 
1 K187 GARNA LKQP QKKIG 0.80 
2 K60 MHEEE AKGE DNIEA 0.79 
3 K27 QQQQC EKED PEIRN 0.50 
4 K6  MTKK RKLE SESNE 0.44 
5 K192 LKQPQ KKIG TRMTA 0.31 
6 K268 KATGR PKGF ALFVY 0.26 
7 K290 ALEEP HKTF EGHVL 0.17 
8 K129 EDLVH RKIF VHGLG 0.09 
 
 
gene: At3g56860 protein: RRM1 
 
  1 MTKKRKLEGE ESNEAEEPSQ KLKQTPEEEQ QLVIKNQDNQ GDVEEVEYEE  
 51 VEEEQEEEVE DDDDEDDGDE NEDQTDGNRI EAAATSGSGN QEDDDDEPIQ  
101 DLLEPFSKEQ VLSLLKEAAE KHVDVANRIR EVADEDPVHR KIFVHGLGWD  
151 TKTETLIEAF KQYGEIEDCK AVFDKISGKS KGYGFILYKS RSGARNALKQ  
201 PQKKIGSRMT ACQLASKGPV FGGAPIAAAA VSAPAQHSNS EHTQKKIYVS  
251 NVGAELDPQK LLMFFSKFGE IEEGPLGLDK YTGRPKGFCL FVYKSSESAK  
301 RALEEPHKTF EGHILHCQKA IDGPKPGKQQ QHHHNPHAYN NPRYQRNDNN  
351 GYGPPGGHGH LMAGNPAGMG GPTAQVINPA IGQALTALLA SQGAGLAFNP  
401 AIGQALLGSL GTAAGVNPGN GVGMPTGYGT QAMAPGTMPG YGTQPGLQGG  
451 YQTPQPGQGG TSRGQHGVGP YGTPYMGH 
 
SUMOylation consensus motifs (http://www.abgent.com/tools/sumoplot): 
No. Pos. Group Score 
1 K199 GARNA LKQP QKKIG 0.80 
2 K6  MTKK RKLE GEESN 0.44 
3 K325 KAIDG PKPG KQQQH 0.43 
4 K204 LKQPQ KKIG SRMTA 0.31 
5 K286 KYTGR PKGF CLFVY 0.26 
6 K308 ALEEP HKTF EGHIL 0.17 
7 K141 EDPVH RKIF VHGLG 0.09 
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gene: At2g43970 protein: LA 
 
  1 MADQQTLDSS TPPPTQSDDL SHSHSTSSTT SASSSSDPSL LRSLSLSRLN  
 51 AGAPEFVPGR TTPPLPQPPR MIIPPPPPHG MLHMYHHQPP FNTPVLGPVP  
101 IQPHLVPVQN HHPHHRFHQH HHHNRHQNQQ YVPVRNHGEY QQRGGVGGEQ  
151 EPDLVSKNKD RRDHSKRESK NDQVTETGAS VSIDSKTGLP EDSIQKIVNQ  
201 VEYYFSDLNL ATTDHLMRFI CKDPEGYVPI HVVASFKKIK AVINNNSQLA  
251 AVLQNSAKLF VSEDGKKVRR ISPITESAIE ELQSRIIVAE NLPEDHCYQN  
301 LMKIFSTVGS VKNIRTCQPQ NNGSGAPPAA RSAAKSDGTL FSNKVHAFVE  
351 YEIVELAERA VTELSEAGNW RSGLKVRLML KHQTKEPKQG QGRGRKGHDA  
401 DVEHEEDDAT TSEQQPIEKQ SDDCSGEWDT HMQEQPIGED QGNEKAAGQR  
451 KGRNRGRGKG RGRGQPHQNQ NQNNNHSHNQ NHNHNGRGNH HHHHHHQVGT  
501 QPSNNPMNNM EQPGMGKQQP PGPRMPDGTR GFSMGRGKPV MVQAE  
 
SUMOylation consensus motifs (http://www.abgent.com/tools/sumoplot): 
No. Pos. Group Score 
1 K335 AARSA AKSD GTLFS 0.79 
2 K158 PDLVS KKND RRDHS 0.48 
3 K303 CYQNL MKIF STVGS 0.45 
4 K258 VLQNS AKLF VSEDG 0.44 
5 K388 HQTKE PKQG QGRGR 0.43 
 
 
gene: At1g55300 protein: TAF7 
 
  1 MEEQFILRVP PSVSERIDRL LSEDASTSDE IPLDLFFSED GRNGTFMIGN  
 51 DEFPASLLDL PAVVESFKTY DDCALVKTAD IGQMIMVREP GDPAPNTVEY  
101 RHGLTPPMKD ARKRRFRREP DLNPELVQRV ERDLLNILSG GTVENVSFSF  
151 YFRHMMCLYL LLGFSNFIYL NFFWCRYMSK RNQLRTRMLV MQVRKYLLLH  
201 LHLLKSLKLL RQALVIQQEL NRREVNQKIL MIQCEFIII  
 
 
gene: At1g29400 protein: AML5 
 
  1 MDIPHEAEAG AWGILPGFGR HHHPSSDATL FSSSLPVFPR GKLQLSDNRD  
 51 GFSLIDDTAV SRTNKFNESA DDFESHSIGN LLPDEEDLLT GMMDDLDLGE  
101 LPDADDYDLF GSGGGMELDA DFRDNLSMSG PPRLSLSSLG GNAIPQFNIP  
151 NGAGTVAGEH PYGEHPSRTL FVRNINSNVE DSELTALFEQ YGDIRTLYTT  
201 CKHRGFVMIS YYDIRSARMA MRSLQNKPLR RRKLDIHFSI PKDNPSEKDM  
251 NQGTLVVFNL DPSISNDDLH GIFGAHGEIK EIRETPHKRH HKFVEFYDVR  
301 GAEAALKALN RCEIAGKRIK VEPSRPGGAR RSLMLQLNQD LENDDLHYLP  
351 MIGSPMANSP PMQGNWPLNS PVEGSPLQSV LSRSPVFGLS PTRNGHLSGL  
401 ASALNSQGPS SKLAPIGRGQ IGSNGFQQSS HLFQEPKMDN KYTGNLSPSG  
451 PLISNGGGIE TLSGSEFLWG SPNARSEPSS SSVWSTSSTG NPLFSTRVDR  
501 SVPFPHQHQN QSRSHHHFHV GSAPSGVPLE KHFGFVPESS KDALFMNTVG  
551 LQGMSGMGLN GGSFSSKMAN NGIINSGSMA ENGFSSYRMM SSPRFSPMFL  
601 SSGLNPGRFA SGFDSLYENG RPRRVENNSN QVESRKQFQL DLEKILNGED  
651 SRTTLMIKNI PNKYTSKMLL AAIDEKNQGT YNFLYLPIDF KNKCNVGYAF  
701 INMLNPELII PFYEAFNGKK WEKFNSEKVA SLAYARIQGK SALIAHFQNS  
751 SLMNEDMRCR PIIFDTPNNP ESVEQVVDEE SKNMDLLDSQ LSDDDGRERS 
 
SUMOylation consensus motifs (http://www.abgent.com/tools/sumoplot): 
No. Pos. Group Score 
1 K320 IAGKR IKVE PSRPG 0.94 
2 K437 HLFQE PKMD NKYTG 0.61 
3 K720 EAFNG KKWE KFNSE 0.48 
4 K233 KPLRR RKLD IHFSI 0.44 
5 K531 SGVPL EKHF GFVPE 0.15 
6 K636 NQVES RKQF QLDLE 0.09 
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gene: At5g08450 protein: Rxt3 
 
  1 MSGVPKRSHE EGVTHPSSSS SVAKYPHEDS GSYPKSPHQP VTPPPAQVHH  
 51 NHQQPHQHPQ SQSQSQPQPH LQALPHPHSH SHSHSPLAAA ASASAPYEVE  
101 SRTVVKVARS EPRDGERRSP LPLVYRSPSL PTTVSSSDPH LTHAPVPMEP  
151 RDGAKDGREI RVESRENRSD GREIYGETKR EIQGPKGDRD VKFERSVDDF  
201 SGKGNTGSYT RNDGREMYGE TKREIQGPKS DRDAKFERPG DDFSGKSNAG  
251 SYTRDTKFDR ENQNYNEQKG EIKMEKEGHA HLAWKEQKDY HRGKRVAEGS  
301 TANVDPWVVS RGNPQGPTEV GPKDLSAPVE GSHLEGRETV GENKVDAKNE  
351 DRFKEKDKKR KELKHREWGD RDKDRNDRRV SVLVGSVMSE PKEIGREERE  
401 SDRWERERME QKDRERNKEK DKDHIKREPR TGAEKEISQN EKELGEASAK  
451 PSEQEYVAPE QKKQNEPDNC EKDERETKEK RRERDGDSEA ERAEKRSRIS  
501 EKESEDGCLE GEGATEREKD AFNYGVQQRK RALRPRGSPQ TTNRDNVRSR  
551 SQDNEGVQGK SEVSIVVYKV GECMQELIKL WKEYDLSHPD KSGDFANNGP  
601 TLEVRIPAEH VTATNRQVRG GQLWGTDIYT DDSDLVAVLM HTGYCRPTAS  
651 PPPPTMQELR TTIRVLPSQD YYTSKLRNNV RSRAWGAGIG CSYRVERCYI  
701 LKKGGGTIEL EPSLTHSSTV EPTLAPMAVE RSMTTRAAAS NALRQQRFVR  
751 EVTIQYNLCN EPWIKYSISI VADKGLKKPL FTSARLKKGE VLYLETHSCR  
801 YELCFAGEKT IKAIQASQQQ SSHEAMETDN NNNKSQNHLT NGDKTDSDNS  
851 LIDVFRWSRC KKPLPQKLMR SIGFPLPADH IEVLEENLDW EDVQWSQTGV  
901 WIAGKEYTLA RVHFLSPN  
 
SUMOylation consensus motifs (http://www.abgent.com/tools/sumoplot): 
No. Pos. Group Score 
1 K273 EQKGE IKME KEGHA 0.94 
2 K426 KDKDH IKRE PRTGA 0.94 
3 K192 KGDRD VKFE RSVDD 0.93 
4 K777 VADKG LKKP LFTSA 0.80 
5 K348 ENKVD AKNE DRFKE 0.79 
6 K235 KSDRD AKFE RPGDD 0.79 
7 K787 FTSAR LKKG EVLYL 0.73 
8 K702 ERCYI LKKG GGTIE 0.73 
9 K24 SSSSV AKYP HEDSG 0.69 
10 K560 NEGVQ GKSE VSIVV 0.67 
11 K155 EPRDG AKDG REIRV 0.62 
12 K229 REIQG PKSD RDAKF 0.61 
13 K186 REIQG PKGD RDVKF 0.61 
14 K269 QNYNE QKGE IKMEK 0.50 
15 K35 DSGSY PKSP HQPVT 0.50 
16 K472 EPDNC EKDE RETKE 0.50 
17 K844 HLTNG DKTD SDNSL 0.50 
18 K788 TSARL KKGE VLYLE 0.48 
19 K591 DLSHP DKSG DFANN 0.33 
20 K276 GEIKM EKEG HAHLA 0.33 
21 K703 RCYIL KKGG GTIEL 0.31 
 
 
gene: At2g19480 protein: NAF 
 
  1 MSNDKDSMNM SDLSTALNEE DRAGLVNALK NKLQNLAGQH SDVLENLTPP  
 51 VRKRVEFLRE IQNQYDEMEA KFFEERAALE AKYQKLYQPL YTKRYEIVNG  
101 VVEVEGAAEE VKSEQGEDKS AEEKGVPDFW LIALKNNEIT AEEITERDEG  
151 ALKYLKDIKW SRVEEPKGFK LEFFFDQNPY FKNTVLTKTY HMIDEDEPIL  
201 EKALGTEIEW YPGKCLTQKI LKKKPKKGSK NTKPITKTED CESFFNFFSP  
251 PQVPDDDEDL DDDMADELQG QMEHDYDIGS TIKEKIISHA VSWFTGEAVE  
301 ADDLDIEDDD DEIDEDDDEE DEEDDEDDEE EDDEDDDEEE EADQGKKSKK  
351 KSSAGHKKAG RSQLAEGQAG ERPPECKQQ  
  
SUMOylation consensus motifs (http://www.abgent.com/tools/sumoplot): 
No. Pos. Group Score 
1 K112 GAAEE VKSE QGEDK 0.93 
2 K170 EEPKG FKLE FFFDQ 0.85 
3 K71 YDEME AKFF EERAA 0.44 
4 K226 ILKKK PKKG SKNTK 0.43 
5 K223 TQKIL KKKP KKGSK 0.37 
6 K358 SSAGH KKAG RSQLA 0.31 
7 K167 SRVEE PKGF KLEFF 0.26 
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gene: At1g51950 protein: IAA 18 
 
  1 MEGYSRNGEI SPKLLDLMIP QERRNWFHDE KNSVFKTEEK KLELKLGPPG  
 51 EEDDDESMIR HMKKEPKDKS ILSLAGKYFS PSSTKTTSHK RTAPGPVVGW  
101 PPVRSFRKNL ASGSSSKLGN DSTTSNGVTL KNQKCDAAAK TTEPKRQGGM  
151 FVKINMYGVP IGRKVDLSAH NSYEQLSFTV DKLFRGLLAA QRDFPSSIED  
201 EKPITGLLDG NGEYTLTYED NEGDKMLVGD VPWQMFVSSV KRLRVIKTSE  
251 ISSALTYGNG KQEKMRR 
 
SUMOylation consensus motifs (http://www.abgent.com/tools/sumoplot): 
No. Pos. Group Score 
1 K36 EKNSV FKTE EKKLE 0.85 
2 K63 SMIRH MKKE PKDKS 0.80 
3 K45 EKKLE LKLG PPGEE 0.73 
4 K261 LTYGN GKQE KMRR  0.67 
5 K134 VTLKN QKCD AAAKT 0.50 
6 K41 FKTEE KKLE LKLGP 0.48 
7 K164 GVPIG RKVD LSAHN 0.44 
8 K64 MIRHM KKEP KDKSI 0.37 
9 K77 ILSLA GKYF SPSST 0.32 
10 K182 LSFTV DKLF RGLLA 0.15 
 
 
gene: At5g15840 protein: CO 
 
  1 MLKQESNDIG SGENNRARPC DTCRSNACTV YCHADSAYLC MSCDAQVHSA  
 51 NRVASRHKRV RVCESCERAP AAFLCEADDA SLCTACDSEV HSANPLARRH  
101 QRVPILPISG NSFSSMTTTH HQSEKTMTDP EKRLVVDQEE GEEGDKDAKE  
151 VASWLFPNSD KNNNNQNNGL LFSDEYLNLV DYNSSMDYKF TGEYSQHQQN  
201 CSVPQTSYGG DRVVPLKLEE SRGHQCHNQQ NFQFNIKYGS SGTHYNDNGS  
251 INHNAYISSM ETGVVPESTA CVTTASHPRT PKGTVEQQPD PASQMITVTQ  
301 LSPMDREARV LRYREKRKTR KFEKTIRYAS RKAYAEIRPR VNGRFAKREI  
351 EAEEQGFNTM LMYNTGYGIV PSF 
 
SUMOylation consensus motifs (http://www.abgent.com/tools/sumoplot): 
No. Pos. Group Score 
1 K3     M LKQE SNDIG 0.91 
2 K217 DRVVP LKLE ESRGH 0.91 
3 K347 VNGRF AKRE IEAEE 0.79 
4 K237 NFQFN IKYG SSGTH 0.77 
5 K321 EKRKT RKFE KTIRY 0.44 
 
 
gene: At5g12840 protein: Hap2a 
 
  1 MQSKPGRENE EEVNNHHAVQ QPMMYAEPWW KNNSFGVVPQ ARPSGIPSNS  
 51 SSLDCPNGSE SNDVHSASED GALNGENDGT WKDSQAATSS RSVDNHGMEG  
101 NDPALSIRNM HDQPLVQPPE LVGHYIACVP NPYQDPYYGG LMGAYGHQQL  
151 GFRPYLGMPR ERTALPLDMA QEPVYVNAKQ YEGILRRRKA RAKAELERKV  
201 IRDRKPYLHE SRHKHAMRRA RASGGRFAKK SEVEAGEDAG GRDRERGSAT  
251 NSSGSEQVET DSNETLNSSG AP  
 
SUMOylation consensus motifs (http://www.abgent.com/tools/sumoplot): 
No. Pos. Group Score 
1 K193 RRKAR AKAE LERKV 0.79 
2 K230 GGRFA KKSE VEAGE 0.48 
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gene: At2g22540 protein: SVP 
 
  1 MAREKIQIRK IDNATARQVT FSKRRRGLFK KAEELSVLCD ADVALIIFSS  
 51 TGKLFEFCSS SMKEVLERHN LQSKNLEKLD QPSLELQLVE NSDHARMSKE  
101 IADKSHRLRQ MRGEELQGLD IEELQQLEKA LETGLTRVIE TKSDKIMSEI  
151 SELQKKGMQL MDENKRLRQQ GTQLTEENER LGMQICNNVH AHGGAESENA  
201 AVYEEGQSSE SITNAGNSTG APVDSESSDT SLRLGLPYGG  
 
SUMOylation consensus motifs (http://www.abgent.com/tools/sumoplot): 
No. Pos. Group Score 
1 K78 QSKNL EKLD QPSLE 0.50 
2 K31 RRGLF KKAE ELSVL 0.48 
3 K10 EKIQI RKID NATAR 0.44 
4 K155 EISEL QKKG MQLMD 0.33 
5 K53 IFSST GKLF EFCSS 0.32 
 
 
gene: At5g10140 protein: FLC 
 
  1 MGRKKLEIKR IENKSSRQVT FSKRRNGLIE KARQLSVLCD ASVALLVVSA  
 51 SGKLYSFSSG DNLVKILDRY GKQHADDLKA LDHQSKALNY GSHYELLELV  
101 DSKLVGSNVK NVSIDALVQL EEHLETALSV TRAKKTELML KLVENLKEKE  
151 KMLKEENQVL ASQMENNHHV GAEAEMEMSP AGQISDNLPV TLPLLN 
 
SUMOylation consensus motifs (http://www.abgent.com/tools/sumoplot): 
No. Pos. Group Score 
1 K154 EKEKM LKEE NQVLA 0.91 
2 K135 SVTRA KKTE LMLKL 0.48 
3 K5   MGR KKLE IKRIE 0.48 
 
 
gene: At2g32950 protein: COP1 
 
  1 MEEISTDPVV PAVKPDPRTS SVGEGANRHE NDDGGSGGSE IGAPDLDKDL  
 51 LCPICMQIIK DAFLTACGHS FCYMCIITHL RNKSDCPCCS QHLTNNQLYP  
101 NFLLDKLLKK TSARHVSKTA SPLDQFREAL QRGCDVSIKE VDNLLTLLAE  
151 RKRKMEQEEA ERNMQILLDF LHCLRKQKVD ELNEVQTDLQ YIKEDINAVE  
201 RHRIDLYRAR DRYSVKLRML GDDPSTRNAW PHEKNQIGFN SNSLSIRGGN  
251 FVGNYQNKKV EGKAQGSSHG LPKKDALSGS DSQSLNQSTV SMARKKRIHA  
301 QFNDLQECYL QKRRQLADQP NSKQENDKSV VRREGYSNGL ADFQSVLTTF  
351 TRYSRLRVIA EIRHGDIFHS ANIVSSIEFD RDDELFATAG VSRCIKVFDF  
401 SSVVNEPADM QCPIVEMSTR SKLSCLSWNK HEKNHIASSD YEGIVTVWDV  
451 TTRQSLMEYE EHEKRAWSVD FSRTEPSMLV SGSDDCKVKV WCTRQEASVI  
501 NIDMKANICC VKYNPGSSNY IAVGSADHHI HYYDLRNISQ PLHVFSGHKK  
551 AVSYVKFLSN NELASASTDS TLRLWDVKDN LPVRTFRGHT NEKNFVGLTV  
601 NSEYLACGSE TNEVYVYHKE ITRPVTSHRF GSPDMDDAEE EAGSYFISAV  
651 CWKSDSPTML TANSQGTIKV LVLAA  
 
SUMOylation consensus motifs (http://www.abgent.com/tools/sumoplot): 
No. Pos. Group Score 
1 K193 TDLQY IKED INAVE 0.94 
2 K14 PVVPA VKPD PRTSS 0.93 
3 K653 ISAVC WKSD SPTML 0.64 
4 K273 SSHGL PKKD ALSGS 0.61 
5 K396 GVSRC IKVF DFSSV 0.59 
6 K178 HCLRK QKVD ELNEV 0.50 
7 K259 GNYQN KKVE GKAQG 0.48 
8 K154 LAERK RKME QEEAE 0.44 
9 K593 RGHTN EKNF VGLTV 0.15 
 
 
 
 
 
 
  
133 Supplementary 
gene: At5g50870 protein: UBC27 
 
  1 MIDFSRIQKE LQDCERNQDS SGIRVCPKSD NLTRLTGTIP GPIGTPYEGG  
 51 TFQIDITMPD GYPFEPPKMQ FSTKVWHPNI SSQSGAICLD ILKDQWSPAL  
101 TLKTALVSIQ ALLSAPEPKD PQDAVVAEQY MKNYQVFVST ARYWTETFAK  
151 KSSLEEKVKR LVEMGFGDAQ VRSAIESSGG DENLALEKLC SA  
  
SUMOylation consensus motifs (http://www.abgent.com/tools/sumoplot): 
No. Pos. Group Score 
1 K28 GIRVC PKSD NLTRL 0.61 
2 K119 LSAPE PKDP QDAVV 0.50 
 
 
gene: At3g15355 protein: PFU1 
 
  1 MEPNVVEIAT PPAASCSRIR TPTKAETPEV IDVEEYDLQN GGVPNGNNVD  
 51 YKNKGKAIDF DSMSYGDYGE EDEYAVGSPG DDYGYPESSP LSNSLLDPES  
101 LIYEDDENYS EQYDFEMEAE PDNYSMYQDL FDGKDIPTGV EVSMDWFPNS  
151 ADKESASSSK SSHANNGNNS SKKATKASGI HSQFSSDMET PVAQPWNALP  
201 HKAEGVIPNS AYALPQNSKA FQPPYAVHYS ALKTAFSNYL QPQTPDTVLG  
251 EAPAPAAGSS GLLPPNTPGF KSNAARFKEE PPILPPDDSR VKRNMEDYLG  
301 LYLFFKRFDI VEDFSDHHYA SKGTTSKQHS KDWAKRIQDE WRILEKDLPE  
351 MIFVRAYESR MDLLRAVIIG AQGTPYHDGL FFFDIFFPDT YPSTPPIVHY  
401 HSGGLRINPN LYNCGKVCLS LLGTWSGNQR EKWIPNTSTM LQVLVSIQGL  
451 ILNQKPYFNE PGYERSAGSA HGESTSKAYS ENTFILSLKT MVYTMRRPPK  
501 YFEDFAYGHF FSCAHDVLKA CNAYRNGATP GYLVKGAPDV EENSAGMSSL  
551 KFRTDVATFV ETVLLKEFIL LGVLGLEPEE EEKTPETIIV AESSKCTRSR  
601 SKRDRVSSS  
  
SUMOylation consensus motifs (http://www.abgent.com/tools/sumoplot): 
No. Pos. Group Score 
1 K278 SNAAR FKEE PPILP 0.85 
2 K566 VETVL LKEF ILLGV 0.56 
3 K202 WNALP HKAE GVIPN 0.52 
4 K306 GLYLF FKRF DIVED 0.50 
5 K583 EPEEE EKTP ETIIV 0.39 
6 K500 TMRRP PKYF EDFAY 0.26 
 
 
gene: At1g75940 protein: β glucosidase 
 
  1 MGRFHKFPLL GLVLFLGLTG SLIAANEYAC SSTDIHFTRA NFPKGFIFGT  
 51 ATAAFQVEGA VNEGCRGPSM WDVYTKKFPH KCNYHNADVA VDFYHRYKED  
101 IKLMKNLNTD GFRFSIAWPR IFPHGRMEKG ISKAGVQYYH DLIDELLANG  
151 ITPLVTVFHW DTPQDLEDEY GGFLSDRIIK DFTEYANFTF QEYGDKVKHW  
201 ITFNEPWVFS RAGYDIGNKA PGRCSKYIKE HGEMCHDGRS GHEAYIVSHN  
251 MLLAHADAVD AFRKCDKCKG GKIGIAHSPA WFEAHELSDE EHETPVTGLI  
301 DFILGWHLHP TTYGDYPQSM KDHIGHRLPK FTEAQKEKLK NSADFVGINY  
351 YTSVFALHDE EPDPSQPSWQ SDSLVDWEPR YVDKFNAFAN KPDVAKVEVY  
401 AKGLRSLLKY IKDKYGNPEI MITENGYGED LGEQDTSLVV ALSDQHRTYY  
451 IQKHLLSLHE AICDDKVNVT GYFHWSLMDN FEWQDGYKAR FGLYYVDYKN  
501 NLTRHEKLSA QWYSSFLHDG SKEFEIEHEF EHDEL 
  
SUMOylation consensus motifs (http://www.abgent.com/tools/sumoplot): 
No. Pos. Group Score 
1 K396 NKPDV AKVE VYAKG 0.79 
2 K180 LSDRI IKDF TEYAN 0.59 
3 K272 DKCKG GKIG IAHSP 0.50 
4 K264 AVDAF RKCD KCKGG 0.44 
5 K6  MGRF HKFP LLGLV 0.41 
6 K77 WDVYT KKFP HKCNY 0.37 
7 K414 LKYIK DKYG NPEIM 0.33 
8 K44 TRANF PKGF IFGTA 0.26 
 
 
  
8.2 Analysis of flowering time of SUMO ligase mutants
8.2.1  Data of flowering time experiments of 
Below, the original data for the flowering time experiments concerning the SUMO 
ligase mutants are listed in Table 
 
Table 8.2: Data of flowering time 
 
 LD 
date of sowing: 03.08.06 
condition: LD 16 hours light per day
Col WT siz1a 
leaves leaves 
# date r c date r c 
1 28.08. 13 1 05.09. 9 2 31.08.
2 30.08. 11 2 11.09. 11 2 04.09.
3 30.08. 15 3 11.09. 9 2 04.09.
4 28.08. 14 1 07.09. 10 0 04.09.
5 30.08. 11 3 08.09. 13 0 04.09.
6 30.08. 11 1 12.09. 12 2 05.09.
7 29.08. 12 1 11.09. 11 2 11.09.
8 28.08. 11 1 19.09. 14 2 05.09.
9 29.08. 11 1 07.09. 11 3 06.09.
10 28.08. 10 1 05.09.
11 29.08. 10 3 08.09.
12 29.08. 9 3 06.09.
13 28.08. 12 1 05.09.
14 31.08. 11 2 06.09.
15 29.08. 10 1 06.09.
16 28.08. 10 1 08.09.
17 28.08. 11 1 06.09.
18 28.08. 11 1 06.09.
19 29.08. 10 2 
20 29.08. 13 2 
21 28.08. 11 2 
  
Supplementary
pil1pil2 mutants
8.2. 
analysis of different SUMO ligase
 
siz1c pil1apil2b pil1cpil2a 
leaves leaves leaves 
date r c date r c date r c 
 10 2 31.08. 10 2 30.08. 11 2 
 9 2 30.08. 12 2 30.08. 12 2 
 9 2 30.08. 11 3 30.08. 11 2 
 8 2 29.08. 10 2 31.08. 11 3 
 11 3 29.08. 9 2 31.08. 11 2 
 12 1 31.08. 13 2 30.08. 12 2 
 8 2 30.08. 8 3 31.08. 10 2 
 9 2 30.08. 11 3 04.09. 10 2 
 8 1 29.08. 11 2 30.08. 8 2 
 11 2 29.08. 10 2 30.08. 12 3 
 11 2 29.08. 11 2 31.08. 12 2 
 10 1 30.08. 11 3 29.08. 9 1 
 7 1 30.08. 8 2 31.08. 11 2 
 8 1 31.08. 14 2 30.08. 10 1 
 9 2 30.08. 14 1 04.09. 15 2 
 10 2 28.08. 12 2 30.08. 10 2 
 9 2 29.08. 11 2 29.08. 10 2 
 9 1 29.08. 12 2 30.08. 11 3 
31.08. 10 2 04.09. 13 2 
29.08. 11 3 28.08. 9 2 
04.09. 13 2 
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 mutants 
  
 LD 
date of sowing: 29.09.06 
condition: LD 16 hours light per day
Col WT siz1a 
leaves leaves 
# date r c date r c 
1 07.11. 39 4 07.11. 6 4 
2 06.11. 36 4 08.11. 7 2 
3 06.11. 28 3 08.11. 6 4 
4 04.11. 34 5 09.11. 7 4 
5 06.11. 25 4 06.11. 12 3 
6 30.10. 25 4 06.11. 12 3 
7 04.11. 32 5 06.11. 7 4 
8 27.10. 9 2 31.10. 7 4 
9 29.10. 19 2 06.11. 7 3 
10 27.10. 16 2 06.11. 7 5 
11 06.11. 28 5 03.11. 14 3 
12 07.11. 39 6 04.11. 10 3 
13 08.11. 49 4 31.10. 13 3 
14 31.10. 21 4 31.10. 16 2 
15    31.10. 10 3 
16    31.10. 9 3 
17    02.11. 16 3 
 
  
Supplementary
 
 
  
 
siz1c siz1f pil1apil2b 
leaves leaves leaves 
date r c date r c date r c date
02.11. 12 2 06.11. 29 4 07.11. 28 4 04.11.
31.10. 14 3 07.11. 18 3 06.11. 37 4 08.11.
31.10. 15 4 08.11. 22 3 06.11. 26 4 10.11.
09.11. 6 2 07.11. 28 4 06.11. 26 3 06.11.
06.11. 5 3 06.11. 13 4 04.11. 26 3 07.11.
09.11. 8 3 09.11. 20 4 07.11. 28 5 08.11.
06.11. 5 3 02.11. 24 4 06.11. 29 4 30.10.
06.11. 5 4 31.10. 24 3 29.10. 16 3 30.10.
30.10. 19 3 02.11. 21 4 31.10. 18 4 30.10.
31.10. 17 4 03.11. 20 6 31.10. 25 4 02.11.
31.10. 11 3 03.11. 13 4 31.10. 16 3 31.10.
03.11. 6 3 04.11. 13 4 08.11. 24 5 07.11.
08.11. 5 2 04.11. 21 4 06.11. 22 4 08.11.
04.11. 9 4 31.10. 21 3 06.11. 41 5 07.11.
04.11. 10 3 06.11. 14 5 02.11. 17 4 06.11.
04.11. 15 4 06.11. 28 4 04.11. 32 6 06.11.
29.10. 8 2 08.11. 27 5 04.11. 27 6 06.11.
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 pil1cpil2a 
 leaves 
 r c 
 31 5 
 30 4 
 32 5 
 22 4 
 25 5 
 19 3 
 18 4 
 15 3 
 16 4 
 22 3 
 19 3 
 39 6 
 27 5 
 29 5 
 24 4 
 37 5 
 34 4 
  
 extended SD 
date of sowing: 03.08.06 
condition: LD 16 hours light per day
Col WT siz1a 
leaves leaves 
# date r c date r c 
1 19.09. 46 7 19.09. 27 6 19.09.
2 19.09. 47 7 13.09. 18 2 21.09.
3 19.09. 48 7 19.09. 36 8 19.09.
4 21.09. 44 6 13.09. 21 3 19.09.
5 19.09. 41 4 19.09. 35 5 19.09.
6 19.09. 46 5 22.09. 31 5 13.09.
7 19.09. 40 7 11.09. 18 0 19.09.
8 19.09. 43 8 19.09. 26 4 19.09.
9 15.09. 43 6 19.09. 29 4 19.09.
10 13.09. 36 5 19.09. 20 1 19.09.
11 19.09. 47 5 15.09. 26 5 15.09.
12 13.09. 41 5 19.09. 23 3 13.09.
13 15.09. 39 6 19.09. 23 3 19.09.
14 19.09. 35 7 19.09. 31 5 19.09.
15 19.09. 35 5 14.09. 18 4 19.09.
16 19.09. 40 6 19.09. 24 5 19.09.
17 19.09. 55 6 20.09. 37 6 21.09.
18 15.09. 37 6 19.09. 30 6 19.09.
19 20.09. 47 5 19.09. 41 6 19.09.
20 19.09. 37 7 19.09. 27 5 19.09.
21 19.09. 42 6 
 
  
Supplementary
 
siz1c pil1apil2b pil1cpil2a 
leaves leaves leaves 
date r c date r c date r c 
 26 6 19.09. 36 5 19.09. 43 6 
 46 5 14.09. 38 5 19.09. 48 6 
 35 5 14.09. 29 6 19.09. 40 5 
 30 6 19.09. 47 5 15.09. 43 5 
 25 5 15.09. 31 6 19.09. 39 6 
 18 1 15.09. 33 6 19.09. 40 6 
 31 5 15.09. 41 6 19.09. 40 6 
 35 2 15.09. 33 6 19.09. 43 7 
 24 5 14.09. 28 5 19.09. 48 6 
 30 5 14.09. 31 5 19.09. 49 6 
 27 5 19.09. 38 7 19.09. 50 6 
 20 3 19.09. 47 6 19.09. 44 6 
 30 4 19.09. 38 7 19.09. 54 7 
 39 4 19.09. 40 5 19.09. 53 8 
 30 4 19.09. 38 6 20.09. 50 6 
 32 4 19.09. 35 9 19.09. 44 6 
 47 5 19.09. 41 6 19.09. 50 6 
 35 4 15.09. 41 7 19.09. 40 6 
 35 5 19.09. 35 6 20.09. 51 7 
 28 3 19.09. 32 6 19.09. 45 6 
15.09. 35 4 19.09. 42 6 
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 SD 
date of sowing: 29.09.06 
condition: SD 8 hours light per day 
Col WT siz1a 
leaves leaves 
# date r c date r c 
1 04.12. 89 9 29.12. 55 7 03.01.
2 05.12. 85 8 26.12. 43 4 12.01.
3 04.12. 86 10 11.12. 15 6 04.12.
4 12.11. 37 5 09.01. 94 6 12.12.
5 12.11. 38 5 15.12. 37 4 29.12.
6 08.12. 85 7 01.01. 65 7 22.01.
7 14.11. 49 5 12.12. 34 3 11.01.
8 15.11. 38 5 26.12. 43 5 22.01.
9 05.12. 82 8 20.12. 60 7 04.01.
10 05.12. 79 9 11.01. 87 7 26.12.
11 09.11. 34 5 01.01. 71 8 01.12.
12 11.12. 88 10 14.12. 60 5 22.12.
13 13.11. 43 5 30.11. 41 6 13.12.
14 18.11. 51 3 22.12. 51 3 09.01.
15    12.12. 31 6 13.12.
16       11.12.
17        
 
 
The original data for the flowering time determination of the different SUMO ligase mutants are 
shown above. Rosette leaves (r) and cauline leaves (c) were counted at the opening of the first 
flower bud. 
 
 
Supplementary
 
 
 
 
siz1c siz1f pil1apil2b  
leaves leaves leaves  
date r c date r c date r c date
 76 5 19.12. 96 10 04.12. 101 8 01.12.
 40 6 12.12. 88 12 12.12. 111 8 01.12.
 57 5 15.12. 89 11 18.12. 77 11 06.12.
 58 6 13.12. 89 11 11.12. 70 10 06.12.
 48 3 22.12. 94 11 05.12. 82 9 04.12.
 100 4 29.12. 70 4 04.12. 81 8 01.12.
 45 4 11.12. 78 11 06.12. 90 8 07.12.
 99 4 01.01. 106 11 01.12. 95 8 09.12.
 56 6 11.12. 83 7 08.12. 93 9 30.11.
 66 5 14.12. 95 8 04.12. 70 8 04.12.
 65 5 18.12. 117 10 04.12. 73 9 01.12.
 58 6 04.01. 94 5 01.12. 81 8 04.12.
 87 8 29.12. 91 9 08.12. 86 10 04.12.
 64 6 01.01. 104 11 04.12. 89 9 14.12.
 32 6 10.12. 100 10 30.11. 92 7 11.12.
 40 6 11.12. 79 10 28.11. 94 8 15.12.
     28.11. 93 8 04.12.
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pil1cpil2a 
leaves 
 r c 
 82 9 
 109 9 
 100 10 
 109 11 
 109 8 
 78 9 
 96 8 
 96 9 
 91 8 
 103 8 
 87 9 
 81 8 
 72 8 
 101 8 
 80 10 
 98 8 
 75 10 
  
8.2.2  Data of flowering time experiments of 
 
 LD 
date of sowing: 10.03.08 
condition: LD 16 hours light per day
Col WT WS WT
leaves leaves
# date r c date r 
1 10.04. 13 3 02.04. 6 
2 13.04. 10 3 05.04. 11 
3 09.04. 11 3 07.04. 8 
4 12.04. 13 2 05.04. 9 
5 14.04. 13 3 07.04. 9 
6 10.04. 12 3 04.04. 9 
7 08.04. 14 2 03.04. 9 
8 10.04. 11 3 03.04. 8 
9 15.04. 15 3 07.04. 13 
10 12.04. 10 2 05.04. 9 
11 13.04. 12 2 05.04. 6 
12 
 
 LD 
date of sowing: 05.05.08 
condition: LD 16 hours light per day
Col WT WS WT
leaves leaves
# date r c date r 
1 07.06. 27 2 05.06. 10 
2 10.06. 16 4 05.06. 10 
3 05.06. 15 3 05.06. 12 
4 09.06. 14 3 05.06. 8 
5 07.06. 13 3 05.06. 8 
6 10.06. 13 3 05.06. 8 
7 09.06. 13 3 05.06. 9 
8 07.06. 11 2 05.06. 9 
9 05.06. 12 3 07.06. 11 
10 07.06. 13 3 05.06. 11 
11 08.06. 11 2 
12 
 
 
Supplementary
el1 mutants 
 
 el1a  el1b el1c 
 leaves leaves leaves
c date R c date r c date r c
2 07.04. 10 7 12.04. 12 3 09.04. 12 3
3 12.04. 9 9 14.04. 15 4 12.04. 13 3
3 07.04. 10 6 10.04. 10 3 12.04. 14 3
3 08.04. 10 7 12.04. 14 3 09.04. 9 3
3 05.04. 10 6 12.04. 12 2 09.04. 8 3
2 12.04. 10 6 08.04. 12 2 07.04. 11 3
3 07.04. 10 6 08.04. 11 2 08.04. 13 3
3 05.04. 9 8 07.04. 14 3 12.04. 11 2
3 10.04. 11 6 12.04. 13 2 10.04. 10 2
3 07.04. 8 5 09.04. 13 3 12.04. 12 2
5 12.04. 9 6 12.04. 13 2 09.04. 9 3
07.04. 9 6 10.04. 9 2 
  
 
 el1a  el1b el1c 
 leaves leaves leaves
c date R c date r c date r c
3 05.06. 9 2 10.06. 17 3 10.06. 19 4
3 07.06. 11 3 12.06. 17 4 11.06. 19 4
3 05.06. 10 3 12.06. 22 4 12.06. 14 3
4 05.06. 11 3 07.06. 17 3 08.06. 20 4
3 07.06. 11 3 13.06. 18 4 13.06. 13 4
4 07.06. 11 3 12.06. 15 4 11.06. 20 5
3 07.06. 12 3 08.06. 12 3 10.06. 14 4
3 05.06. 12 2 08.06. 18 3 05.06. 13 3
3 05.06. 10 2 10.06. 13 4 06.06. 13 3
4 05.06. 11 2 13.06. 11 3 13.06. 15 3
05.06. 11 3 06.06. 12 3 08.06. 13 3
05.06. 11 3 07.06. 18 4 11.06. 11 2
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 siz1f 
  leaves 
 date r c 
 10.04. 11 4 
 10.04. 10 4 
 12.04. 9 2 
 10.04. 11 3 
 08.04. 11 3 
 08.04. 11 2 
 10.04. 11 2 
 10.04. 8 3 
 08.04. 10 3 
 07.04. 11 2 
 09.04. 9 3 
 
   
   
   
 siz1f 
  leaves 
 date r c 
 08.06. 13 4 
 07.06. 15 4 
 08.06. 17 4 
 07.06. 11 4 
 07.06. 21 3 
 05.06. 11 3 
 07.06. 10 2 
 08.06. 15 3 
 07.06. 9 3 
 06.06. 11 3 
 07.06. 14 3 
 07.06. 12 3 
  
 SD 
date of sowing: 05.05.08 
condition: SD 8 hours light per day 
Col WT WS WT
leaves leaves
# date r c date r 
1 28.07. 99 9 11.07. 71 
2 21.07. 92 6 05.07. 63 
3 14.07. 55 15 28.07. 84 
4 05.07. 108 9 18.07. 69 
5 08.07. 52 11 15.07. 86 
6 07.07. 29 12 18.07. 96 
7 09.07. 73 13 27.06. 111 
8 09.07. 69 12 17.07. 12 
9 13.07. 18 
10 07.07. 37 
11 08.07. 46 
 
 
 
 
 
  
Supplementary
 el1a  el1b el1c 
 leaves leaves leaves
c date R c date r c date r c
8 13.07. 63 7 05.07. 105 9 30.07. 113 7
6 17.07. 20 5 28.07. 77 10 11.08. 83 8
9 13.07. 83 7 11.08. 100 9 19.07. 105 9
8 13.07. 68 8 13.07. 65 15 30.07. 86 8
7 10.07. 60 7 08.07. 56 11 15.07. 56 14
7 10.07. 36 6 14.07. 49 16 14.07. 82 16
8 07.07. 20 4 30.07. 31 2 07.07. 99 11
7 07.07. 45 7 17.07. 33 12 13.07. 56 15
8 30.06. 82 3 13.07. 63 15 17.07. 42 13
8 09.07. 16 4 09.07. 66 12
8 07.07. 45 6 
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 siz1f 
  leaves 
 date r c 
 07.08. 64 8 
 29.07. 63 8 
 18.07. 22 11 
 18.07. 31 12 
 19.07. 28 10 
 17.07. 41 15 
 13.07. 65 12 
 14.07. 46 10 
 13.07. 36 10 
    
   
  
8.3 Data analysis with SigmaPlot 10 and SigmaStat3
In the following, the data analysis of the flowering time experiments for the 
and pil mutants is shown that was c
 
Table 8.3: Data of flowering time analysis of different SUMO ligase
 
 LD 
One Way Analysis of Variance 
Dependent Variable: Rosette leaves  
Normality Test:  Failed (P < 0.050) 
Group Name  N 
Col WT 21 
siz1a 9 
siz1c 18 
pil1apil2b 20 
pil1cpil2a 21 
Source of Variation DF 
Between Groups 4 
Residual 84 
Total 88 
The differences in the mean values among the treatment groups are greater than would be expected by 
chance; there is a statistically significant difference
Power of performed test with alpha = 0.050: 0.890
All Pairwise Multiple Comparison Procedures (Holm
Comparisons for factor: Genotype 
Comparison Diff of Means
Col WT vs. siz1c 1.952
pil1cpil2a vs. siz1c 1.667
pil1apil2b vs. siz1c 1.617
siz1a vs. siz1c 1.778
Col WT vs. pil1apil2b 0.336
Col WT vs. pil1cpil2a 0.286
Col WT vs. siz1a 0.175
siz1a vs. pil1apil2b 0.161
siz1a vs. pil1cpil2a 0.111
pil1cpil2a vs. pil1apil2b 0.0500
Supplementary
onducted with SigmaPlot 10 and SigmaStat3.
Equal Variance Test: Passed (P = 0.471)
Missing Mean Std Dev 
0 11.286 1.454 
0 11.111 1.691 
0 9.333 1.328 
0 10.950 1.638 
0 11.000 1.581 
SS MS F 
45.403 11.351 4.862 
196.125 2.335  
241.528   
 (P = 0.001). 
 
-Sidak method): Overall significance level = 0.01
 T Unadjusted P Critical Level 
 3.978 0.000147 0.001 
 3.396 0.00105 0.001 
 3.257 0.00163 0.001 
 2.850 0.00550 0.001 
 0.703 0.484 0.002 
 0.606 0.546 0.002 
 0.287 0.775 0.003 
 0.263 0.793 0.003 
 0.183 0.856 0.005 
 0.105 0.917 0.010 
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siz1 
 
 mutants 
 
SEM 
0.317 
0.564 
0.313 
0.366 
0.345 
P 
0.001 
 
 
 
Significant? 
Yes 
Yes 
No 
No 
No 
No 
No 
No 
No 
No 
 
  
 LD 
One Way Analysis of Variance 
Dependent Variable: Cauline leaves 
Normality Test:  Failed (P < 0.050) 
Group Name  N 
Col WT 21 
siz1a 9 
siz1c 18 
pil1apil2b 20 
pil1cpil2a 21 
Source of Variation DF 
Between Groups 4 
Residual 84 
Total 88 
The differences in the mean values among the treatment groups are greater than would be expected by 
chance; there is a statistically significant difference
Power of performed test with alpha = 0.050: 0.525
All Pairwise Multiple Comparison Procedures (Holm
Comparisons for factor: Genotype 
Comparison Diff of Means
pil1apil2b vs. Col WT 0.581
pil1apil2b vs. siz1c 0.478
pil1cpil2a vs. Col WT 0.429
pil1apil2b vs. siz1a 0.533
pil1cpil2a vs. siz1c 0.325
pil1cpil2a vs. siz1a 0.381
pil1apil2b vs. pil1cpil2a 0.152
siz1c vs. Col WT 0.103
siz1c vs. siz1a 0.0556
siz1a vs. Col WT 0.0476
 
  
 
  
Supplementary
 
Equal Variance Test: Failed (P < 0.050)
Missing Mean Std Dev 
0 1.619 0.805 
0 1.667 1.000 
0 1.722 0.575 
0 2.200 0.523 
0 2.048 0.498 
SS MS F 
4.925 1.231 2.817 
36.716 0.437  
41.640   
 (P = 0.030). 
 
-Sidak method):Overall significance level = 0.01
 T Unadjusted P Critical Level 
 2.812 0.00612 0.001 
 2.224 0.0288 0.001 
 2.101 0.0387 0.001 
 2.010 0.0477 0.001 
 1.532 0.129 0.002 
 1.446 0.152 0.002 
 0.738 0.463 0.003 
 0.486 0.628 0.003 
 0.206 0.837 0.005 
 0.181 0.857 0.010 
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SEM 
0.176 
0.333 
0.135 
0.117 
0.109 
P 
0.030 
 
 
 
Significant? 
No 
No 
No 
No 
No 
No 
No 
No 
No 
No 
  
 LD 
One Way Analysis of Variance 
Dependent Variable: Rosette leaves  
Normality Test: Passed (P = 0.235) 
Group Name  N 
Col WT 14 
siz1a 17 
siz1c 17 
siz1f 17 
pil1apil2b 17 
pil1cpil2a 17 
Source of Variation DF 
Between Groups 5 
Residual 93 
Total 98 
The differences in the mean values among the treatment groups 
chance; there is a statistically significant difference
Power of performed test with alpha = 0.050: 1.000
All Pairwise Multiple Comparison Procedures (Holm
Comparisons for factor: Genotype 
Comparison Diff of Means
Col WT vs. siz1a 18.807
Col WT vs. siz1c 18.571
pil1cpil2a vs. siz1a 16.059
pil1apil2b vs. siz1a 16.000
pil1cpil2a vs. siz1c 15.824
pil1apil2b vs. siz1c 15.765
siz1f vs. siz1a 11.176
siz1f vs. siz1c 10.941
Col WT vs. siz1f 7.630
pil1cpil2a vs. siz1f 4.882
pil1apil2b vs. siz1f 4.824
Col WT vs. pil1apil2b 2.807
Col WT vs. pil1cpil2a 2.748
siz1c vs. siz1a 0.235
pil1cpil2a vs. pil1apil2b 0.0588
 
 
Supplementary
Equal Variance Test: Failed (P < 0.050)
Missing Mean Std Dev 
0 28.571 10.552 
0 9.765 3.456 
0 10.000 4.623 
0 20.941 5.414 
0 25.765 6.915 
0 25.824 7.333 
SS MS F 
5664.820 1132.964 25.857 
4074.958 43.817  
9739.778   
are greater than would be expected by 
 (P = <0.001). 
 
-Sidak method):Overall significance level = 0.01
 T Unadjusted P Critical Level 
 7.872 6.259E-012 0.001 
 7.774 1.003E-011 0.001 
 7.073 0.000000000278 0.001 
 7.047 0.000000000314 0.001 
 6.969 0.000000000451 0.001 
 6.943 0.000000000509 0.001 
 4.923 0.00000369 0.001 
 4.819 0.00000560 0.001 
 3.194 0.00192 0.001 
 2.150 0.0341 0.002 
 2.124 0.0363 0.002 
 1.175 0.243 0.003 
 1.150 0.253 0.003 
 0.104 0.918 0.005 
 0.0259 0.979 0.010 
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SEM 
2.820 
0.838 
1.121 
1.313 
1.677 
1.779 
P 
<0.001 
 
 
 
Significant? 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
No 
No 
No 
No 
No 
No 
No 
  
 LD 
One Way Analysis of Variance 
Dependent Variable: Cauline leaves 
Normality Test: Failed (P < 0.050) 
Group Name  N 
Col WT 14 
siz1a 17 
siz1c 17 
siz1f 17 
pil1apil2b 17 
pil1cpil2a 17 
Source of Variation DF 
Between Groups 5 
Residual 93 
Total 98 
The differences in the mean values among the treatment groups are greater than would be expected by 
chance; there is a statistically significant difference
Power of performed test with alpha = 0.050: 0.940
All Pairwise Multiple Comparison Procedures (Holm
Comparisons for factor: Genotype 
Comparison Diff of 
pil1cpil2a vs. siz1c 1.176
pil1apil2b vs. siz1c 1.118
siz1f vs. siz1c 0.941
pil1cpil2a vs. siz1a 0.941
pil1apil2b vs. siz1a 0.882
Col WT vs. siz1c 0.798
siz1f vs. siz1a 0.706
Col WT vs. siz1a 0.563
pil1cpil2a vs. Col WT 0.378
pil1apil2b vs. Col WT 0.319
pil1cpil2a vs. siz1f 0.235
siz1a vs. siz1c 0.235
pil1apil2b vs. siz1f 0.176
siz1f vs. Col WT 0.143
pil1cpil2a vs. pil1apil2b 0.0588
 
  
Supplementary
 
Equal Variance Test: Passed (P = 0.627)
Missing Mean Std Dev 
0 3.857 1.231 
0 3.294 0.772 
0 3.059 0.748 
0 4.000 0.791 
0 4.176 0.951 
0 4.235 0.903 
SS MS F 
19.942 3.988 4.899 
75.714 0.814  
95.657   
 (P = <0.001). 
 
-Sidak method):Overall significance level = 0.01
Means T Unadjusted P Critical Level 
 3.801 0.000257 0.001 
 3.611 0.000494 0.001 
 3.041 0.00306 0.001 
 3.041 0.00306 0.001 
 2.851 0.00537 0.001 
 2.452 0.0161 0.001 
 2.281 0.0248 0.001 
 1.729 0.0871 0.001 
 1.161 0.249 0.001 
 0.981 0.329 0.002 
 0.760 0.449 0.002 
 0.760 0.449 0.003 
 0.570 0.570 0.003 
 0.439 0.662 0.005 
 0.190 0.850 0.010 
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SEM 
0.329 
0.187 
0.181 
0.192 
0.231 
0.219 
P 
<0.001 
 
 
 
Significant? 
Yes 
Yes 
No 
No 
No 
No 
No 
No 
No 
No 
No 
No 
No 
No 
No 
  
 extended SD 
One Way Analysis of Variance 
Dependent Variable: Rosette leaves  
Normality Test:  Passed (P = 0.055) 
Group Name  N 
Col WT 21 
siz1a 21 
siz1c 21 
pil1apil2b 21 
pil1cpil2a 21 
Source of Variation DF 
Between Groups 4 
Residual 100 
Total 104 
The differences in the mean values among the treatment groups are greater than would be expected by 
chance; there is a statistically significant difference
Power of performed test with alpha = 0.050: 1.000
All Pairwise Multiple Comparison Procedures (Holm
Comparisons for factor: Genotype 
Comparison Diff of Means
pil1cpil2a vs. siz1a 17.381
pil1cpil2a vs. siz1c 14.667
Col WT vs. siz1a 14.190
Col WT vs. siz1c 11.476
pil1cpil2a vs. pil1apil2b 9.000
pil1apil2b vs. siz1a 8.381
Col WT vs. pil1apil2b 5.810
pil1apil2b vs. siz1c 5.667
pil1cpil2a vs. Col WT 3.190
siz1c vs. siz1a 2.714
 
 
  
Supplementary
Equal Variance Test: Passed (P = 0.289)
Missing Mean Std Dev 
0 42.333 5.092 
0 28.143 8.242 
0 30.857 7.330 
0 36.524 5.212 
0 45.524 4.708 
SS MS F 
4556.705 1139.176 28.926 
3938.286 39.383  
8494.990   
 (P = <0.001). 
 
-Sidak method):Overall significance level = 0.01
 T Unadjusted P Critical Level 
 8.975 1.746E-014 0.001 
 7.573 1.859E-011 0.001 
 7.327 6.161E-011 0.001 
 5.926 0.0000000444 0.001 
 4.647 0.0000103 0.002 
 4.327 0.0000358 0.002 
 3.000 0.00341 0.003 
 2.926 0.00425 0.003 
 1.647 0.103 0.005 
 1.402 0.164 0.010 
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SEM 
1.111 
1.799 
1.600 
1.137 
1.027 
P 
<0.001 
 
 
 
Significant? 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
No 
No 
No 
No 
  
 extended SD 
One Way Analysis of Variance 
Dependent Variable: Cauline leaves 
Normality Test: Failed (P < 0.050) 
Group Name  N 
Col WT 21 
siz1a 21 
siz1c 21 
pil1apil2b 21 
pil1cpil2a 21 
Source of Variation DF 
Between Groups 4 
Residual 100 
Total 104 
The differences in the mean values among the treatment groups are
chance; there is a statistically significant difference
Power of performed test with alpha = 0.050: 1.000
All Pairwise Multiple Comparison Procedures (Holm
Comparisons for factor: Genotype 
Comparison Diff of Means
pil1cpil2a vs. siz1c 1.810
pil1cpil2a vs. siz1a 1.762
Col WT vs. siz1c 1.667
Col WT vs. siz1a 1.619
pil1apil2b vs. siz1c 1.571
pil1apil2b vs. siz1a 1.524
pil1cpil2a vs. pil1apil2b 0.238
pil1cpil2a vs. Col WT 0.143
Col WT vs. pil1apil2b 0.0952
siz1a vs. siz1c 0.0476
 
  
  
Supplementary
 
Equal Variance Test: Failed (P < 0.050)
Missing Mean Std Dev 
0 6.000 1.000 
0 4.381 1.884 
0 4.333 1.238 
0 5.905 1.044 
0 6.143 0.655 
SS MS F 
69.962 17.490 11.507 
152.000 1.520  
221.962   
 greater than would be expected by 
 (P = <0.001). 
 
-Sidak method):Overall significance level = 0.01
 T Unadjusted P Critical Level
 4.756 0.00000665 0.001 
 4.631 0.0000110 0.001 
 4.380 0.0000292 0.001 
 4.255 0.0000471 0.001 
 4.130 0.0000753 0.002 
 4.005 0.000119 0.002 
 0.626 0.533 0.003 
 0.375 0.708 0.003 
 0.250 0.803 0.005 
 0.125 0.901 0.010 
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SEM 
0.218 
0.411 
0.270 
0.228 
0.143 
P 
<0.001 
 
 
 
 Significant? 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
No 
No 
No 
No 
  
 SD 
One Way Analysis of Variance 
Dependent Variable: Rosette leaves  
Normality Test: Passed (P = 0.636) 
Group Name  N 
Col WT 14 
siz1a 15 
siz1c 16 
siz1f 16 
pil1apil2b 17 
pil1cpil2a 17 
Source of Variation DF 
Between Groups 5 
Residual 89 
Total 94 
The differences in the mean values among the treatment groups are greater than would be expected by 
chance; there is a statistically significant difference
Power of performed test with alpha = 0.050: 1.000
All Pairwise Multiple Comparison Procedures (Holm
Comparisons for factor: Genotype 
Comparison Diff of Means
pil1cpil2a vs. siz1a 39.710
siz1f vs. siz1a 39.596
pil1apil2b vs. siz1a 34.475
pil1cpil2a vs. siz1c 30.239
siz1f vs. siz1c 30.125
pil1cpil2a vs. Col WT 29.034
siz1f vs. Col WT 28.920
pil1apil2b vs. siz1c 25.004
pil1apil2b vs. Col WT 23.798
Col WT vs. siz1a 10.676
siz1c vs. siz1a 9.471
pil1cpil2a vs. pil1apil2b 5.235
siz1f vs. pil1apil2b 5.121
Col WT vs. siz1c 1.205
pil1cpil2a vs. siz1f 0.114
 
  
Supplementary
Equal Variance Test: Failed (P < 
Missing Mean Std Dev 
0 63.143 23.075 
0 52.467 21.206 
0 61.938 20.181 
0 92.063 11.625 
0 86.941 11.088 
0 92.176 12.441 
SS MS F 
24380.424 4876.085 16.823 
25796.734 289.851  
50177.158   
 (P = <0.001). 
 
-Sidak method):Overall significance level = 0.01
 t Unadjusted P Critical Level 
 6.584 0.00000000309 0.001 
 6.471 0.00000000514 0.001 
 5.716 0.000000143 0.001 
 5.099 0.00000191 0.001 
 5.005 0.00000280 0.001 
 4.725 0.00000854 0.001 
 4.642 0.0000118 0.001 
 4.216 0.0000595 0.001 
 3.873 0.000205 0.001 
 1.687 0.0950 0.002 
 1.548 0.125 0.002 
 0.897 0.372 0.003 
 0.864 0.390 0.003 
 0.193 0.847 0.005 
 0.0192 0.985 0.010 
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0.050) 
SEM 
6.167 
5.475 
5.045 
2.906 
2.689 
3.017 
P 
<0.001 
 
 
 
Significant? 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
No 
No 
No 
No 
No 
No 
  
 SD 
One Way Analysis of Variance 
Dependent Variable: Cauline leaves 
Normality Test: Failed (P < 0.050)) 
Group Name  N 
Col WT 14 
siz1a 15 
siz1c 16 
siz1f 16 
pil1apil2b 17 
pil1cpil2a 17 
Source of Variation DF 
Between Groups 5 
Residual 89 
Total 94 
The differences in the mean values among the treatment groups are greater than would be expected by 
chance; there is a statistically significant difference
Power of performed test with alpha = 0.050: 1.000
All Pairwise Multiple Comparison Procedures (Holm
Comparisons for factor: Genotype 
Comparison Diff of Means
siz1f vs. siz1c 4.125
siz1f vs. siz1a 3.838
pil1cpil2a vs. siz1c 3.511
pil1apil2b vs. siz1c 3.276
pil1cpil2a vs. siz1a 3.224
pil1apil2b vs. siz1a 2.988
siz1f vs. Col WT 2.723
pil1cpil2a vs. Col WT 2.109
pil1apil2b vs. Col WT 1.874
Col WT vs. siz1c 1.402
Col WT vs. siz1a 1.114
siz1f vs. pil1apil2b 0.849
siz1f vs. pil1cpil2a 0.614
siz1a vs. siz1c 0.287
pil1cpil2a vs. pil1apil2b 0.235
 
 
Supplementary
 
Equal Variance Test: Passed (P = 0.121)
Missing Mean Std Dev 
0 6.714 2.268 
0 5.600 1.549 
0 5.313 1.195 
0 9.438 2.308 
0 8.588 1.004 
0 8.824 0.951 
SS MS F 
249.264 49.853 19.090 
232.420 2.611  
481.684   
 (P = <0.001). 
 
-Sidak method):Overall significance level = 0.01
 t Unadjusted P Critical Level 
 7.220 0.000000000168 0.001 
 6.607 0.00000000278 0.001 
 6.238 0.0000000146 0.001 
 5.820 0.0000000916 0.001 
 5.631 0.000000206 0.001 
 5.220 0.00000116 0.001 
 4.605 0.0000137 0.001 
 3.617 0.000495 0.001 
 3.213 0.00183 0.001 
 2.370 0.0199 0.002 
 1.856 0.0668 0.002 
 1.509 0.135 0.003 
 1.091 0.278 0.003 
 0.495 0.622 0.005 
 0.425 0.672 0.010 
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SEM 
0.606 
0.400 
0.299 
0.577 
0.243 
0.231 
P 
<0.001 
 
 
 
Significant? 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
Yes 
No 
No 
No 
No 
No 
No 
No 
  
Table 8.4: Data of flowering time analysis of 
 
 LD 
One Way Analysis of Variance 
Dependent Variable: Rosette leaves  
Normality Test:  Failed (P < 0.050) 
Group Name  N 
Col WT 11 
WS WT 11 
el1a 12 
el1b 12 
el1c 11 
siz1f 11 
Source of Variation DF 
Between Groups 5 
Residual 62 
Total 67 
The differences in the mean values among the treatment groups are greater than would be expected by 
chance; there is a statistically significant difference
Power of performed test with alpha = 0.050: 1.000
All Pairwise Multiple Comparison Procedures (Holm
Comparisons for factor: Genotype 
Comparison Diff of 
el1b vs. WS WT 3.515
Col WT vs. WS WT 3.364
el1b vs. el1a1 2.750
Col WT vs. el1a 2.598
el1c vs. WS WT 2.273
el1b vs. siz1f 2.152
Col WT vs. siz1f 2.000
el1c vs. el1a1 1.508
siz1f vs. WS WT 1.364
el1b vs. el1c3 1.242
Col WT vs. el1c 1.091
el1c vs. siz1f 0.909
el11a vs. WS WT 0.765
siz1f vs. el1a 0.598
el1b vs. Col WT 0.152
 
 
 
 
 
 
Supplementary
el1 mutants 
Equal Variance Test: Failed (P < 0.050)
Missing Mean Std Dev 
0 12.182 1.601 
0 8.818 1.991 
0 9.583 0.793 
0 12.333 1.723 
0 11.091 1.921 
0 10.182 1.079 
SS MS F 
114.716 22.943 9.273 
153.402 2.474  
268.118   
 (P = <0.001). 
 
-Sidak method): Overall significance level = 0.01
Means t Unadjusted P Critical Level 
 5.354 0.00000133 0.001 
 5.015 0.00000472 0.001 
 4.282 0.0000654 0.001 
 3.958 0.000198 0.001 
 3.389 0.00123 0.001 
 3.277 0.00172 0.001 
 2.982 0.00409 0.001 
 2.296 0.0251 0.001 
 2.033 0.0463 0.001 
 1.892 0.0631 0.002 
 1.626 0.109 0.002 
 1.355 0.180 0.003 
 1.165 0.248 0.003 
 0.912 0.366 0.005 
 0.231 0.818 0.010 
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SEM 
0.483 
0.600 
0.229 
0.497 
0.579 
0.325 
P 
<0.001 
 
 
 
Significant? 
Yes 
Yes 
Yes 
Yes 
No 
No 
No 
No 
No 
No 
No 
No 
No 
No 
No 
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